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Abstract: 1 Summary The kidney regulates the body’s fluid volume, mineral composition and acidity by
excretion and reabsorption of electrolytes and water. The ability of the kidney to regulate salt home-
ostasis and extracellular fluid volume is crucial for blood pressure maintenance. The mineralocorticoid
hormone aldosterone adjusts salt homeostasis largely by regulating sodium reabsorption across principal
cells of the aldosterone-sensitive distal nephron (ASDN). The stimulatory action of aldosterone on sodium
reabsorption in the distal nephron has been shown to depend mainly on transcriptional regulation that
is mediated by the activation of the mineralocorticoid receptor, a member of the family of nuclear recep-
tors. Early genomic effects on sodium reabsorption are thought to be mediated mostly by the induction
or repression of elements of the regulatory pathways that control the function of preexisting epithelial
sodium channel (ENaC), sodium potassium pump (Na+-K+-ATPase) and potassium channel (ROMK).
Aldosterone regulates the cell-surface expression and function and subsequent internalization of ENaC in
its target cells partly by the transcriptional induction of the serum- and glucocorticoid-regulated kinase 1
(Sgk1). This kinase prevents the ubiquitylation of ENaC by phosphorylating the ubiquitin ligase Nedd4-2.
The aim of my project was to investigate the mechanism by which the early aldosterone- induced changes
in gene expression impact on sodium and potassium transport in aldosterone target cells in the kidney.
A microarray of RNA extracted from mouse epithelial cells of the ASDN had identified 22 significantly
and more than two-fold early aldosterone-regulated RNA in vivo. The focus of this work was on three
of these significantly up-regulated gene products: the ubiquitin-specific proteases Usp2 and Usp53 and
the voltage gated proton channel Hv1. In exogenous gene expression systems like Xenopus laevis oocytes
and cultured mouse cortical collecting duct cells their impact on channels and transporters involved in
the sodium absorption in the collecting duct was investigated using electrophysiological techniques. A
pronounced induction of ENaC mediated currents by the co-expression of the Usp2 isoform Usp2-45 was
detected using two-electrode voltage-clamp recordings. The stimulatory effect on ENaC was not additive
to that of Sgk1. This suggests that Usp2-45 1 acts on the same regulatory pathway as Sgk1, namely
the ubiquitylation/deubiquitylation of ENaC. The stimulation of ENaC is further due to the catalytic
action of Usp2-45 since substitution of Cys67 with Ala within the catalytic site of Usp2-45 abolished
its effect. Further experiments performed in cultured human embryonic kidney cells showed that indeed
Usp2-45 deubiquitylates and thereby activates ENaC. Another ubiquitin-specific protease, Usp53 was
significantly up-regulated in the mouse distal nephron. Experiments aiming at investigating the pos-
sible impact of Usp53 on sodium transport molecules (ENaC, Na+-K+-ATPase) expressed in Xenopus
laevis oocytes were inconclusive and the role of Usp53 in regulating salt reabsorption remains elusive.
The third investigated gene product, a voltage gated proton channel (Hv1) structurally resembles the
voltage sensor of typical voltage gated channels of the S4-family. Hv1 substantially decreases ENaC and
ROMK function in oocytes which appears contradictory to the fact that it is up-regulated by aldosterone.
However, early up- regulation of a voltage gated proton channel in the ASDN could be essential in the
regulatory control of salt reabsorption fine tuning by aldosterone. 2 2. Die Nieren sind für die Aufrechter-
haltung des Flüssigkeitsvolumens, der Salzzusammensetzung und des Säure-Base-Haushaltes des Körpers
zuständig. Dies geschieht durch Ausscheidung und Reabsorption von Elektrolyten und Wasser. Die
Regulierung des Salzhaushaltes und des Volumens der extrazellulären Flüssigkeit ist für die Aufrechter-
haltung des Blutdrucks essentiell. Das Mineralokortikoidhormon Aldosteron regelt den Salzhaushalt vor
allem durch die Stimulation der Natriumrückresorption durch die Hauptzellen des Aldosteron sensitiven
distalen Nephrons (ASDN). Die Wirkung von Aldosteron auf die Rückresorption von Natrium im dis-
talen Nephron hängt vor allem von der Regulierung der Transkription ab. Diese Aufgabe übernimmt
der Mineralokortikoidrezeptor, der zur Familie der nukleären Rezeptoren gehört und durch Aldosteron
aktiviert wird. Rasche Änderungen der Transkription wirken sich innerhalb kurzer Zeit auf die Natrium-
rückresorption aus. Dies wird grösstenteils durch die transkriptionelle Aktivierung und Repression von
regulatorischen Faktoren erreicht, die die Funktion von bereits vorhandenen Natriumkanälen (ENaC),
Natriumpumpen (Na+- K+-ATPase) und Kaliumkanälen (ROMK) regulieren. Es ist bekannt, dass die
Oberflächenexpression und die Funktion von ENaC teilweise durch die transkriptionelle Aktivierung von
Sgk1 gesteigert werden. Sgk1 ist eine Kinase, welche die Ubiquitylierung von ENaC verhindert, indem sie
die Ubiquitin Ligase Nedd4-2 phosphoryliert und so deren Funktion inhibiert. Das Ziel meines Projek-
tes war es, Mechanismen zu untersuchen, durch welche frühe Aldosteron-induzierte Veränderungen der
Genexpression zur Regulation von Natrium und Kalium Transport in Aldosteron Zielzellen führen. Mit
Hilfe eines RNA-Microarrays konnten 22 mRNAs identifiziert werden, die in Epithelialzellen des ASDN
durch Aldosteron mehr als zweifach hochreguliert sind. Im Fokus dieser Arbeit lagen drei dieser Genpro-
dukte: Die Ubiquitinproteasen Usp2 und Usp53 und ein spannungsabhängiger Protonenkanal (Hv1). Ihr
Einfluss auf Kanäle und Transporter, die bei der Natriumrückresorption wichtig sind, wurde vor allem
anhand von elektrophysiologischen Methoden an Expressionsystemen wie Xenopus laevis Oozyten 3 und
kultivierten Sammelrohrzellen aus der Maus untersucht. Elektrophysiologische Messungen an koexprim-
ierenden X. laevis Oozyten zeigten, dass die Funktion von ENaC durch eine Isoform von Usp2 (Usp2-45)
signifikant verstärkt wird. Dieser stimulierende Effekt von Usp2-45 auf ENaC ist nicht additiv zu dem
bereits beschriebenen Effekt von Sgk1. Das bedeutet, dass Usp2-45 in dem Selben Regulationsmechanis-
mus eingebunden ist wie Sgk1, nämlich Ubiquitylierung / Deubiquitylierung. Es konnte weiterhin gezeigt
werden, dass die Stimulierung von ENaC auf die katalytische Aktivität von Usp2-45 zurückzuführen ist,
da durch die Cys67Ala Substitution im katalytischen Zentrum der stimulatorische Effekt von Usp2-45
ausblieb. Weitere Experimente mit kultivierten menschlichen embryonalen Nierenzellen wiesen darauf
hin, dass Usp2-45 ENaC in der Tat deubiquityliert und dadurch aktiviert. Im distalen Nephron der
Maus ist die mRNA Expression von Usp53, einer weiteren Ubiquitinprotease, ebenfalls durch Aldosteron
signifikant hochreguliert. Experimente zur Erforschung ihres möglichen Einflusses auf Natriumtransport-
moleküle wurden in X. laevis Oozyten durchgeführt. Die Ergebnisse waren jedoch kontrovers und es
bleibt unklar, welche Rolle Usp53 bei der Regulation der Salzrückresorption spielt. Ferner wurde ein
Genprodukt untersucht, welches einen spannungsabhängigen Protonenkanal (Hv1) kodiert. Dieser weist
eine strukturelle Ähnlichkeit zu dem Sensordomäne von typischen spannungsabhängigen Ionenkanälen
der S4 Familie auf. Werden die beiden Ionenkanäle ENaC und ROMK zusammen mit Hv1 exprimiert,
verringert sich deren Funktion signifikant. Dieser Effekt steht im Widerspruch zur Aktivierung von Hv1
durch Aldosteron. Die frühe Regulation eines spannungsabhängigen Protonenkanals im ASDN könnte
allerdings für die Feinabstimmung der Salzrückresorption durch Aldosteron bedeutungsvoll sein. 4
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1 Summary 
  
The kidney regulates the body’s fluid volume, mineral composition and acidity by 
excretion and reabsorption of electrolytes and water. The ability of the kidney to regulate 
salt homeostasis and extracellular fluid volume is crucial for blood pressure maintenance. 
The mineralocorticoid hormone aldosterone adjusts salt homeostasis largely by regulating 
sodium reabsorption across principal cells of the aldosterone-sensitive distal nephron 
(ASDN). The stimulatory action of aldosterone on sodium reabsorption in the distal 
nephron has been shown to depend mainly on transcriptional regulation that is mediated 
by the activation of the mineralocorticoid receptor, a member of the family of nuclear 
receptors. Early genomic effects on sodium reabsorption are thought to be mediated 
mostly by the induction or repression of elements of the regulatory pathways that control 
the function of preexisting epithelial sodium channel (ENaC), sodium potassium pump 
(Na+-K+-ATPase) and potassium channel (ROMK). Aldosterone regulates the cell-surface 
expression and function and subsequent internalization of ENaC in its target cells partly 
by the transcriptional induction of the serum- and glucocorticoid-regulated kinase 1 
(Sgk1). This kinase prevents the ubiquitylation of ENaC by phosphorylating the ubiquitin 
ligase Nedd4-2. 
The aim of my project was to investigate the mechanism by which the early aldosterone-
induced changes in gene expression impact on sodium and potassium transport in 
aldosterone target cells in the kidney. A microarray of RNA extracted from mouse 
epithelial cells of the ASDN had identified 22 significantly and more than two-fold early 
aldosterone-regulated RNA in vivo. The focus of this work was on three of these 
significantly up-regulated gene products: the ubiquitin-specific proteases Usp2 and Usp53 
and the voltage gated proton channel Hv1. In exogenous gene expression systems like 
Xenopus laevis oocytes and cultured mouse cortical collecting duct cells their impact on 
channels and transporters involved in the sodium absorption in the collecting duct was 
investigated using electrophysiological techniques. 
A pronounced induction of ENaC mediated currents by the co-expression of the Usp2 
isoform Usp2-45 was detected using two-electrode voltage-clamp recordings. The 
stimulatory effect on ENaC was not additive to that of Sgk1. This suggests that Usp2-45 
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acts on the same regulatory pathway as Sgk1, namely the ubiquitylation/deubiquitylation 
of ENaC. The stimulation of ENaC is further due to the catalytic action of Usp2-45 since 
substitution of Cys67 with Ala within the catalytic site of Usp2-45 abolished its effect. 
Further experiments performed in cultured human embryonic kidney cells showed that 
indeed Usp2-45 deubiquitylates and thereby activates ENaC.  
Another ubiquitin-specific protease, Usp53 was significantly up-regulated in the mouse 
distal nephron. Experiments aiming at investigating the possible impact of Usp53 on 
sodium transport molecules (ENaC, Na+-K+-ATPase) expressed in Xenopus laevis 
oocytes were inconclusive and the role of Usp53 in regulating salt reabsorption remains 
elusive.  
The third investigated gene product, a voltage gated proton channel (Hv1) structurally 
resembles the voltage sensor of typical voltage gated channels of the S4-family. Hv1 
substantially decreases ENaC and ROMK function in oocytes which appears 
contradictory to the fact that it is up-regulated by aldosterone. However, early up-
regulation of a voltage gated proton channel in the ASDN could be essential in the 
regulatory control of salt reabsorption fine tuning by aldosterone.  
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2. Zusammenfassung 
 
Die Nieren sind für die Aufrechterhaltung des Flüssigkeitsvolumens, der 
Salzzusammensetzung und des Säure-Base-Haushaltes des Körpers zuständig. Dies 
geschieht durch Ausscheidung und Reabsorption von Elektrolyten und Wasser. Die 
Regulierung des Salzhaushaltes und des Volumens der extrazellulären Flüssigkeit ist für 
die Aufrechterhaltung des Blutdrucks essentiell. Das Mineralokortikoidhormon 
Aldosteron regelt  den Salzhaushalt vor allem durch die Stimulation der 
Natriumrückresorption durch die Hauptzellen des Aldosteron sensitiven distalen 
Nephrons (ASDN).  
Die Wirkung von Aldosteron auf die Rückresorption von Natrium im distalen Nephron 
hängt vor allem von der Regulierung der Transkription ab. Diese Aufgabe übernimmt der 
Mineralokortikoidrezeptor, der zur Familie der nukleären Rezeptoren gehört und durch 
Aldosteron aktiviert wird. Rasche Änderungen der Transkription wirken sich innerhalb 
kurzer Zeit auf die Natriumrückresorption aus. Dies wird grösstenteils durch die 
transkriptionelle Aktivierung und Repression von regulatorischen Faktoren erreicht, die 
die Funktion von bereits vorhandenen Natriumkanälen (ENaC), Natriumpumpen (Na+-
K+-ATPase) und Kaliumkanälen (ROMK) regulieren. Es ist bekannt, dass die 
Oberflächenexpression und die Funktion von ENaC teilweise durch die transkriptionelle 
Aktivierung von Sgk1 gesteigert werden. Sgk1 ist eine Kinase, welche die 
Ubiquitylierung von ENaC verhindert, indem sie die Ubiquitin Ligase Nedd4-2 
phosphoryliert und so deren Funktion inhibiert. Das Ziel meines Projektes war es, 
Mechanismen zu untersuchen, durch welche frühe Aldosteron-induzierte Veränderungen 
der Genexpression zur Regulation von Natrium und Kalium Transport in Aldosteron 
Zielzellen führen.  
Mit Hilfe eines RNA-Microarrays konnten 22 mRNAs identifiziert werden, die in 
Epithelialzellen des ASDN durch Aldosteron mehr als zweifach hochreguliert sind. Im 
Fokus dieser Arbeit lagen drei dieser Genprodukte: Die Ubiquitinproteasen Usp2 und 
Usp53 und ein spannungsabhängiger Protonenkanal (Hv1). Ihr Einfluss auf  Kanäle und 
Transporter, die bei der Natriumrückresorption wichtig sind, wurde vor allem anhand von 
elektrophysiologischen Methoden an Expressionsystemen wie Xenopus laevis Oozyten 
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und kultivierten Sammelrohrzellen aus der Maus untersucht. Elektrophysiologische 
Messungen an koexprimierenden X. laevis Oozyten zeigten, dass die Funktion von ENaC 
durch eine Isoform von Usp2 (Usp2-45) signifikant verstärkt wird. Dieser stimulierende 
Effekt von Usp2-45 auf ENaC ist nicht additiv zu dem bereits beschriebenen Effekt von 
Sgk1. Das bedeutet, dass Usp2-45 in dem Selben Regulationsmechanismus eingebunden 
ist wie Sgk1, nämlich Ubiquitylierung / Deubiquitylierung. Es konnte weiterhin gezeigt 
werden, dass die Stimulierung von ENaC auf die katalytische Aktivität von Usp2-45 
zurückzuführen ist, da durch die Cys67Ala Substitution im katalytischen Zentrum der 
stimulatorische Effekt von Usp2-45 ausblieb. Weitere Experimente mit kultivierten 
menschlichen embryonalen Nierenzellen wiesen darauf hin, dass Usp2-45 ENaC in der 
Tat deubiquityliert und dadurch aktiviert.  
Im distalen Nephron der Maus ist die mRNA Expression von Usp53, einer weiteren  
Ubiquitinprotease, ebenfalls durch Aldosteron signifikant hochreguliert. Experimente zur 
Erforschung ihres möglichen Einflusses auf Natriumtransportmoleküle wurden in X. 
laevis Oozyten durchgeführt. Die Ergebnisse waren jedoch kontrovers und es bleibt 
unklar, welche Rolle Usp53 bei der Regulation der Salzrückresorption spielt.  
Ferner wurde ein Genprodukt untersucht, welches einen spannungsabhängigen 
Protonenkanal (Hv1) kodiert. Dieser weist eine strukturelle Ähnlichkeit zu dem 
Sensordomäne von typischen spannungsabhängigen Ionenkanälen der S4 Familie auf. 
Werden die beiden Ionenkanäle ENaC und ROMK zusammen mit Hv1 exprimiert, 
verringert sich deren Funktion signifikant. Dieser Effekt steht im Widerspruch zur 
Aktivierung von Hv1 durch Aldosteron. Die frühe Regulation eines spannungsabhängigen 
Protonenkanals im ASDN könnte allerdings für die Feinabstimmung der 
Salzrückresorption durch Aldosteron  bedeutungsvoll sein.  
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3 Introduction 
 
3.1 Structure and function of the kidney  
The kidneys are a pair of vertebrate organs situated in the body cavity near the spinal 
column. They are responsible for removal of toxic substances from the body and are 
involved in the maintenance of water and electrolyte balance of the whole body. In 
addition kidneys are endocrine organs which produce and secrete hormones that are 
involved in the regulation of erythrogenesis, calcium metabolism and the regulation of 
blood pressure. The functional unit of the kidney is the nephron, the structure of which is 
crucial to accomplish multiple functions of the kidney (Boron W F 2005).  
 
3.1.1 The nephron 
The nephron is the functional unit of the kidney. One human kidney consists of around 
one million nephrons. A nephron is divided in different segments that can be 
distinguished by function and ultrastructure.  
 
Table 1 
Segment Abbreviation 
Glomerulus  
Proximal convoluted tubule PCT 
Proximal straight tubule PST 
Thin descending limb of the loop of Henle tDLH 
Thin ascending limb of the loop of Henle tALH 
Thick ascending limb of the loop of Henle TAL 
Distal convoluted tubule DCT 
Connecting tubule CNT 
Cortical collecting duct CCD 
Outer medullary collecting duct OMCD 
Inner medullary collecting duct IMCD 
Some of the mentioned segments can further be divided into subsegments, which is 
explained more in detail in the following section.  
In the glomerulus primary urine is produced from the blood by filtration across the wall 
of small capillaries that are set up in a tuft like structure within the surrounding 
Bowman’s space which leads the primary urine to the tubular lumen. Solute 
concentrations in the ultrafiltrate are similar to the concentrations in the plasma. The main 
task of the glomerular filter is to prevent red and white blood cells and large proteins to 
enter the tubular lumen. The passage of proteins through the filter depends on their size 
and charge. The ultrafiltrate is subsequently processed to final urine while flowing 
through the following nephron segments. The main bulk of the filtered fluid and solutes is 
then reabsorbed by the epithelial cells of the nephron tubules. 
 
Figure 1 
  
 
 
 
 
 
 
 
 
 
Figure 1: Anatomy of the kidney. On the left side of the figure, an anatomical view of the kidney is shown. 
The right side illustrates the structure of two nephrons. A juxtamedullary nephron is shown on the left side 
and a superficial one on the right side. Different colours depict the different segments of the nephrons. This 
figure was taken from Boron and Boulpaep: Medical Physiology (Boron W F 2005). 
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Following the glomerulus the largest fraction of the ultrafiltrate is retrieved by the 
proximal tubule (PT). It reabsorbs nearly 100 % of the most important nutrients like 
amino acids or glucose and the biggest portion of solutes and water without changing the 
osmolality of the filtrate. Together with two third of the filtered fluid a large fraction of 
NaCl, NaHCO3 as well as divalent ions are reabsorbed and delivered back to the body. 
Structurally the PT can be divided into three distinct segments: S1, S2 and S3. These 
segments mainly differ in their ultrastructure and particular function. The S1 segment is 
located directly after the glomerulus and belongs to the proximal convoluted tubule 
(PCT). The S2 segment is also part of the PCT but differs from S1 in terms of specific 
functional issues. The proximal straight tubule (PST) which is following the PCT can be 
equated to S3 and recognized by its distinct structure  (Boron W F 2005).  
The S3 segment of the PT is followed by the loop of Henle that is divided into the tDLH, 
tALH and the TAL (Table 1). The main function of the loop of Henle is to participate in 
the formation of concentrated urine. To accomplish the formation of urine concentration 
the subsegments of the loop of Henle have distinct functional features. The function of the 
loop of Henle is to produce an increasing osmotic gradient from the cortex to the tip of 
the renal papilla by the counter-current multiplier mechanism. The thin limbs are lined 
with epithelium which has no capacity for active transport but allows diffusion. The 
tDLH has a great permeability for water but only low permeability for ions and urea. This 
leads to an increased osmolarity of the tubular fluid since the surrounding interstitial fluid 
is highly osmolar. In contrast the tALH and the TAL are not permeable to water. The 
TAL (Table 1) is very important for setting a concentration gradient between the 
interstitium and the tubular lumen by actively pumping ions against its gradient from the 
lumen into the interstitium. Since the TAL is water impermeable it is creating a hypotonic 
tubular fluid. As a result urine osmolality in the following collecting ducts can far exceed 
that of the plasma considering that water can cross their epithelia driven by the high 
osmolarity in the surrounding interstitium. The region where the TAL “contacts” the 
glomerulus is called juxtaglomerular apparatus (JGA). The JGA is important for giving 
regulatory feedback from the TAL directly towards the glomerulus. Parts of the JGA are 
in charge to sense the current NaCl concentration in the tubular lumen and to provide 
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specific signals to start regulatory mechanisms as described later more in detail  (Boron 
W F 2005).  
The classic distal tubule can be divided into three different parts: the distal convoluted 
tubule (DCT), the connecting tubule (CNT) and the initial collecting duct. The classical 
distal tubule and the collecting duct system (CCD, OMCD, IMCD) are primarily sites for 
the fine tuning of salt and water excretion (Table 1). Several hormones carry out their 
main effects on electrolyte and water excretion at these sites, including the 
mineralocorticoid hormone aldosterone and vasopressin  (Boron W F 2005). Aldosterone 
action in the kidney is mainly taking place in the aldosterone sensitive distal nephron 
(ASDN) which consists of the second part of the DCT, the CNT, the CCD and the 
medullary collecting ducts (OMCD and IMCD) (Table 1). These nephron segments 
exhibit distinct structural and functional features that allow the reabsorption of salt and 
water under strict regulation. The DCT, CNT, CCD and medullary collecting ducts are 
composed of two different cell types (principal cells and intercalated cells) that show 
striking differences in function and morphology (Wall 2005). One third of the cell 
population consists of intercalated cells and two thirds of principal cells. Intercalated cells 
are separated in two subpopulations: α and β intercalated cells. Each of these cell types 
exhibits a specialized morphology and function. Principle cells are the classical target 
cells of the mineralocorticoid hormone aldosterone that triggers the salt and water 
reabsorption in the ASDN  (Boron W F 2005). 
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3.2 Blood pressure is regulated by the kidney 
The kidneys regulate the body's fluid volume, mineral composition and acidity by 
excreting and reabsorbing water and inorganic electrolytes. They help to balance these 
solutes (which include Na+, K+, Cl-, Ca2+, Mg2+, phosphate and protons) in the body and 
keep their normal concentrations in the extracellular fluid. Body fluid volume is directly 
associated to blood volume and the arterial blood pressure. The ability of the kidney to 
regulate salt homeostasis and extracellular fluid volume within the whole body is crucial 
for blood pressure maintenance. Changes in blood pressure are sensed by receptors which 
generate distinct hormonal and neuronal signals. The kidney has the ability to adjust body 
fluid volume and its osmolality in response to these signals. For instance, a decrease of 
the extracellular fluid volume is followed immediately by the stimulation of hormonal 
effector pathways, such as the renin-angiotensin-aldosterone system (RAAS) and the 
inhibition of Atrial Natriuretic Peptide (ANP) (Boron W F 2005).  
Since the extracellular osmolality has per se to be kept constant and also may reflect the 
status of general body water content it is an important issue to regulate it as tightly as 
possible. Dehydration of the body leads to an increased plasma osmolality that is sensed 
by special receptors in the hypothalamus. The activation of these osmoreceptors 
subsequently leads to the release of the neuropeptide hormone arginine vasopressin 
(AVP, antidiuretic hormone) that is synthesized in the hypothalamus. AVP acts in the 
collecting duct where it increases water reabsorption via the regulation of water channel 
trafficking (Boron W F 2005). 
 
 
3.2.1 Atrial Natriuretic Peptide (ANP) 
ANP promotes natriuresis (Na+-excretion) in response to an increase in blood pressure. 
Stretch receptors located in the atrial myocytes sense high blood pressure and release 
signals that lead to liberation of ANP from intracellular stores into the circulation  (Boron 
W F 2005). ANP has synergistic effects that activate renal Na+ and water excretion. It 
directly inhibits Na+ transport in the medullary collecting ducts, decreases the release of 
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renin and increases the glomerular flitration rate. However the major effect of ANP is 
hemodynamic, because it triggers renal vasodilatation and massively increases renal 
blood flow which supports the activation of salt and water secretion  (Boron W F 2005). 
 
 
3.2.2 The Renin Angiotensin Aldosterone System RAAS 
The RAAS is an integrative system that links the cardiovascular system to the renal 
functions by regulating salt and water homeostasis and therefore the blood pressure. 
Renin is an endopeptidase that had first been identified in the kidney, specifically in the 
cells of the JGA. It cleaves the circulating alpha 2 globulin angiotensinogen that is mainly 
synthesized in the liver and fat tissue and generates the dekapeptide angiotensin I 
(Williams 2005). Angiotensin I is an inactive molecule that is converted to the active 
octapeptide angiotensin II (AngII) by the angiotensin converting enzyme (ACE), which is 
localized in vascular endothelial cells  in many tissues of the body (Williams 2005) 
(Boron W F 2005). AngII has two main distinct effects on the regulation of blood 
pressure: It directly mediates vasoconstriction and it regulates production and release of 
aldosterone (Figure 2) (Boron W F 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The Renin-Angiotensin-Aldosterone System. This hormonal pathway integrates different organs 
and exhibits some important feedback mechanisms. JGA = juxtaglomerular apparatus, ACE = angiotensin 
converting enzyme. This figure was adopted from Boron and Boulpaep: Medical Physiology (Boron W F 
2005). 
 
The release of renin from specialized granular cells in the JGA is regulated by several 
factors including renal perfusion pressure, beta adrenergic stimulation, potassium, AngII 
and ANP (Williams 2005). The most important regulatory mechanism is triggered by the 
renal perfusion pressure. Changes in perfusion pressure are sensed by baroreceptors 
located in the afferent arteriole that send signals to the granular cells modifying the level 
of renin release. A decrease in blood pressure leads to an increase in renin release and 
subsequently to an increase in aldosterone production.  
In addition to the above mentioned systemic RAAS, several tissues and organs have been 
found to have their own local RAAS (Tahmasebi, Puddefoot et al. 1999). Such local 
RAASs have been found to either potentiate the systemic functions or have completely 
separate actions to adjust the specific local functions of their particular tissues and organs. 
These effects are normally mediated in a paracrine and autocrine manner (Cooper and 
Boner 2004).  
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Angiotensin II (AngII) 
AngII has various functions in different target organs that are mediated by distinct 
mechanisms. On the one hand it stimulates AngII receptors on smooth muscle cells, to 
induce vasoconstriction mediated by a direct release of intracellular calcium. These 
actions of AngII are increased by high levels of salt concentration in the body. 
Furthermore AngII also acts on brain where it activates thirst and the release of specific 
hormones from the hypophysis, in particular arginine vasopressin (AVP) and 
adrenocorticotropic hormone (ACTH) (Figure 2) (Chung O 2006). To finally increase 
renal Na+ reabsorption and thereby increase the volume of extracellular fluid and blood 
pressure AngII alters renal hemodynamics in different ways (Figure 2). The 
hemodynamic effects of AngII on the one hand lead to an increase in the glomerular 
filtration fraction by increasing the constriction of the efferent but not the afferent 
arterioles. On the other hand they enhance the Na+ absorption in the IMCD by decreasing 
the medullary blood flow and thereby minimizing the medullary washout. Another 
important task of AngII is to raise the sensitivity of specialized feedback mechanisms in 
the JGA that trigger the glomerular filtration rate (Boron W F 2005). It also exhibits a 
direct effect on the Na+ absorption in the renal tubules by increasing the abundance of 
Na+-proton exchangers in the TAL as well as Na+ channels in the ICT. This effect is then 
enhanced by the activation of hypertrophy in the renal tubular system. Last but not least 
AngII activates the synthesis and release of aldosterone in the adrenal glands (Figure 2). 
As soon as AngII is binding to the AngII receptor AT1 on the plasma membrane of 
granulosa cells in the adrenal cortex a cascade of different intracellular signals leads to 
the production and release of the mineralocorticoid hormone aldosterone. This hormone is 
the major regulator of salt balance and extracellular fluid (ECF) volume in the human 
body which is a prime determinant of arterial blood pressure (Figure 2) (Boron W F 
2005).  
 
 
 
 13 
 
Aldosterone 
One of the most important regulators of salt and water handling in the distal nephron is 
the mineralocorticoid hormone aldosterone. It is synthesized from cholesterol in a series 
of enzymatic reactions in the granulosa cells located in the cortex of the adrenal gland 
(Williams 2005). Aldosterone production is essentially restricted to these specialized 
cells, because the last step of the synthesis is done by the enzyme aldosterone synthase 
which is present in these cells (Boron W F 2005). Around 75% of the circulating 
aldosterone is inactivated by the liver. Aldosterone inactivation in the kidney leads to a 
glucuronide conjugate which is used as a diagnostic indicator for aldosterone production 
measured in the urine (Williams 2005).  
Synthesis and release of aldosterone by the adrenal gland is regulated by different factors. 
K+ directly activates the aldosterone production via direct action on the glomerulosa cells 
(Williams 2005) (Figure 2). High K+ levels depolarize the plasma membrane of these 
cells which leads to an intracellular signalling cascade and subsequently to the synthesis 
and release of aldosterone (Boron W F 2005). K+ is the mediator of a short feedback loop, 
since aldosterone increases renal excretion of K+. AngII activates aldosterone release by 
binding to AT1 receptors on the surface of glomerulosa cells. A signal cascade that 
involves the Gαq-mediated pathway to stimulate phospholipase C (PLC) leads to the 
release of intracellular Ca2+. The rise in Ca2+ is primarily responsible for triggering 
synthesis and secretion of aldosterone. Other regulators of aldosterone secretion are 
mainly involved in the response to stress, like ACTH, endothelin or serotonin. They 
generally have minor impact on the release of aldosterone (Boron W F 2005).  
Aldosterone has diverse effects in different tissues. It is known, that it acts on epithelial as 
well as nonepithelial tissues in genomic as well as nongenomic ways mostly to regulate 
salt homeostasis. In the cardiovascular system aldosterone promotes cardiac hypertrophy, 
fibrosis and abnormal vascular endothelial function, while in the CNS it impacts on blood 
pressure control, salt appetite and sympathetic tone (Young and Funder 2000). These 
latter effects are mediated by the Mineralocorticoid Receptor (MR) and are considered to 
be genomic. As mentioned above aldosterone was found to trigger also nongenomic rapid 
effects that appear already after seconds or minutes and that are not sensitive to inhibitors 
for translation and transcription, like actinomycin and cyclohexamide. These actions are 
 14 
 
considered to be independent of direct effects on gene expression (Booth, Johnson et al. 
2002). Many of these nongenomic effects are not blocked by MR antagonists implicating, 
that they are not mediated by the MR but by a nonclassical aldosterone receptor. However 
a nonclassical receptor for aldosterone was not yet found and it is still unclear whether 
nongenomic actions can be mediated by the MR (Good 2007). Nevertheless, nongenomic 
actions of aldosterone have impact on a number of ion transport proteins in the renal 
tubule that are involved in absorptive and secretory functions. Different studies showed 
that ion transport proteins like the Na+ proton exchanger 1 and 3 (NHE1, NHE3), the H+-
ATPase, the Epithelial Na+ Channel (ENaC) and the Na+-K+-ATPase are regulated within 
minutes by aldosterone, indicating to be a nongenomic effect. It was suggested that these 
actions of aldosterone are more important for responses mediated by the local aldosterone 
production (Connell and Davies 2005).  
The classic action of aldosterone is the regulation of salt and water reabsorption in the 
ASDN (Rozansky 2006). The ASDN as well as other aldosterone sensitive epithelia 
exhibit special characteristics: They are tight epithelia with high resistance tight junctions. 
Aldosterone is able to increase their permeability to Na+ by increasing the activity of 
ENaC and the basolateral Na+-K+-ATPase. Furthermore the extrusion of K+ and protons 
is augmented. As a consequence water follows the movement of Na+ across the 
epithelium, which results in an increase in the extracellular fluid volume, blood volume 
and blood pressure.  
 
3.2.3 Arginine Vasopressin (AVP) 
AVP is a neuropeptide hormone that acts on the collecting duct to increase water 
reabsorption. The release of AVP can be stimulated by a decrease in arterial blood 
pressure, an increase in ECF osmolarity as well as by the action of AngII (Boron W F 
2005). Water permeability is increased by AVP in all nephron segments beyond the DCT. 
AVP dramatically increases water permeabilities of the collecting tubules and ducts by 
causing aquaporin 2 (AQP2) water channels to insert into the apical membrane. Water 
channels present in the basolateral membrane of these nephron segments are not sensitive 
to AVP (Boron W F 2005). 
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3.3 The aldosterone sensitive distal nephron (ASDN) 
The ASDN is the most important site of the regulated salt and water reabsorption. It is 
defined by the coexpression of ENaC, 11-β-hydroxysteroid dehydrogenase type 2 and 
MR. These features are given for the late part of the DCT (DCT2), the CNT and the 
collecting ducts. The classic aldosterone target cells are the principal cells of the 
collecting duct, although intercalated cells are also in some respect sensitive to 
aldosterone. For example, it was shown that aldosterone has a nongenomic effect on the 
activity of the proton pump that is expressed in α- intercalated cells but not in principal 
cells (Winter, Schulz et al. 2004). In the following chapters I am going to focus on the 
mechanisms and effects of the classical model of aldosterone action in the ASDN.  
 
3.3.1 The principal cells of the ASDN 
The Na+ reabsorption in the ASDN is transcellular and mediated by the majority cell type: 
the principal cells (Boron W F 2005) (Figure 3). Sodium ions have to cross the apical and 
the basolateral membrane of principal cells. Specialized Na+ channels (ENaC) in the 
apical membrane mediate a central step of the Na+ absorption over this tight epithelium 
(Figure 3). ENaC functions under tight control and is the limiting factor of the Na+ 
absorption. The regulation of its functional expression in the apical membrane is crucial 
for the amount of salt and water reabsorbed.  
To protect the cells from Na+ overload, ATP driven Na+ pumps are located in the 
basolateral side (Na+-K+-ATPase) (Figure 3). These pumps exchange 3 sodium ions for 2 
potassium ions by hydrolyzing one ATP. The Na+-K+-ATPase is basically expressed in 
every cell in the body and has mainly the tasks of a housekeeping protein. Nevertheless 
this pump is crucial for Na+ reabsorption in the principal cells since it is providing the 
electrochemical driving force for the apical Na+ entry (Boron W F 2005). The cell surface 
expression and function of the Na+-K+-ATPase is also regulated by aldosterone (Zecevic, 
Heitzmann et al. 2004).   
 
Figure 3      
 
 
 
 
 
 
 
 
Figure 3: Scheme of a principal cell in the cortical collecting duct. On the luminal or apical side 
Na+ and K+ channels are expressed. The basolateral side of this epithelial cell faces the 
interstitial space and expresses the Na+-K+-ATPase and also K+ channels. This figure was taken 
from Boron and Boulpaep: Medical Physiology (Boron W F 2005).
 
 
Since the Na+-K+-ATPase is exchanging K+ for Na+ it is necessary for the cell to release 
K+. Therefore K+ channels are expressed in the apical and in the basolateral membrane of 
principal cells that are in charge of releasing potassium from the cell (Figure 3). The 
apically expressed potassium channel is additionally in charge to oppose the lumen 
negative potential generated by the entry of Na+. The regulation of function and 
expression of the apical renal outer medullary potassium channels (ROMK) is partly 
mediated by aldosterone (Fuller and Young 2005).  
 
3.3.2 Classical action of aldosterone in the ASDN 
Aldosterone’s action is divided into three distinct phases: The rapid nongenomic, the 
early and the late action (Verrey 1998).  Nongenomic effects of aldosterone were 
described before. The late action of aldosterone is predominantly a chronic effect that 
occurs after three to six hours and is characterized by an increase in the number of ENaC 
and Na+-K+-ATPase in the membranes of the epithelial cells (Verrey 1998). 
Subsequently, a long term exposure to aldosterone induces morphological changes in the 
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target cells for example an increase in the surface of the basolateral membrane (Kaissling 
and Le Hir 1982).  
Early genomic aldosterone effects, mediated by the mineralocorticoid receptor (MR), 
occur already after 20 minutes. These actions are important for a quick reaction to 
environmental changes by rapid activation of the Na+ transport machinery in the ASDN. 
This challenge is achieved by the activation of a preexisting pool of transport proteins 
through the increase of trafficking to the membrane or through direct channel or pump 
activation. The major regulatory site of transepithelial Na+ transport across tight epithelia 
is ENaC (Verrey 1998). Early actions of aldosterone are suggested to be mediated by 
regulatory proteins that are transcriptionally activated via the MR. These regulatory 
proteins act presumably on the preexisting pool of transport proteins like ENaC (Lu, 
Pribanic et al. 2007; Harris, Garcia-Caballero et al. 2008) (Figure 4). The aim of my work 
was to find players of the early aldosterone response that are regulated by the MR and 
that modulate directly the Na+ transport machinery in the aldosterone target cells. 
Since aldosterone belongs to the class of steroid hormones it is able to enter cells by 
diffusion through the plasma membrane. It binds to the MR in the cytoplasm and the MR-
aldosterone complex subsequently translocates to the nucleus where it functions as a 
transcription factor (Boron W F 2005). The MR dimerizes and binds to specific steroid 
response elements (SRE) in the DNA to positively or negatively regulate the expression 
of responsive genes (Walter F. Boron 2005; Thomas, McEneaney et al. 2007). The MR 
reflects a high degree of similarity to the glucocorticoid receptor (GR) in terms of DNA 
and ligand binding domains (Connell and Davies 2005). MRs are mainly expressed in 
aldosterone target tissues whereas GRs are ubiquitously expressed. Glucocorticoid 
hormones (like cortisol and corticosterone) and aldosterone bind with approximately the 
same high affinity to the MR and lower affinities to the GR. Since plasma levels of 
glucocorticoids are more than 100fold greater than that of aldosterone, glucocorticoids 
would be likely to occupy the MR under most circumstances.  
 
 
 
Figure 4  
 
 
 
 
 
 
 
 
 Figure 4: Model of the classical aldosterone action in a principal cell. The asterisks assign final 
effectors of aldosterone that are participating in the transepithelial Na+ and K+ transport. The 
early aldosterone induced proteins (Sgk, Ki-RasA (K-Ras2), CHIF, GILZ) modulate the activity 
of effector transport proteins. Hsp = Heat shock protein, MR = mineralocorticoid receptor, GR = 
glucocorticoid receptor, SRE = Steroid response element, 11β-HSD2 = 11-β-hydroxysteroid 
dehydrogenase type 2. This figure is adapted from Booth, Johnsen et al 2002.  
 
 
 
 
 
In 1988 a protein was found that prevents MR from binding to glucocorticoids: The 
enzyme 11-β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). It protects the MR from 
glucocorticoid occupancy by converting glucocorticoids into inactive metabolites which 
have little affinity to the MR (Figure 4) (Booth, Johnson et al. 2002). Mutations of the 
gene encoding 11β-HSD2 results in the syndrome of apparent mineralocorticoid excess 
which is inherited in an autosomal recessive manner in humans (Connell and Davies 
2005). 
The early action of aldosterone on ion transport already appears after half an hour. Since 
transcription, translation, posttranslational modification and trafficking of a substantial 
portion of the involved transport proteins together takes more than one that it can be 
expected that for instance ENaC is not regulated directly by transcriptional activation 
within the early aldosterone response. The common idea is that early effects of 
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aldosterone on ENaC are due to a reversible activation of preexisting transport proteins 
(Booth, Johnson et al. 2002). In contrast long term exposure to aldosterone results in a 
transcriptional induction of the α-subunit of ENaC in the ASDN while γ- and β-subunits 
are not regulated at that level (Snyder 2005). The activation of a preexisting pool of Na+ 
channels is thus mediated by regulatory proteins. In the following section I am going to 
focus on a number of early aldosterone regulated gene products that where found to be 
regulators of the transepithelial Na+ transport (Spindler, Mastroberardino et al. 1997; 
Naray-Fejes-Toth 1999; Naray-Fejes-Toth, Canessa et al. 1999).  
The best studied early aldosterone induced gene product that affect ENaC mediated Na+ 
reabsorption is the serum and glucocorticoid activated kinase Sgk1. This is a serine-
threonine kinase that phosphorylates the ubiquitin ligase Nedd4-2 (Neural precursor-
expressed and developmentally down-regulated protein 4-2). Nedd4-2 was shown to 
transfer ubiquitin to ENaC and to target it therefore for endocytosis (Kamynina, 
Debonneville et al. 2001; Kamynina, Debonneville et al. 2001). Since Sgk1 inhibits 
Nedd4-2 action by phosphorylation surface expression of ENaC increases based on a 
decrease of its endocytosis (Bhalla, Soundararajan et al. 2006; Rozansky 2006). It was 
also reported that Sgk1 increases the density of ROMK channels in the plasma membrane 
(Fuller and Young 2005). Next to ENaC and ROMK also the basolateral surface 
expression of the Na+-K+-ATPase is controlled by Sgk1 (Verrey, Summa et al. 2003; 
Zecevic, Heitzmann et al. 2004). Since Sgk1 also colocalizes with the Na+-K+-ATPase in 
the kidney it is tempting to propose that Sgk1 is a key player in mediating a coordinated 
aldosterone response in the ASDN (Verrey, Summa et al. 2003; Zecevic, Heitzmann et al. 
2004; Lang, Capasso et al. 2005). 
Nevertheless Sgk1 is not the only kinase that has an impact on the Na+ transport 
machinery in the ASDN and is regulated by aldosterone on the transcriptional level after a 
short time. The transcription of a specific isoform of the With No Lysine Kinases 
(Kindney-specific WNK1, KS-WNK1), that is specifically expressed in the ASDN is also 
sensitive to aldosterone (Naray-Fejes-Toth, Snyder et al. 2004; O'Reilly, Marshall et al. 
2006).  KS-WNK1 was also shown to increase transepithelial Na+ currents in mouse 
collecting duct cells. Since the KS-WNK1 isoform lacks the kinase domain it is proposed, 
that this effect is mediated via protein/protein interactions rather then a kinase activity. 
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KS-WNK1 does not have any effect on ENaC that carries a mutation in the Nedd4-2 
binding motif. This leads to the presumption that Nedd4-2 could be a target molecule of 
that kinase (Naray-Fejes-Toth, Snyder et al. 2004; Subramanya, Yang et al. 2006). 
However, the exact mechanism of the KS-WNK1 action on transepithelial Na+ transport 
is still not fully understood (Subramanya, Yang et al. 2006).  
The ubiquitin ligase Nedd4-2 is also a target of the 14-3-3 protein. 14-3-3 proteins are 
highly conserved regulatory proteins that in general bind to phosphorylated motifs within 
their target proteins and function as homo- and heterodimers (Aitken 2002; Yaffe 2002; 
Wilker and Yaffe 2004). 14-3-3 proteins modulate the expression of ENaC probably by 
blocking the interaction of ENaC with Nedd4-2 and therefore inhibiting ENaC 
ubiquitylation (Bhalla, Daidie et al. 2005; Ichimura, Yamamura et al. 2005; Liang, Peters 
et al. 2006). Evidence for this hypothesis was found by Liang et al, showing that specific 
14-3-3 isoforms associate selectively with phosphorylated Nedd4-2 in CCD cells (Liang, 
Peters et al. 2006). The fact that the transcription of 14-3-3 protein isoforms is regulated 
by aldosterone in mouse CCD epithelia supports the notion that 14-3-3 proteins are key 
modulators in the regulation of Na+ transport by aldosterone in the ASDN.  
The small G-protein Ki-Ras (K-Ras2A) which is upregulated by aldosterone in amphibian 
cells increases the function and in the same time decreases surface expression of ENaC in 
X. laevis oocytes (Spindler, Mastroberardino et al. 1997; Mastroberardino, Spindler et al. 
1998; Stockand, Spier et al. 1999; Verrey 1999; Rotin 2000; Booth, Johnson et al. 2002). 
Therefore it was suggested that Ki-Ras plays a role in the mediation of the early effect of 
aldosterone on Na+ transport in the ASDN (Spindler, Mastroberardino et al. 1997; 
Mastroberardino, Spindler et al. 1998; Stockand, Spier et al. 1999; Booth, Johnson et al. 
2002; Bhalla, Daidie et al. 2005). Ki-Ras activates ENaC open probability most likely by 
a GTP-dependent mechanism that is reliant on phosphoinositide 3-OH kinase signaling 
(Staruschenko, Patel et al. 2004). Conversely, recent in vivo studies displayed that Ki-Ras 
is upregulated in the rat distal colon but not in the kidney (Brennan and Fuller 2006).  
The glucocorticoid-induced leucin zipper protein (GILZ) was also shown to be rapidly 
induced by aldosterone in mpkCCDc14 cells and to increase ENaC mediated Na+ currents 
in X. laevis oocytes by inhibiting extracellular signal-regulated kinase (ERK) signaling 
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(Soundararajan, Zhang et al. 2005; Bhalla, Soundararajan et al. 2006). Since ERK 
signaling is constitutively active, these findings lead to the hypothesis that GILZ plays a 
role in the early aldosterone mediated regulation of Na+ transport (Soundararajan, Zhang 
et al. 2005; Bhalla, Soundararajan et al. 2006).  
A further aldosterone-induced protein that modulates the function of the Na+ transport 
machinery in the ASDN is the corticosteroid hormone induced factor CHIF (Wald, 
Goldstein et al. 1996; Wald, Popovtzer et al. 1997). CHIF first identified as an 
aldosterone-induced protein is an accessory subunit of the Na+-K+-ATPase and regulates 
its function in the colon and in the kidney (Beguin, Crambert et al. 2001). Investigations 
using a CHIF knock out mouse model support the assumption that it plays a crucial role 
in maintaining body Na+ and K+ homeostasis in aldosterone-responsive tissues (Beguin, 
Crambert et al. 2001; Goldschimdt, Grahammer et al. 2004).  
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3.4 The Epithelial Na+ Channel ENaC  
 
ENaC, the epithelial Na+ channel, is a Na+-selective, non-voltage gated non-inactivating 
ion channel and a member of the ENaC/DEG superfamily. It localizes to the apical 
membrane of re(absorbing) epithelial cells (Garty and Palmer 1997; Benos and Stanton 
1999; Alvarez de la Rosa, Canessa et al. 2000; Kellenberger and Schild 2002; Pochynyuk, 
Tong et al. 2007). ENaC plays the key role in the movement of electrolytes and water 
across epithelial barriers in the lung, the kidney, the colon and sweat glands. In concert 
with the Na+-K+-ATPase ENaC allows the directed transepithelial Na+ transport, since the 
influx of Na+ takes place along the electrochemical gradient, which is established by the 
basolateral Na+-K+-ATPase. Several regulatory mechanisms are able to adapt the 
basolateral efflux and the apical influx of Na+ (Boron W F 2005). 
 
3.4.1 Structure and function of ENaC 
ENaC forms a heteromultimer consistent of three different subunits (α, β, γ), each with 
two transmembrane spanning domains and a large extracellular domain (~450 amino 
acids) (Canessa, Horisberger et al. 1993; McNicholas and Canessa 1997; Fyfe and 
Canessa 1998; Fyfe, Quinn et al. 1998).The comparatively short N- and C-termini (~50-
100 amino acids) are located to the cytoplasmic side of the membrane (Canessa, Schild et 
al. 1994; Renard, Lingueglia et al. 1994; Snyder, McDonald et al. 1994).  The three 
different subunits heteromultimerize to build a pore that is highly selective for sodium 
ions and sensitive to amiloride at submillimolar concentrations. All three subunits are 
required for the maximal activity of the channel (Canessa, Horisberger et al. 1993; 
Canessa, Schild et al. 1994; McNicholas and Canessa 1997; Fyfe and Canessa 1998). The 
stoichiometry of the heteromultimer is still uncertain. Two different models have been 
proposed for the stoichiometry of ENaC: The work of Firsov and colleges and Kosari and 
coworkers suggested ENaC being a heterotetramer with a stoichiometry of 
α2:β1:γ1(Firsov, Gautschi et al. 1998; Kosari, Sheng et al. 1998). Other investigators 
showed that the subunits of ENaC are forming a pore each with the same relative ratio: 
3α:3β:3γ (Snyder, Cheng et al. 1998; Eskandari, Snyder et al. 1999; Staruschenko, 
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Medina et al. 2004; Staruschenko, Adams et al. 2005). Recently the structure of the acid 
sensing ion channel 1 was solved at a resolution of 1.9 Å and showed a heterotrimeric 
structure (1α:1β:1γ) (Jasti, Furukawa et al. 2007). Since this acid sensing channel is a 
member of the ENaC/DEG family and closely related to ENaC it is now proposed, that 
ENaC has a trimeric structure with the stoichiometry 1α:1β:1γ (Canessa 2007). The single 
channel conductance of ENaC is relatively small, but it is highly selective for Na+, with a 
ratio greater than 100:1 over potassium (Canessa 2007). Moreover ENaC exhibits a 
selectivity for Li+ over Na+ by a factor of - 1.3- 1.5:1 (Garty and Palmer 1997) and is to a 
small extend able to conduct protons (Palmer 1982; Palmer 1987; Garty and Palmer 
1997). 
ENaC is expressed in many different epithelial tissues where it has the task to absorb and 
reabsorb Na+ from the environment or from an extracellular fluid compartment. Its 
physiological importance is exciting since it was found to be a key player in keeping the 
balance of Na+ and K+ in the body and in extracellular fluids like the mucus in lungs. First 
Koefoed and Ussing identified a Na+ conductance at a macroscopic level in the amphibian 
skin by transepithelial current measurements (Koefoed-Johnsen and Ussing 1958). Later 
on it was found that these Na+ currents are mediated by a specific channel (ENaC) that 
was found to be expressed also in other osmoregulatory organs in amphibians (Koefoed-
Johnsen and Ussing 1958; Uchiyama and Konno 2006). Since amphibians occupy a wide 
variety of ecological habitats they exhibit a great ability to adapt. This is only made 
possible by the specialization of osmoregulatory epithelial tissues like their skin, kidney 
or urinary bladder. In each of these organs ENaC was found to be highly expressed and to 
be involved in osmoregulatory mechanisms (Uchiyama and Konno 2006). In mammals 
ENaC is expressed in the kidney, the urinary bladder, the colon and in the lungs, as well 
as in glandular ducts like sweat glands and salivary glands. All of these tissues have a 
crucial role in fluid transport (Garty and Palmer 1997).  
The malfunction of ENaC or its regulation is always linked to diseases. Excessive Na+ 
absorption for example results in hypertension whereas diminished Na+ absorption is 
linked to hypotension (Gordon 1995; Snyder 2002). Na+ absorption in the lung is 
compulsory to convert the lung at the time of birth from a fluid filled to an air filled 
organ. Afterwards the Na+ content of the surface liquid in the lungs has to be under tight 
control which is achieved partly via the regulation of ENaC (Snyder 2002; Snyder 2005). 
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Excessive Na+ current in the airways may contribute to the pathogenesis of cystic fibrosis. 
Two genetic disorders are known that are directly caused by mutations in ENaC: Liddle’s 
syndrome which is an inherited form of hypertension and caused by a dominant gain-of-
function mutation (Shimkets, Warnock et al. 1994; Hansson, Nelson-Williams et al. 1995; 
Snyder 2002) and pseudohypoaldosteronism type 1 that is characterized by hypotension 
and salt wasting and caused by a loss-of-function mutation of ENaC (Snyder 2002) 
(Chang, Grunder et al. 1996; Strautnieks, Thompson et al. 1996). Additionally defects in 
the regulation of ENaC underlie all of the known inherited monogenetic forms of 
hypertension (Lifton 1996; Snyder 2002).  
 
3.4.2 Regulation of ENaC 
Since ENaC has these essential tasks it is evident that its functional surface expression 
has to be regulated very tightly. Its regulation indeed is critical to maintain a fine balance 
between Na+ depletion and excess. Therefore a bunch of mechanisms are involved in the 
direct regulation of functional expression of ENaC on the cell surface of epithelial cells. 
Posttranslational modifications and other regulations are very direct and quick; whereas 
the control of transcription has a slower but therefore also a more durable effect. ENaC 
exhibits several specific regions within its amino acid sequence that are involved in the 
mediation of posttranslational control of the functional expression in apical membranes of 
epithelial cells.  
 
The trafficking of ENaC is controlled by different mechanisms 
Defects in ENaC trafficking are responsible for inherited forms of hypertension and 
hypotension (Snyder 2005). Little is known about the mechanisms that trigger exocytosis 
of ENaC, but some groups showed that members of the family of N-ethylmaleimide-
sensitive attachment receptor (SNARE) proteins can modulate ENaC current (Qi, Peters 
et al. 1999; Saxena, Quick et al. 1999; Condliffe, Carattino et al. 2003; Berdiev, Jovov et 
al. 2004; Snyder 2005). Two members of the SNARE family, synthaxin 1A and SNAP23 
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have been shown to interact with ENaC (Saxena and Kaur 2006) and each of which 
differentially affects ENaC function (Saxena and Kaur 2006; Saxena, Singh et al. 2006). 
Efficient trafficking from the ER to the cell surface requires the assembly of all three 
ENaC subunits. Under normal circumstances the principal cells in the collecting duct 
express γ and β subunits to a higher extend than α subunits, therefore trafficking to the 
cell surface is controlled by the expression level of the α subunit. Since the transcription 
of α subunits but not the transcription of β and γ subunits is activated by aldosterone in 
these cells it directly enhances trafficking just by transcriptional regulation of one subunit 
(Asher, Wald et al. 1996; Escoubet, Coureau et al. 1997; Snyder 2005). This 
uncoordinated transcription is tissue specific and shows different subunits expressed to a 
lower or higher extend in different tissues (Snyder 2005). 
A sequence conserved at the C-terminus of all three ENaC subunits was identified to 
impact on its surface expression as mutations in this motifs lead to an increase in the 
number of channels expressed at the cell surface and are the cause of the inherited disease 
Liddle’s syndrome (Liddle, Island et al. 1963; Shimkets, Warnock et al. 1994; Firsov, 
Schild et al. 1996; Warnock 1998; Schild 2004; Snyder 2005). It was found that these 
conserved regions are involved in protein interactions since they show similarities to the 
known protein interaction motif (PY motif) (Chen and Sudol 1995; Snyder, Price et al. 
1995; Sudol, Chen et al. 1995; Schild 1996). The ENaC PY (PPPXYXXL) motifs were 
then identified to function as a binding site for an ubiquitin ligase namely Neural 
precursor-expressed and developmentally down-regulated protein 4-2 (Nedd4-2) (Staub, 
Dho et al. 1996; Kamynina, Debonneville et al. 2001; Kamynina, Debonneville et al. 
2001). As discussed later more in detail, Nedd4-2 is able to ligate ubiquitin molecules to 
ENaC and therefore target it for internalization via endocytosis and subsequently for 
degradation in the proteasome (Staub, Gautschi et al. 1997; Goulet, Volk et al. 1998; 
Abriel, Loffing et al. 1999; Snyder 2005). Furthermore the interaction of Nedd4-2 with 
ENaC is stimulated by its phosphorylation through the extracellular signal-regulated 
kinase ERK (Shi, Asher et al. 2002). ENaC surface expression is additionally altered by a 
diversity of other mechanisms that are right now still not fully understood (Snyder 2005).  
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Protons regulate ENaC activity 
Ussing and Zerahn discovered in 1951 on frog skin that intracellular acidification 
decreases Na+ permeability of epithelia (Ussing and Zerahn 1951; Palmer 2001). This 
finding could be confirmed by different groups using different models and techniques 
(Palmer 1985; Palmer and Frindt 1987; Harvey and Ehrenfeld 1988; Chuard and Durand 
1992; Chalfant, Denton et al. 1999). It was discovered that intracellular pH (pHi) but not 
extracellular pH (pHo) has an impact on ENaC activity. Indeed, further investigation 
showed that pHi serves also as an important modulator of ROMK (Harvey and Ehrenfeld 
1988; Duffey and Devor 1990; Kolb 1990; Wang, Schwab et al. 1990; Wang and 
Giebisch 1991), and the Na+-K+-ATPase (Skou 1982; Eaton, Hamilton et al. 1984; 
Urbach, Van Kerkhove et al. 1996). The effect of protons on the activity of ENaC is until 
now not well understood. However, it was observed that the α subunit of ENaC is the one 
that responds to changes in pHi (Chalfant, Denton et al. 1999) and that the single channel 
open probability of apical Na+ channels in the CCD is affected by pHi (Palmer and Frindt 
1987; Chalfant, Denton et al. 1999). Nevertheless early studies on isolated membrane 
vesicles from the toad bladder showed no effect on the amiloride sensitive currents at pH 
7 to 8 which lead to the suggestion that pH effects would probably be indirect and just 
appear in intact cells (Garty, Civan et al. 1985; Palmer and Frindt 1987). Since pHi is 
altered by aldosterone and ENaC as well as ROMK and the Na+-K+-ATPase are important 
players in the aldosterone regulated Na+ absorption in the ASDN pHi could play a role as 
a second messenger for the rapid effect of aldosterone (Garty and Palmer 1997; Palmer 
2001). 
 
Na+ regulates ENaC activity 
The activity of ENaC is regulated also by Na+ itself in two distinct ways: Na+ self 
inhibition and feedback inhibition (Garty and Palmer 1997; Bize and Horisberger 2007). 
Na+ self inhibition initially found in experiments done on frog skin (Fuchs, Larsen et al. 
1977), is a decrease of inwardly directed Na+ currents as Na+ concentration is elevated on 
the outside (Abriel and Horisberger 1999; Bize and Horisberger 2007).  The effect of 
extracellular Na+ on ENaC has a rapid time course (~3 s) and is highly temperature 
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dependent (Chraibi and Horisberger 2002) with the highest efficiency at 37°C (Chraibi 
and Horisberger 2002). The rapid kinetics of this effect gives rise to the assumption that 
ENaC is rather directly affected then accessory proteins would be involved (Chraibi and 
Horisberger 2002). The current opinion is that extracellular Na+ interacts with a special 
Na+ sensing site in the extracellular loop of the Na+ channel since the effect is prevented 
through cleavage of the extracellular loop by proteases like furin or trypsin (Chraibi and 
Horisberger 2002; Bize and Horisberger 2007). However, the exact mechanism of Na+ 
self inhibition is still not clear (Bize and Horisberger 2007). 
The Na+ feedback mechanism occurs upon an increase of the intracellular Na+ 
concentration and has a slow time course of about 10 – 20 min (Abriel and Horisberger 
1999; Bize and Horisberger 2007). The increase in intracellular Na+ concentration 
significantly decreases the number of ENaC molecules at the cell surface (Kellenberger, 
Gautschi et al. 1998). The fact that channels carrying a mutation within the PY motif are 
not affected by intracellular Na+ lead to the conclusion that an intact PY motif is required 
for the Na+ feedback mechanism (Kellenberger, Gautschi et al. 1998).  The Na+ feedback 
regulation is considered as an important mechanism to control Na+ reabsorption and to 
maintain Na+ balance (Kellenberger, Gautschi et al. 1998).   
 
Other ions alter ENaC activity 
ENaC activity can also be altered by a range of divalent ions. A stimulatory effect of low 
concentrations of extracellular Ni2+ had been observed using the amphibian A6 cell line 
and X. laevis oocytes (Cucu, Simaels et al. 2003). This effect might be due to the 
inhibition of Na+ self inhibition (Horisberger and Chraibi 2004). Also Zn2+ was found to 
modulate ENaC by relieving it from Na+ self inhibition (Sheng, Perry et al. 2004). Both 
Zn2+ and Ni2+ have stimulatory effects on the activity of ENaC at low extracellular 
concentrations. In addition the intracellular Cl- concentration can modulate ENaC 
function. Cl– was shown to have an inhibitory effect on ENaC, when accumulating on the 
cytosolic side (Kunzelmann, Schreiber et al. 2002; Adam, Ousingsawat et al. 2005).   
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Regulation of ENaC by proteases 
The limited proteolysis of α and γ subunits of ENaC plays a key role in regulating channel 
gating (Snyder 2005; Kleyman, Myerburg et al. 2006). The proteolysis was found to 
occur on furin consensus sites in the extracellular loops of the α and γ ENaC subunits near 
the first membrane spanning domains (Thomas and Itani 2004; Snyder 2005). Furin, a 
proprotein convertase was suggested to be the responsible enzyme that acts on ENaC 
within the Trans Golgi Network (Thomas and Itani 2004). The cleavage activates ENaC, 
converting near silent channels into active channels that are capable of transporting Na+ 
ions (Hughey, Bruns et al. 2004; Snyder 2005). On the cell surface, cleaved as well as 
non-cleaved forms of ENaC are present. The unprocessed population of channels might 
subsequently be cleaved and activated by serine proteases like trypsin, channel activating 
protease 1-3 (CAP1-3), TMPRSS3 and neutrophil elastase (Vallet, Chraibi et al. 1997; 
Chraibi, Vallet et al. 1998; Guipponi, Vuagniaux et al. 2002; Rossier 2004; Caldwell, 
Boucher et al. 2005; Snyder 2005). Until now it stayed uncertain whether ENaC cleavage 
is regulated or whether it is a basic step in channel maturation.  
 
CFTR regulates ENaC 
The Cystic Fibrosis Transmembrane Conductance Regulator protein CFTR is an ABC 
transport protein that is expressed in apical membranes of a range of epithelia where it 
works as a chloride channel and a regulator of other channels (Kunzelmann 1999; 
Kunzelmann and Schreiber 1999; Gormley, Dong et al. 2003; Adam, Ousingsawat et al. 
2005). Several studies showed that ENaC function decreases when CFTR is activated by 
a cAMP dependent pathway (Stutts, Canessa et al. 1995; Letz and Korbmacher 1997; 
Ling, Zuckerman et al. 1997; Mall, Bleich et al. 1998; Kunzelmann 1999; Mall, Bleich et 
al. 1999; Berdiev, Shlyonsky et al. 2000). This phenomenon was shown in kidney, 
intestine and trachea epithelia (Letz and Korbmacher 1997; Mall, Bleich et al. 1998; 
Kunzelmann 1999; Mall, Bleich et al. 1999). Evidence was found that the first nucleotide 
binding fold of CFTR is important for the inhibition of ENaC (Schreiber, Hopf et al. 
1999) and that a direct interaction between ENaC and CFTR takes place (Berdiev, 
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Cormet-Boyaka et al. 2007). These findings suggest that CFTR directly influences ENaC 
activity in the membrane.  
 
Phophatidylinosites control ENaC activity 
Several types of ion channels are directly regulated by phosphatidylinositides and 
disruption of this mechanism leads in some cases to disease like Bartter’s syndrome or 
Andersen’s syndrome (Pochynyuk, Tong et al. 2006). Phosphatidylinositol 4,5-
bisphosphate (PIP2) and phosphatidylinositol 3,4,5-triphosphate (PIP3) are 
phosphatidylinositides that directly interact with these channels. Diverse studies suggest 
that ENaC is also a target of phosphatidylinositide regulation (Pochynyuk, Tong et al. 
2006). Decreasing levels of PIP2 lead to a decrease in ENaC activity and open probability 
(Ma, Saxena et al. 2002; Yue, Malik et al. 2002; Tong and Stockand 2005; Pochynyuk, 
Tong et al. 2007) whereas the addition of exogenous PIP3 increases ENaC activity 
(Pochynyuk, Tong et al. 2007). The identification of a putative PIP3 binding site within 
the channel supported the hypothesis that direct binding of PIP3 affects ENaC gating 
(Pochynyuk, Tong et al. 2007).  
 
Hormonal regulation 
Aldosterone, AVP and Insulin are the major hormonal regulators of ENaC (Garty and 
Palmer 1997). These hormones have been shown to increase Na+ transport by altering 
ENaC trafficking to and from the cell surface by different pathways (Snyder 2005; 
Saxena, George et al. 2006; Saxena and Kaur 2006). In the following section I am giving 
a short summary of hormonal effects on ENaC. 
  
Arginine Vasopressin (AVP) activate ENaC trafficking 
The peptide hormone AVP is synthesized in the hypothalamus and released by the 
posterior pituitary in response to increased plasma osmolality and hypovolemia. Next to 
its action on the vasculature where it promotes vasoconstriction AVP is the major 
regulator of water excretion in the kidney (Boron W F 2005). AVP increases intracellular 
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cAMP levels by activating V2 receptors located in the basolateral membrane of collecting 
duct cells. The activation of V2 receptors increases ENaC mediated Na+ transport through 
a pathway that includes cAMP and PKA. cAMP is known to increase the surface 
expression of water channels (AQP) as well as ENaC mediated Na+ currents in target 
cells. ENaC function is augmented by cAMP via an increase in channel exocytosis and 
open probability. In contrast to aldosterone AVP increases ENaC activity as rapidly as 
five minutes after stimulation because it does not depend on de novo synthesis of proteins 
(Snyder 2002; Snyder 2005).  
 
Aldosterone increases ENaC abundance at the apical membrane 
The mineralocorticoid hormone aldosterone is important for the regulation of ENaC, to 
establish Na+ homeostasis and stabilize blood pressure. The effect of aldosterone can be 
divided into an early (20 min – 3 h) and a late phase (6 - 24 h). In the early phase the 
transcription of certain genes is apparently leading to the regulation of ENaC pools at the 
membrane and in vesicles close to the membrane (Lu, Pribanic et al. 2007; Harris, Garcia-
Caballero et al. 2008). Most of the channel proteins are actually located in vesicles close 
to the apical membrane, a so called silent pool of ENaC (Loffing, Zecevic et al. 2001; Lu, 
Pribanic et al. 2007). This pool ensures that the epithelial cell is able to respond very 
quickly to changes in the environment, and mobilize a lot of channels very quickly. To 
mobilize and/or stabilize this pool the cell needs to be able to regulate the endo- and 
exocytosis of these vesicles. Aldosterone is in charge to regulate the transcription of 
specific genes that encode regulatory proteins acting on the activation and trafficking of 
ENaC (Spindler, Mastroberardino et al. 1997; Ichimura, Yamamura et al. 2005; Bhalla, 
Soundararajan et al. 2006; Liang, Peters et al. 2006; Rozansky 2006). Known proteins 
that are transcriptionally regulated by aldosterone and influence the Na+ transport in 
aldosterone target cells were mentioned and described above. In the late phase the 
transcription of α ENaC is induced by aldosterone in collecting duct cells. This triggers 
the assembly and trafficking of the whole channel complex (Asher, Wald et al. 1996; 
Escoubet, Coureau et al. 1997; Loffing, Zecevic et al. 2001; Snyder 2005). 
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Insulin influences ENaC trafficking 
Transepithelial Na+ transport in principal cells of the CCD is also regulated by insulin 
and/or Insulin-like growth factor 1 (IGF-1), which is thought to induce a rapid increase in 
the number of Na+ channels in the luminal membrane (Record, Johnson et al. 1996; 
Gonzalez-Rodriguez, Gaeggeler et al. 2007). This hypothesis is supported by the fact that 
insulin also increases the density of Na+ channels expressed in the apical membrane in a 
toad kidney cell line (A6 cell line) (Erlij, De Smet et al. 1994).  The increase of Na+ 
transport in these cells mediated by insulin treatment is synergistic to the effect of 
aldosterone which can be explained by the fact that insulin activates Sgk1 by 
phosphorylation while aldosterone increases Sgk1 expression (Record, Johnson et al. 
1996; Wang, Barbry et al. 2001; Faletti, Perrotti et al. 2002; Lee, Ma et al. 2007; Tiwari, 
Nordquist et al. 2007). These findings suggest that insulin influences ENaC trafficking. 
Furthermore insulin has been suggested to induce the direct phosphorylation of ENaC 
which is linked to an increase in channel activity (Shimkets, Lifton et al. 1998; Zhang, 
Alvarez de la Rosa et al. 2005).  
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3.5  Ubiquitylation / Deubiquitylation 
 
Ubiquitylation is not only involved in the regulation of ENaC as mentioned earlier but 
rather a general mechanism for triggering many different cellular mechanisms.  Ubiquitin 
a small 7.6 kDa protein which is ubiquitously expressed in eukaryotic cells plays an 
important role in mechanisms regarding a variety of cellular functions (Stryer 1999; 
Haglund and Dikic 2005; Staub and Rotin 2006). It is highly conserved through the 
evolution and can be covalently bound to ε amino goups of lysine residues of specific 
target proteins. The ubiquitylation of proteins shows similarities to the phosphorylation of 
proteins: it is inducible, reversible and specific (Haglund and Dikic 2005). The 
attachment of ubiquitin to proteins regulates gene transcription, DNA repair and 
replication, intracellular trafficking as well as virus budding (Haglund and Dikic 2005). 
Proteins are beforehand targeted for ubiquitylation, which can be genetically programmed 
or acquired by phosphorylation or by binding to an adapter protein as well as by protein 
damage (Wilkinson 2000). The covalent binding to target proteins is performed in a 
process with three distinct steps involving ubiquitin-activating (E1), ubiquitin-conjugating 
(E2) and ubiquitin-ligating (E3) enzymes (Haglund and Dikic 2005). The E1 enzyme is in 
charge to activate ubiquitin. The terminal carboxyl group of ubiquitin is bound by a 
thiolesther bond to a sulfhydryl group of the E1 enzyme. This reaction reminds the ATP 
driven activation of fatty acids or amino acids. The activated ubiquitin is then transferred 
to a sulfhydryl group of the E2 Enzyme. The ubiquitin ligase E3 finally catalyses the 
transfer of ubiquitin from E2 enzymes to target proteins (Stryer 1999) and is responsible 
for substrate recognition (Staub and Rotin 2006). Two major types of E3 enzymes are 
existing:  HECT (homologous to E6-AP COOH terminal) E3s and RING (really 
interesting new gene) finger E3s. RING finger E3 enzymes have a cluster containing 
cystein and histidin residues which are coordinated by zinc ions. RING finger E3 
enzymes work in concert with the E2 enzyme to ubiquitylate the target. Target proteins 
are directly ubiquitylated by HECT E3 enzymes after ubiquitin was transferred to a 
conserved cystein within the HECT domain of the E3 enzyme. HECT domain E3 
enzymes include the family of Nedd4/Nedd4-like ubiquitin protein ligases (Staub and 
Rotin 2006). 
 Figure 5  
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Figure 5:  Ubiquitylation of substrates through two different E3 enzymes. An ubiquitin-activating enzyme, 
E1, activates ubiquitin in an ATP-dependent manner, whereby a transfer of ubiquitin to the active site 
cysteine of an ubiquitin-conjugating enzyme, E2 is accomplished. A) E3 is an ubiquitin-protein ligase that 
facilitates the transfer of ubiquitin from the E2 onto a lysine residue of a target protein (substrate). B) HECT 
domain containing E3 ligases carry out isopeptide formation between ubiquitin and the substrate. E4 
enzymes promote the construction of polyubiquitin chains and deubiquitylating enzymes (DUBs) are in 
charge to reverse the ubiquitylation reaction. This figure was adapted from Staub and Rotin 2006. 
 
 
Ubiquitylation occurs in different flavours: Monubiquitylation, diubiquitylation, 
multiubiquitylation and polyubiquitylation. Monoubiquitylation occurs if one ubiquitin is 
linked to a lysine residue of the targed protein, while diubiquitylation is the attachement 
of one diubiquitin on one lysine residue. Are several lysine residues tagged with a single 
ubiquitin molecule the target is multiubiquitylated. In contrast, polyubiquitylation is 
defined by the binding of ubiquitin chains to the target protein. Cytosolic proteins that are 
designated for proteosomal degradation are in general polyubiquitylated while membrane 
proteins and proteins of the trafficking machinery are usually monoubiquitylated or 
diubiquitylated (Staub and Rotin 2006).  
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3.5.1 The ubiquitylation of ENaC 
 
Each of the ENaC subunits contains a PY motif at its cytoplasmic C-terminus that was 
identified as a binding site for members of the Nedd4/Nedd4-like ubiquitin protein ligase 
family (Schild, Lu et al. 1996; Staub, Dho et al. 1996; Abriel and Staub 2005; Staub and 
Rotin 2006). One member of the Nedd4 family, Nedd4-2 was identified to regulate ENaC 
activity by controlling its cell surface stability (Staub, Dho et al. 1996; Staub, Gautschi et 
al. 1997; Rotin, Staub et al. 2000). Mutations in the PY motifs of ENaC lead to the 
inherited disease Liddle’s syndrome since ENaC ubiquitylation is impaired and channel 
internalization is reduced (Abriel and Staub 2005; Staub and Rotin 2006). Nedd4-2 
exhibits three consensus phosphorylation sites for Sgk1 and protein kinase A (PKA) 
which are mediators of the aldosterone and the AVP pathways respectively 
(Debonneville, Flores et al. 2001; Snyder, Olson et al. 2002; Snyder, Olson et al. 2004; 
Snyder 2005). ENaC is ubiquitylated at lysine residues of the α, β and γ subunit.  
Subsequently its surface expression and the Na+ transport are decreased (Adam, Fakitsas 
et al 2007; Snyder 2005). Sgk1 is decreasing the internalization of ENaC by 
phosphorylating and blocking Nedd4-2. It was shown that indeed Nedd4-2 
phosphorylation blocks the interaction with ENaC (Staub, Dho et al. 1996; Staub, 
Gautschi et al. 1997; Staub, Yeger et al. 1997; Abriel and Staub 2005; Butterworth, 
Edinger et al. 2007). Further involved in the ubiquitylation of ENaC is the aldosterone 
induced protein 14-3-3, a member of a family of highly conserved regulatory molecules 
(Yaffe 2002; Liang, Peters et al. 2006). The functionally important Sgk1 target motif 
within Nedd4-2 conforms to the 14-3-3 consensus motif. It could be shown that Nedd4-2 
is a substrate of 14-3-3 protein binding in response to Sgk1 phosphorylation (Bhalla, 
Daidie et al. 2005; Liang, Peters et al. 2006). It is suggested that binding of 14-3-3 
physically obstructs the interaction between ENaC and Nedd4-2 and that the concerted 
action of 14-3-3 and Sgk1 inhibit ENaC ubiquitylation by Nedd4-2 (Bhalla, Daidie et al. 
2005; Liang, Peters et al. 2006).  
 
 
 
Figure 6 
 
 
Figure 6. Schematic representation of the effect 
of serum and glucocorticoid induced kinase 1 
(Sgk1) and Nedd4-2 on the regulation of ENaC. 
Sgk1 that is transcriptionally induced by 
aldosterone interacts with Nedd4-2 to 
phosphorylate it. Interaction of Nedd4-2 with 
ENaC is inhibited by 14-3-3 that binds to the 
amino acid residue in Nedd4-2 that was 
beforehand phosphorylated by Sgk1. 
Subsequently, ENaC ubiquitylation, 
internalization, and degradation in the lysosomal 
pathways is blocked which leads to an increase 
in the amount of intact Na+ channels at the cell 
surface. (Illustration by Josh Gramling - 
Gramling Medical Illustration. Figure was taken 
from Staub and Verrey 2005.  
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3.6 Voltage gated ion channels 
 
The main types of stimuli known to activate ion channels are changes in membrane 
voltage, mechanical stress and ligand binding. The focus of this section is on the 
activation of ion channels by voltage changes and the structure and function of voltage 
gated ion channels. I have included this section since we identified a voltage gated proton 
channel as one of the early aldosterone induced gene products in mouse ASDN. 
Many physiological processes are mediated by members of the voltage gated ion channel 
superfamily which comprises more than 140 members. Seven groups of ion channel 
families are included in this superfamily. General convergences between all subgroups 
are that they are all transmembrane proteins and triggered by voltage differences over the 
plasma membrane (Yu, Yarov-Yarovoy et al. 2005). Voltage gated ion channels are the 
basis of diverse physiological key functions in the body like nerve impuls conduction, 
muscular contraction and synaptic transmission.  The different voltage gated ion channels 
exhibit different ion selectivities for cations like Na+, K+ or Ca2+ (Terlau and Stuhmer 
1998; Elinder, Nilsson et al. 2007). The best studied voltage gated ion channels are 
voltage gated potassium channels (Kv-channels) which exhibit a secondary structure that 
is typical for the whole voltage gated ion channel protein family (Figure 7). Kv channels 
are a construction of four homologous subunits each of which exhibits six transmembrane 
helices (S1-S6). Corresponding to its functions voltage gated ion channel subunits contain 
two different but functionally coupled domains: The pore domain and the voltage sensor 
domain (VSD). The pore domain, responsible for the selective ion conductance, is 
constructed by two transmembrane segments (S5-S6) and a membrane reentrant loop 
from each subunit which form a cavity that is filled with permeant ions (Figure 7). This 
ion conducting pore contains a selectivity filter that is formed by a characteristic amino 
acid sequence (Sands, Grottesi et al. 2005; Yu, Yarov-Yarovoy et al. 2005; Tombola, 
Pathak et al. 2006). Since the Kv channels are homotetramers the pore is built by the 
arrangement of four S6/S5 domains surrounded by the four VSDs (Tombola, Pathak et al. 
2006) (Figure 7). 
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Figure 7: Topology model of a Kv channel (A) The transmembrane topology of a Kv channel 
subunit, showing the voltage sensor domain (VSD) in red, the pore domain in blue, the S4-S5 
linker in purple, and the tetramerization domain in green. The intact channel is made up of four 
such subunits. (B) The Kv1.2 tetramer is shown in a top view (extracellular side) whereby each 
subunit is revealed in a different color. Potassium ions are colored purple. This figure was 
adapted from Tombola, Pathak et al. 2006.  
Since voltage gated channels need to sense the electrical field over the plasma membrane, 
they contain a so called “voltage sensor”. The VSD, responsible for the voltage sensing 
and gating reacts to changes in the electrical field by a conformational change within the 
protein which is driven by the movement of electrical charges (Sands, Grottesi et al. 
2005; Yu, Yarov-Yarovoy et al. 2005). The charge movement within the molecule is 
called gating current and causes the pore structure to open and to conduct ions. During 
channel activation an outward translocation of positive charges takes place. The S4 
transmembrane helix is responsible for the ability of the VSD to act as a molecular 
voltmeter. It contains repeated motifs of one positively charged amino acid surrounded by 
hydrophobic residues (Catterall 1986; Yu, Yarov-Yarovoy et al. 2005) (Figure 7). It is 
believed that these positively charged amino acid residues are forcing the VSD to move 
within the lipid bilayer dependent on the transmembrane voltage (Miller 2006).  Different 
models of voltage sensor movement are currently discussed within the field. However, it 
is known that the four VSD of a typical Kv channel are working independently but that 
the opening of the pore only happens after allosteric interaction between all four subunits 
(Okamura 2007). 
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3.6.1 Voltage sensor domain proteins (VSP) 
Until recently the VSD was considered to be a structure that only regulates the gating of 
voltage gated ion channels, but proteins were discovered that have the structure of a VSD 
and do not include a pore domain. These types of proteins were named voltage sensor 
proteins (VSP) (Okamura 2007). It was found that these proteins exhibit diverse voltage 
regulated functions like enzymatic activity or proton conductance (Murata, Iwasaki et al. 
2005; Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006). One of these proteins is 
composed of a VSD with four transmembrane segments and a phosphatase domain that is 
similar to the well characterized phosphatase PTEN (phosphatase and tensin homologue 
deleted on chromosome 10) (Maehama, Taylor et al. 2001; Murata, Iwasaki et al. 2005). 
Since gating currents in response to changes in membrane voltage could be observed in 
oocytes expressing this voltage sensor containing phosphatase (Murata, Iwasaki et al. 
2005) it is assumed that the VSD is a functional unit by itself.  Furthermore, it is the first 
phosphatase characterized which is directly regulated by voltage changes over the 
membrane (Murata and Okamura 2007).  However, the stoichiometry and the mechanism 
of voltage dependent regulation within the voltage sensor containing phosphatase is still 
uncertain and remains to be explored in detail (Okamura 2007). Next to the VSD 
containing phosphatase also a Na+-H+-exchanger, an adenylate cyclase and a proton 
channel was found within the VSPs (Okamura 2007). 
 
 
 
 
 
 
 
 
Figure 9 
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A    B    C 
gure 9: Membrane topology model of a voltage gated ion channel and two voltage sensor domain 
roteins: A voltage-regulated phosphatase and a voltage gated proton channel. (A) Voltage-gated ion 
3.6.2 Voltage gated proton channels 
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conductance in heterologous expression systems (Ramsey, Moran et al. 2006; Sasaki, 
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channel, (B) voltage-regulated phosphatase, (C) voltage-gated proton channel. The voltage sensing TM 
domain is depicted in dark gray and shows a number of positive charges. Arrows are showing the ion flow 
though the protein. This figure was taken from Okamura 2007. 
 
In 2006 a VSP was identified that show
Takagi et al. 2006). Two independent research groups investigated the human (Hv1) and 
the mouse (mVSOP) ortholog, respectively. Similar to other VSP these voltage gated 
proton channels are composed of four transmembrane helices (S1-S4) whereupon the S4 
transmembrane helix comprises three positively charged arginine residues bordered by 
each two hydrophobic residues. Voltage gated proton channels (Hv channels) were first 
described 1982 by Thomas et al in snail neurons and subsequently found in rat alveolar 
epithelial cells, mammalian eosinophils, macrophages, microglia, and in a wide variety of 
other cell types (Thomas and Meech 1982; Decoursey 2003; Morgan and DeCoursey 
2003). H  channels exhibit several properties that distinguish them from other ion channel 
or proton transporters. 
v
Their characteristic feature is the unique pH dependence of gating, 
in which the voltage activation relationship depends strongly on the intracellular (pHi) 
and extracellular pH (pHo) (Decoursey 2003; Sasaki, Takagi et al. 2006). These channels 
were until recently only characterized by electrophysiology and it was proposed that the 
newly identified VSPs (H 1 and mVSOP) which exhibit a voltage dependent proton 
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metal ions are potent 
 
conductance could be the molecular basis of electrophysiologically well characterized Hv 
channels (Decoursey 2003; Okamura 2007).  
Hv channels were found to be highly selective for protons, while other ion permeabilities 
could not be detected. External Zn2+, Cd2+ and other polyvalent 
inhibitors for Hv channels. Noteworthy is that the conductance and gating kinetics of Hv 
channels are remarkably temperature dependent (Decoursey 2003). Even though all Hv 
channels exhibit voltage and pH dependent gating many different types of Hv channels 
exist which are mainly distinguished by their differences in gating kinetics (Decoursey 
2003). 
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4 Material and Methods 
 
4.1 Constructs for in vitro cRNA synthesis, retroviral 
      transfection and site-directed mutagenesis  
 
Mouse kidney, spleen or muscle RNA was isolated with RNeasy Mini Kit according to 
the manufacturer’s protocol (Qiagen, Hombrechtikon, Switzerland) and reverse 
transcribed (oligoDT primers) using the TaqMan Reverse Transcription Kit (Applied 
Biosystem, Foster City, USA). cDNAs were amplified by PCR using 2.5 U of a 
proofreading polymerase (Pfu) (Promega, Madison, USA), 1x Pfu-reaction buffer 
(Promega), 2 mM dNTPs, 0.5 µM 5’-Primer, 0.5 µM 3’-Primer for 40 cycles (30 sec 
95°C, 1 min 50-68°C, 1-7 min 68°C). Primers for PCR were designed to include 
restriction sites for cloning and were synthesized by Microsynth (Balgach, Switzerland) 
(Table 2). PCR products were separated from the template by agarose gel electrophoresis 
and purified with Quiagen Gel extraction kit. The amplified PCR fragments were cloned 
in oocyte and cell expression vectors (Table 2). PCR products and target vectors were cut 
with the corresponding restriction enzymes (Fermentas, Harrington, Canada; New 
England Biolabs Inc., Ipswich, USA) and ligated using T4 ligase (Fermentas). The 
constructs were used to transform supercompetent E. coli bacteria (DH5 alpha, 
Invitrogen, Basel, Switzerland). Correct cloning was checked by DNA sequencing 
(Microsynth, Balgach, Switzerland). 
For changing cysteine 67 of Usp2-45 to alanine the QuickChange® site directed 
mutagenesis kit (Stratagene, La Jolla, USA) was used with following primer pair: 
 5’-AACCTTGGGAACACGGCTTTCATGAACTCAATT-3’; 
 5’-AATTGAGTTCATGAAAGCCGTGTTCCCAAGGTT-3’. 
 
Oocyte expression vectors containing X. laevis ENaC (αβγXENaC) (Puoti, May et al. 
1997), rat ENaC (αβγrENaC) (Canessa, Schild et al. 1994), X. laevis Sgk1 (XSgk) 
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(Mastroberardino, Spindler et al. 1998; Firsov, Schild et al. 1996; Puoti, May et al. 1995), 
rat ROMK2 (Chen, Bhargava et al. 1999), flounder Napi-IIb (Forster, Wagner et al. 
1997), rat αNa+-K+-ATPase (αrNa+-K+-ATPase) (Shull, Greeb et al. 1986), X. laevis 
βNa+-K+-ATPase (βXNa+-K+-ATPase) (Pfeiffer, Beron et al. 1999) cDNAs were also 
used for cRNA synthesis and microinjection in several experiments (Adam, Fakitsas et al. 
2007). 
 
Table 2 
cDNA Primer Sequences Vector Linearizing 
enzyme 
mUsp2-45: 5’-AAAACTCGAGCCGCGTTGGGTTTGGGGCATAG-3’, 
5’-AAAAAAGCTTGGGGCCACCACAGGGAAGAG-3’ 
pSDeasy 
pLPCX 
BglI 
mUsp15: 
 
5’-AAAACTCGAGGCTAGTGGAAGAAGATGGCGGAAG-3’ 
5’-AAAAAAGCTTGGGATTTATTTGGGATTTCCT-3’. 
pSDeasy PvuI 
mUsp53fl: 5’-AAAACTCGAGGTTGTCCACTGGTCACATTACAGAT-3‘ 
5‘-AAAACCCGGGTAAAGGTCTTTGTTCAGAAGGACAG-3‘ 
KSM 
pCDNA3 
NotI 
mUsp53t: 5’-AAAACTCGAGCTTTGCCTGTCACGACGTT-3’ 
5’-AAAACCCGGGTGTTCAGAAGGACAGTTGACG-3’ 
KSM 
pLNCX 
XbaI 
mUsp2-69 5’-AAAACTCGAGCCCATGAGGCTCCCAGTACC-3’ 
5’-AAAAAAGCTTGGCCACCACAGGGAAGAGGGAAG-3’ 
pSDeasy 
pLPCX 
PvuI 
mVSOP 
(mHv1) 
5’-AAAACTCGAGATGACTTCCCATGACCCAAA-3’ 
5’-AAAAAAGCTTAGGCAGAGATGGAGACTGGA-3’ 
pCDNA3 StuI or SmaI 
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4.2 cRNA synthesis 
 
For cRNA synthesis, plasmids were linearized with distinct restriction enzymes (Table 2), 
purified by using PCR purification kit (Quiagen) and used as template for RNA synthesis 
with T7, T3 or SP6 mMESSAGE mMACHINE™ kit (Ambion, Applied Biosystems) 
dependent on the vector. The procedures were done following the instructions of the 
manufactorers. cRNA was purified with the RNeasy mini kit (Quiagen) and the integrity 
was checked by agarose gel electrophoresis. Quantification was done by using the 
NanoDrop ND-1000 spectrophotometer (Agilent Technologies, Santa Clara, USA) 
(Adam, Fakitsas et al. 2007).  
 
 
 
4.3 Xenopus laevis oocytes 
 
Stage V and VI oocytes were treated for 25-35 minutes at room temperature with 2mg/ml 
collagenase type 1A in Ca2+-free buffer (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 10 
mM HEPES pH7.4) containing 0.2 mg/ml trypsin inhibitor (Sigma-Aldrich Chemie 
GmbH, Buchs, Schwitzerland) to detach from the ovarium and to remove follicular cells. 
The oocytes were then kept at 16°C in Barth’s solution (88 mM NaCl, 1 mM KCl, 0.82 
mM MgSO4, 0.41 mM CaCl2, 0.33 mM Ca(NO3)2, 2.4 mM NaHCO3, 5 mM HEPES, pH 
7.4). After cRNA injection oocytes were incubated at 16°C in ND96 (96 mM NaCl, 2 
mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, HEPES pH 7.4) or ND10 (10 mM NaCl, 2 mM 
KCl, 1.8 mM CaCl2, 1 mM MgCl2, 86 mM NMDG, 5 mM HEPES, pH 7.4) dependent on 
the cRNA injected and the following experimental procedure. All solutions for oocyte 
incubation were supplemented with antibiotics (10 mg/l gentamycin/doxycycline (Fluka, 
Buchs, Switzerland)). 
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4.4 Two-electrode voltage-clamp (TEVC) 
 
The two-electrode voltage clamp technique was used for the recording of whole-cell 
currents from X. laevis oocytes at room temperature 40-48 h after injection of αβγENaC, 
Sgk, Usp15, Usp2-69, Usp2-45, Usp53t/fl, Hv1 and 3 days after injection of  αrNa+-K+-
ATPase, βXNa+-K+-ATPase, NaPi-IIb cRNA using a commercial two electrode voltage-
clamp (Oocytes Clamp OC725C, Warner Instrument Corp. Hamden, USA) connected to a 
data acquisition hardware (Digidata 11322A, Axon Instrument Foster. City, USA). A 
computer running pClamp8 software (Axon Instruments) was used to control the clamp, 
the valves switching the solutions, and to record currents, as previously described 
(Forster, Wagner et al. 1997). Microelectrodes (resistance < 7 MΩ) were filled with 3 M 
KCl. Two basic protocols were used for generating steady-state recordings: (1) 
Continuous current recordings. X. laevis oocytes were tested at a membrane holding 
potential of -50 mV, recorded data was low pass filtered at 10 Hz and digitized at 20 Hz. 
(2) Current-Voltage (I-V) recordings. Oocytes were clamped at -50 mV and step changes 
in membrane holding potential were applied (Range and increments varied dependent on 
the experiment). At each membrane potential four pulses were averaged. Current records 
were low-pass filtered at 500 Hz and digitized at 20 µsec/point. Calculations and graphs 
were made using GraphPad Prism™ Version 4.0 (GraphPad Inc., San Diego, USA) and 
significance was tested using the Student’s t-test, Kruskal-Wallis or Mann-Whitney test 
(Adam, Fakitsas et al. 2007).  
 
 
4.4.1 Electrophysiological measurements of Iamil carried by ENaC 
 
ENaC expressing oocytes as well as the corresponding control oocytes were kept in ND10 
solution for 40-48 hour after cRNA injection (0.05 ng/SU/oocyte ENaC). Recordings 
were made in ND10 and ND96 solutions; 10 µM amiloride (Sigma) was added to the 
ND96 solution to measure the amiloride-sensitive part of the current (Iamil). Applied 
voltage steps were ranging from -140 mV to +20 mV or from -100 to +100 mV in 20 mV 
increments of 80 ms duration. cRNAs of Usp2-45 (10-36 ng cRNA injected), Usp2-
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45mut (10 ng cRNA/oocyte), Usp53t (15 ng cRNA/oocyte), Usp53fl (15 ng 
cRNA/oocyte), Hv1 (1-20 ng cRNA/oocyte) or Usp2-69 (10 ng cRNA/oocyte) were 
coinjected. All measurements were done at similar conditions (Adam, Fakitsas et al. 
2007).  
 
 
4.4.2 TEVC measurements in Hv1 expressing oocytes 
 
Oocytes expressing Hv1 were kept for 2-3 days in ND96 or Barth’s solution at 16°C prior 
the experiment. Applied voltage steps were ranging from -100 mV to +180 mV in 20 mV 
increments of 80-1000 ms duration. Recordings were performed in ND96 solution with 
varying pH (pH 6, pH 7.4, pH 8) or supplemented with 1 µM ZnCl2. pH was adjusted by 
using Tris base. For the examination of Zn2+ sensitivity, a specific voltage step protocol 
was used (Figure 24 A). After clamping the voltage to 100 mV for 150 ms, voltage steps 
ranging from 20 mV to -100 mV in 20 mV increments were applied for 150-300 ms. The 
basic membrane potential was clamped to -50 mV, at each membrane potential four 
pulses were averaged. 
 
 
 
4.4.3 Measurements of ROMK2 mediated K+ current 
 
Oocytes expressing ROMK2 (2 ng cRNA per oocyte injected) and coexpressing ROMK2 
with Hv1 (20 ng cRNA injected) were kept for 40-48 h in ND96 solution. ROMK2-
mediated current was defined as Ba2+-sensitive current. The current recorded at a 
membrane potential of -50 mV was inhibited by substitution of 1.8 mM Ca2+ with Ba2+ in 
the ND96 solution (Chen, Bhargava et al. 1999). 
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4.4.4 Napi-IIb mediated currents  
 
10 ng flounder Napi-IIb cRNA was injected 3-4 days before the TEVC measurements. 
Phosphate currents carried by type IIb Na+/Pi cotransporter (NaPi-IIb) (Forster, Wagner et 
al. 1997) were obtained by addition of 1 µg/ml phosphate (Pi) (K2HPO4 and KH2PO4 
stocks that were mixed to give pH 7.4) to ND96. Currents were recorded at a stable 
membrane potential of -50 mV. Napi-IIb mediated currents were calculated by 
subtracting the values of basal currents from currents obtained after Pi addition. 
 
 
4.4.5 Pump current measurements 
 
The activity of  the exogenous and endogenous Na+-K+-ATPase was determined as the 
outward current activated by addition of K+ in the presence of K+ channel blocker such as 
TEA and BaCl2 (Horisberger, Jaunin et al. 1991). After injection with cRNA for α and β 
subunits of the pump, oocytes were kept in ND10 solution for 2-4 days. Pump current 
measurements were done in two different ways. (1) Coexpression of ENaC for controlled 
Na+ loading (2) Na+ loading without ENaC expressed.  
(1) To control Na+ loading of oocytes I used oocytes coexpressing ENaC. Oocytes were 
kept in Na-free solution (50 mM NMDG-Cl, 40 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 
mM NMDG-HEPES pH 7.4) over night before measurements. For Na+ loading, oocytes 
were first clamped at -50 to -100 mV and washed with K+-free Na+-solution (100 mM 
Na-gluconate, 1 mM  MgCl2, 1 mM CaCl2, 10 mM Na-HEPES pH 7.4) until the 
membrane potential reached a stable baseline. The absence of extracellular K+ prevents 
the pump from functioning as it needs both the intracellular Na+ and the extracellular K+ 
as substrates for its ATPase activity.  The intracellular Na+ concentration was determined 
by applying Na-measurement solution with and without 10 µM amiloride (5 mM Na-
gluconate, 0.5 mM MgCl2, 2.5 BaCl2, 95 mM NMDG-Cl, 10 mM NMDG-HEPES pH 
7.4) (Crambert, Hasler et al. 2000). IV curves performed in voltage steps of 20 mV from -
100 mV to +80 mV of the duration of 80 msec were applied in the Na+-measurement 
solution with or without 10 μM amiloride to identify the Na+ current carried via ENaC.  
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The crossing point of two subsequent current to voltage relationship curves (IV) indicates 
on the voltage axis the reversal potential for Na+ (Erev) from which the intracellular 
concentration for Na+ can be calculated using the Nernst equation. The IV curves were 
performed until the crossing point fell into the range between 0 and +15 mV (equivalent 
to an intracellular Na+ concentration of ~70 mM), ensuring that the starting condition of 
intracellular Na+ concentration was similar for all oocytes. After the determination of the 
intracellular Na+ concentration pump current measurements were performed at a stable 
membrane potential of -50 mV using the pump-current-measurement solution (120 mM 
sucrose, 0.82 mM MgCl2, 0.41 mM CaCl2, 10 mM NMDG-HEPES, 5 mM BaCl2, 10 mM 
TEA-Cl, 10 mM KCl, 10 µM amiloride) (Zecevic, Heitzmann et al. 2004). The current 
carried by the pumps containing the endogenous X. laevis α-subunit is sensitive to 50 µM 
strophantidin and the subsequent addition of 3 mM ouabain blocks the current that 
corresponds to the hybrid pumps (exogenous) containing the ouabain-resistant rat α-
subunit. A typical pump current recording is shown in figure 10. 
(2) Oocytes were first loaded with Na+ by a 2-3 h exposure to a K+ free solution (100 mM 
Na-gluconate, 1 mM MgCl2, 0.5 mM CaCl2, 10 mM HEPES pH 7.4). Whole cell currents 
were measured at membrane potential clamped to -50 mV. The pump was activated by 
application of external K+ upon exposure to K+-containing solution (80 mM Na-
gluconate, 10 mM KCl, 0.8 mM MgCl2, 0.4 mM CaCl2, 5 mM BaCl2, 10 mM TEA-Cl, 10 
mM Hepes-NMDG pH 7.4). Outward current is recorded and its sensitivity to 
strophantidin (50 μM) or ouabain (3 mM) (Sigma) dissolved in the same solution is 
measured (Jaisser, Horisberger et al. 1992).   
 
 
 
 
 
 
Figure 10 
 
 
 
 
 
 
 
 
 
 
Figure 10: Typical recording of Na+-K+ATPase mediated current. As the Na+-K+-ATPase pumps three 
sodium ions out of the cell in exchange for two potassium-ions that enter, the resulting net positive charge 
flux is visible as outward current. Oocytes clamped at -50 mV were perfused with the K+ containing 
solution to activate the pump. The endogenous pump current is inhibited by strophantidin in a µM range, 
while the exogenous rat α Na+-K+-ATPase is almost resistant to this blocker at this concentration. To 
identify the portion of current carried by the rat isoform, 3 mM ouabain is applied in the same solution and 
further decrease of K+ stimulated current is observed (exogenous pump current).  
 
4.5 Culture and retroviral transduction of mpkCCDc14 cells 
The mouse kidney cell line mpkCCDcl4 and its culture were originally described by Bens 
et al. (Bens, Vallet et al. 1999). mpkCCDcl4 cells were seeded respectively on 12 mm 
diameter snapwell filters or 24 mm diameter 24-well plastic plates (Corning Costar) in 
standard medium (DMEM:Ham’s F12, 1:1 vol/vol; 60 nM Na+-selenate, 5 mg/ml 
transferrin, 2 mM glutamine, 50 nM dexamethasone, 1 nM triiodothyronine, 10 ng/ml 
epidermal growth factor, 5 mg/ml insulin, 20 mM D-glucose, 2% fetal calf serum (FCS), 
and 20 mM Hepes, pH 7.4) and incubated at 37°C in 5% CO2/95% air. For 
electrophysiological measurements, real-time PCR or Western blot analysis, cells were 
grown for 5–7 days in standard medium of culture and for electrophysiology an additional 
2-7 days in filter medium (standard medium without serum, Apo-transferrine and EGF) 
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cells were transferred into serum- and hormone-deprived medium 12 – 20 h prior to the 
experiments. To obtain maximal effects that are mediated via the glucocorticoid receptor, 
aldosterone was used at 10 6 M (Bens, Vallet et al. 1999).  
Stable populations of mpkCCDc14 cells expressing Usp2-45, and Usp-2-45mut were 
obtained according to the protocol provided on the website 
http://www.stanford.edu/group/nolan/ with slight modifications (Summa, Camargo et al. 
2004; Adam, Fakitsas et al. 2007). Briefly, ecotropic pseudoretroviral producer cells 
(Phoenix, Nolan Lab, Stanford, USA) were plated 24 h prior to transfection at 50% 
density on 60 mm plates. The next day, 5 µg of the retroviral construct encoding Usp2-45 
or Usp2-45mut were applied using FuGENE6 (Roche, Basel, Switzerland) according to 
the manufacturers recommendation. The medium was replaced after 24 h and the cells 
subsequently kept at 32°C. The pseudo-retrovirus-containing supernatant was harvested 
after 24 h and filtered through a 45 µm sterile filter. After addition of Polybrene (Sigma) 
at a final concentration of 4 µM, the entire supernatant (3 ml) was given to 5% confluent 
mpkCCDcl4 cells plated the day before on 6-well plates (35 mm diameter). The cells were 
centrifuged at 130 g and 32°C for 30 min and then kept for 6 h at 32°C (5% CO2) before 
the supernatant was replaced by usual medium. The procedure was repeated the next day 
using fresh retroviral supernatant harvested from the same Phoenix cells. A transduction 
efficiency of 70–100% was achieved when using EGFP (enhanced green fluorescent 
protein) as a marker. This protocol was repeated 2 times to achieve maximal expression. 
The resulting multiclonal cell populations were then kept under selective pressure with 1 
µg ml−1 puromycin (Adam, Fakitsas et al. 2007). 
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4.6 Western blotting and lysis of mpkCCDc14 cells and X. laevis 
      oocytes 
 
An antibody selective for the mUsp2-45 isoform of mUsp2 was raised against a NH2-
terminal epitope (MRTSYTVTLPEEPAAC) (Pineda Antibody Services, Berlin, 
Germany) and affinity purified on antigen peptide using the SulfoLink® Kit 
(Pierce/Perbio, Bonn, Germany) according to the manufacturer’s protocol (Adam, 
Fakitsas et al. 2007). An antibody selective for the mUsp53 was raised against the epitope 
CGLPFHVDESSVAGK in rabbit and the serum was directly used for detection of 
proteins on Western blot. The antibody specific for mouse Hv1 was raised against an 
epitope (CSEKEQEIERLNKL) as described before (Ramsey, Moran et al. 2006).  The 
antibody against both, Usp2-45 and Usp2-69 (pan Usp2) was ordered from Abgent 
(Cat.Nr.:AP2131c). Anti-myc-HRP monoclonal antibody was ordered at Invitrogen 
(Cat.Nr.:46-0709) and the monoclonal anti-HA antibody was purchased from Sigma 
(Cat.Nr.: H9658). 
mpkCCDc14 cells were harvested from plastic cultures and lysed in RIPA buffer (150 mM 
NaCl, 1% IPGAL, 0.5% DOC, 0.1% SDS, 50 mM Tris, pH 7.5) by passing them 10 times 
through a 25 G needle and X. laevis oocytes were lysed in buffer containing 250 mM 
sucrose, 0.5 mM EDTA, 5 mM Tris-HCl, pH 6.9, 1 mM PMSF, and 1 mg/ml of leupept 
also by passing them 10 times through a 25 G needle. Oocyte debris were pelleted by two 
consecutive centrifugations at 100 g for 10 min at 4°C. Equal amounts of proteins derived 
from mpkCCDc14 cells and a smaller amount from oocyte expressing Usp2-45, Usp2-69, 
Usp53t, Usp53fl, Hv1 and/or ENaC (protein amount per lane equivalent to 1 oocyte) were 
loaded on a 10% or 12% SDS PAGE and subsequently transferred electrophoretically to a 
PVDF-membrane (Immobilon-P, Millipore, USA). After blocking with 3-5% milk in 
Tris-buffered saline / 0.1% Triton X-100 (Sigma) overnight at 4°C or 1 h at room 
temperature, the blots were incubated with primary antibody (10 μg/ml anti-Usp2-45 
affinity purified or anti-Usp53 rabbit serum 1:1000) in 2.5% milk for 2 h at room 
temperature or over night at 4°C. After washing and subsequent blocking for 1 h at room 
temperature, blots were incubated with goat anti-rabbit secondary antibody conjugated 
with horseradish peroxidase (1:10,000; BD Transduction Laboratories, Franklin Lakes, 
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USA) for 1 h at room temperature. Antibody binding was detected with the Super-Signal1 
West Pico Substrate (Pierce). Chemiluminescence was detected with a DIANA III camera 
(Raytest, Straubenhardt, Germany) after different exposure times (Adam, Fakitsas et al. 
2007).  
 
 
4.7 Aldosterone treatment and total RNA extraction from 
       mpkCCDc14 cells 
1 µM aldosterone was added to the minimal culture medium of mpkCCDc14 cells grown 
on 100 mm plastic dishes. At 5 different time points cells were harvested and the RNA 
was extracted. Cells were lysed by scratching them from the plate using RLT buffer 
supplemented with β-mercaptoethanol (10 µl/ml) and passing them at least five times 
through a 20 G needle. For RNA extraction Quiagene RNA extraction Kit was used and 
the procedures were done following the manufacturers instructions. The quantification of 
the total RNA extracted from a 100 mm dish was perfomed using NanoDrop ND-1000 
spectrophotometer (Agilent Technologies). For real-time RT PCR 10-100 ng of RNA per 
reaction was used.  
 
4.8 Real-Time RT-PCR  
Samples of 3 µl RNA (out of 60 µl) were used as templates for reverse transcription using 
TaqMan® Reverse Transcription Kit (Applied Biosystems) in the presence of 2.5 µM 
random hexamer primers (Applied Biosystems). Real-time PCR was performed using 3.5 
µl of the cDNA as template using the TaqMan® Universal PCR master mix (Applied 
Biosystems). Primers and probes were designed using Primer Express 2.0 software 
(Applied Biosystems) to result in amplicons of 70-100 bp that span intron-exon 
boundaries. Each primer pair was first tested on mouse kidney cDNA and resulted in a 
single product of the expected size (data not shown). Probes were labelled with reporter 
dye FAM at the 5’ end and the quencher dye TAMRA at the 3’ end (Microsynth). 
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Reactions were run in 96-well optical reaction plates using a Prism 7700 cycler (Applied 
Biosystems). Thermal cycles were set at 95°C (10 minutes) and the 40 cycles at 95°C (15 
seconds) and 60°C (1 minute) with auto ramp time. To analyze the data, the threshold was 
set to 0.06 (value in the linear range of amplification curves). All reactions were run in 
triplicates and the abundance of the target mRNAs was calculated relative to a reference 
mRNA coding for hypoxanthine guanine phosphoribosyl transferase (HPRT). Assuming 
an efficiency value of 2 (fold-increase in input mRNA required to decrease the cycle 
number by 1), relative expression ratios were calculated as R = 2(Ct(HRPT) – Ct(test)), where Ct 
is the cycle number at the threshold and test stands for the tested mRNAs (Adam, Fakitsas 
et al. 2007). The real-time PCR primers and probes used were the following: 
 
HPRT:  
Forward primer: 5’-TATCAGACTGAAGAGCTACTGTAATGACC-3’ 
Reverse primer: 5’- TTACCAGTGTCAATTATATCTTCAACAACAATC-3’ 
Probe : 5’-TGAGAGATCATCTCCACCAATAACTTTTATGTCCC-3’ 
Usp53:  
Forward primer : 5’-TTGTGTGACTCATCAGAAGTTTGC-3’ 
Reverse primer: 5’-AAAGGGCAGAGGCTCTGAGG-3’ 
Probe: 5’-ACACGTGAAGGAGATGGGAACCAGATG-3’ 
Hv1: 
Forward primer: 5’-CACCAAGATCCAGCATCTGGA-3’ 
Reverse primer: 5’-CAGCTTGTTGAGCCGCTCA-3’ 
Probe: 5’-TTCAGCTGCTCCGAGAAGGAACAAGAA-3’ 
4.9 Transepithelial electrophysiological measurements 
The resistance across intact monolayers of mpkCCDc14 cells was measured with a 
Millicell (Millipore) device. A transepithelial resistance of 2 kOhm x cm2 was considered 
as prerequisite for using the filter cultures for further electrophysiological measurements. 
Filters were mounted in a multichannel voltage current clamp device (Model VCC MC6 
Revision B, Physiological Instruments) and monolayers maintained under current clamp 
conditions at a DC clamp level of 0 µA. Bipolar pulses of 5 µA were given for 620 ms 
every 60 sec. After 90 min, aldosterone (300 nM) was added to the medium. The medium 
was kept at 35-38°C and pH was continuously adjusted by CO2 supply. The ENaC-
mediated Na+ current was specifically blocked by 10 µM amiloride after another 150 min 
and calculated as the difference in short circuit current before and 15 min after amiloride 
addition (Beron, Mastroberardino et al. 1995; Summa, Mordasini et al. 2001; Adam, 
Fakitsas et al. 2007).  
 
 
Figure 11 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 : Original transepithelial current recording using an Ussing chamber system. mpkCCDc14 
monolayers were treated with aldosterone (300 µM) (red) and after 150 min amiloride was applied to 
visualize the ENaC mediated current. In parallel mpkCCDc14 cells were mounted and treated with the 
vehicle as a control (black).  Iamil is significantly higher in aldosterone treated cells.  
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4.10 Kidney fixation 
Male mice were anesthetized with ketamine (90 mg/kg body weight, Narketan 10, 
Vétoquinol, Lure, France) and xylazine (10 mg/kg body weight, Streuli, Uznach, 
Switzerland) intraperitoneally and perfused through the left cardiac ventricle with 
phosphate-buffered saline (PBS, 0.9% NaCl in 10 mM phosphate buffer, pH 7.4) 
followed by a buffered paraformaldehyde solution (4%, pH 7). The thoracic and 
abdominal cages were opened to allow access to the heart and to the vena cava distally to 
the kidneys. The vena cava was sectioned and the whole body perfused through the left 
heart ventricle, with 50 ml of PBS, followed by 50 ml a paraformaldehyde-lysine 
periodate (PLP, 4% paraformaldehyde, 7 mM NaH2PO4, 30.5 mM Na2HPO4, 10.5 mM 
Na+ periodate, 58 mM L-Lysine, 146 mM sucrose), as previously described (Paunescu et 
al Jul 2004). Kidneys were removed, incubated overnight in PLP, washed several times 
with PBS and stored in PBS-0.02% Na+ azide at 4°C (Paunescu, Da Silva et al. 2004). 
Kidney was then mounted with Kryostat OCT (Medite, Nunningen, Switzerland), frozen 
in liquid propane and stored at – 80°C. 
 
4.11 Immunofluorescence  
Kidney sections of 5 µm were cut on a Leica CM1850 cryostat (Leica, Wetzlar, 
Germany), applied to polylysine-coated slides (Kindler, Freiburg, Germany) and stored at 
-20°C. Sections were hydrated 15 min in PBS, washed three times with PBS, and then 
incubated with the primary antibodies diluted in PBS-0.04% Triton X-100 for 1 h at room 
temperature. The primary antibody rabbit anti-mHv1 was diluted 1:50 (Pineda, Berlin, 
Deutschland) and the polyclonal goat anti human AQP2 antibody 1:500 (Santa Cruz 
Biotechnology, Inc, Santa Cruz, USA) and the rabbit anti m-pendrin (kind gift of C. 
Wagner; (Schulz, Dave et al. 2007)). Sections were then washed three times and 
incubated with the secondary antibody diluted in PBS-0.04% Triton X-100 for 1 h at 
room temperature. The secondary antibodies Alexa Fluor 488 donkey anti-goat IgG,  594 
goat anti-mouse IgG (Molecular Probes, Invitrogen, Carlsbad, USA), Cy2 donkey anti-
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guinea pig (Jackson ImmunoResearch Laboratories Inc. Newmarket Suffolk, UK) were 
diluted (1:500 - 1:1000). After being washed three times, the sections were mounted with 
Glycergel medium (DakoCytomation, Glostrup, Denmark). Digital images were viewed 
by using a Nikon Eclipse TE300 epifluorescence microscope (Nikon Instruments Inc., 
Melville, USA) equipped with a DS-5M Standard CCD camera (Nikon) and acquired 
with NIS-Elements (Nikon). Images were further processed using Photoshop 7 (Adobe, 
San Jose, USA) (Romeo, Dave et al. 2006). 
 
4.12 Statistics 
Data were expressed as means ± SEM. Calculations and graphs were made using 
GraphPad Prism™ Version 4.0 (GraphPad Inc.) and significance was tested using the 
Student’s t-test, Kruskal-Wallis or Mann-Whitney test.  
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5 Results 
Using an Affymetrix gene-screen, we identified a list of mouse connecting and collecting 
duct genes that are regulated by aldosterone in a short term manner (Adam, Fakitsas et al. 
2007). The gene screen was done by Panos Fakitsas. My work focused on three 
significantly up-regulated gene products: the ubiquitin-specific proteases Usp2 and Usp53 
and the voltage gated proton channel mVSOP (Hv1). Their impact on channels and 
transporters involved in Na+ absorption in the collecting duct was investigated using 
mainly exogenous co-expression in the X. laevis oocyte system. Further experiments were 
performed in mpkCCDc14 cells. The retroviral transduction of mpkCCDc14 cells was done 
by Dr. Simone M. R. Carmargo and mouse kidney fixation was elegantly performed by 
Dustin Singer.  
 
5.1 Original research article 
This section contains an original research article published in January 2007 in the Journal 
of the American Society of Nephrology. It gives new insights in the short term regulation 
of ENaC by aldosterone via ubiquitylation/deubiquitylation. The article provides 
informations about a gene screen performed on mRNA obtained from microselected 
mouse distal nephron. One of new aldosterone regulated gene products, Usp2-45 was 
shown to regulate ENaC function by deubiquitylation.  
Panos Fakitsas performed the gene screen analysis and members of the laboratory of Prof. 
O. Staub contributed to the article performing experiments in Hek293 cells. My 
contribution to the research article was showing ENaC activation by Usp2-45 in oocytes 
and mpkCCDc14 cells. A more detailed description of the results that I provided to this 
article is to be found in section 5.2 of this thesis. Panos Fakitsas who did the gene screen 
analysis shared with me the first authorship. 
 
Early Aldosterone-Induced Gene Product Regulates the
Epithelial Sodium Channel by Deubiquitylation
Panagiotis Fakitsas,* Gabriele Adam,* Dorothe´e Daidie´,† Miguel X. van Bemmelen,†
Fatemeh Fouladkou,† Andrea Patrignani,‡ Ulrich Wagner,‡ Richard Warth,*
Simone M.R. Camargo,* Olivier Staub,† and Franc¸ois Verrey*
*Institute of Physiology and Centre for Integrative Human Physiology, University of Zurich, ‡Functional Genomics
Centre, Eidgeno¨ssische Technische Hochschule & University of Zurich, Zurich, and †Institute of Pharmacology and
Toxicology, University of Lausanne, Lausanne, Switzerland
The mineralocorticoid hormone aldosterone controls sodium reabsorption and BP largely by regulating the cell-surface
expression and function of the epithelial sodium channel (ENaC) in target kidney tubules. Part of the stimulatory effect of
aldosterone on ENaC is mediated by the induction of serum- and glucocorticoid-regulated kinase 1 (Sgk1), a kinase that
interferes with the ubiquitylation of ENaC by ubiquitin-protein ligase Nedd4-2. In vivo early aldosterone-regulated mRNA
now has been identified in microselected mouse distal nephron by microarray. From 22 mRNA that displayed a two-fold or
more change, 13 were downregulated and nine were upregulated. Besides Sgk1, the induced mRNA include Grem2 (protein
related to DAN and cerebrus [PRDC]), activating transcription factor 3, cAMP responsive element modulator, and the
ubiquitin-specific protease Usp2-45. The induction of this last enzyme isoform was verified in mouse distal nephron tubule
at the protein level. With the use of Hek293 cells, Xenopus oocytes, and mpkCCDc14 cells as expression systems, it was shown
that Usp2-45 deubiquitylates ENaC and stimulates ENaC-mediated sodium transport, an effect that is not additive to that of
Sgk1. A deubiquitylating enzyme that targets ENaC in vitro and thus may play a role in sodium transport regulation was
identified within a series of new in vivo early aldosterone-regulated gene products.
J Am Soc Nephrol 18: 1084–1092, 2007. doi: 10.1681/ASN.2006080902
T he stimulatory action of the mineralocorticoid hormonealdosterone on Na reabsorption and K secretion canbe arbitrarily divided in an early regulatory and a late
anabolic phase (1). Early changes in salt transport can be ob-
served within 30 min after initiation of a hormonal treatment
and correspond to short-term regulatory effects that occur dur-
ing circadian fluctuations and at the onset of more drastic
regulatory changes as elicited by restricted salt uptake or loss of
extracellular volume (2,3). These early actions are thought to be
mediated mostly by the induction/repression of proteins that
belong to the regulatory pathways that control the function of
preexisting transport effectors such as the epithelial sodium
channel (ENaC) and the Na,K-ATPase and K channels. As
yet, only a few aldosterone-induced regulatory proteins have
been identified and experimentally shown to have an impact on
ENaC function. These are K-Ras2, identified in amphibian cells,
GILZ, identified in mammalian kidney cells, and the serum and
glucocorticoid-regulated kinase serum- and glucocorticoid-reg-
ulated kinase 1 (Sgk1) that was also shown to be regulated in
mammalian kidney (4–8). Furthermore, the kidney-specific
short form of Wnk1 that stimulates Na reabsorption via the
Na-Cl co-transporter (NCC) was shown to be regulated by
aldosterone in cultured kidney cells (9).
An important mechanism by which Sgk1 stimulates ENaC
cell-surface expression and function is by phosphorylating the
ubiquitin-protein ligase Nedd4-2 and thereby interfering with
its function. Ubiquitylation (i.e., the labeling of target proteins
with ubiquitin polypeptides) of membrane proteins has been
recognized in recent years as an important mechanism for
controlling the cell-surface expression and endosomal/lysoso-
mal degradation of this type of protein (10,11). When Nedd4-2
is not phosphorylated, it can bind to the PY motif in the
COOH-termini of ENaC subunits and ubiquitylate ENaC on
lysine residues that are situated in the NH2 termini, thereby
inducing channel downregulation at the plasma membrane
(12–16). It is interesting that the lack of PY motif in - or
-ENaC that is characteristic of Liddle syndrome, an inherited
form of salt-sensitive hypertension (17–19), leads to an increase
in cell-surface ENaC expression and possibly also to an aug-
mentation in its open probability (Po), causing Na
 retention,
low K, and hypertension (7,20–22). The short signaling cas-
cade that leads from Sgk1 induction via inhibition of Nedd4-2 to
the activation of ENaC represents the first direct link between
the aldosterone-regulated transcriptional activity of the miner-
alocorticoid receptor and the function of ENaC that has been
demonstrated (13).
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The Sgk1–Nedd4-2 pathway, however, cannot be the only
link between aldosterone and ENaC function. This has been
indicated by the results of experiments that were performed
with mpkCCDcl4 cells that expressed Liddle-type ENaC chan-
nels or with mice that expressed an ENaC- subunit with
Liddle mutation, thus displaying impaired ENaC/Nedd4-2 in-
teraction (23,24). In these systems, aldosterone was still able to
stimulate transepithelial sodium transport. Hence, the path-
ways that link the transcriptional activity of activated miner-
alocorticoid receptor to ENaC function independent of ENaC
PY motif and thus presumably independent of Nedd4-2–medi-
ated ubiquitylation still need to be clarified. In that respect, it is
interesting to mention two observations that support the pos-
sibility of an additional aldosterone-induced regulatory mech-
anism that has an impact on ENaC function/surface expres-
sion, namely the demonstration of an unsuspected regulatory
role of -ENaC in collecting duct cells and of a stimulation of
ENaC by Sgk1 that is mediated by the phosphorylation of the 
subunit (25,26). It therefore is anticipated that other gene prod-
ucts are rapidly regulated by aldosterone in target cells that
participate to the control of Na reabsorption and K secretion.
In this study, we describe the comparison by microarray of
RNA that were extracted from epithelial cells of the aldoste-
rone-sensitive distal nephron (ASDN) of control and aldoste-
rone-treated mice. We thereby identified 22 significantly and
more than two-fold regulated RNA. We anticipate that some of
them encode proteins that participate in early regulatory effects
of aldosterone that are independent of ENaC ubiquitylation.
However, in this study, we focused on the induced deubiqui-
tylating enzyme Usp2-45 and demonstrated in expression sys-
tems that it deubiquitylates ENaC and increases its function.
Materials and Methods
Animal studies were in accordance with the Guide for Care and Use
of Laboratory Animals (Institute of Laboratory Animal Resources, Na-
tional Academy of Science, Bethesda, MD).
Mouse Treatment, Kidney Dissection, and Tubule
Microcollection
Female C57BL/6JOlaHsd mice (Harlan, Horst, The Netherlands),
approximately 8 wk of age, received drinking water that contained
0.3% NaCl for at least 5 d before the treatment. All mice were housed
in a temperature- and humidity-controlled room with an automatic
12-h light/dark cycle (6 a.m./6 p.m.). Aldosterone (Acroˆs Organics,
Pittsburgh, PA; 10 g/kg body wt in 0.33% ethanol and 0.9% NaCl) or
canrenoate (Sigma, Sternheim, Germany; 10 mg/kg in 0.9% NaCl) was
injected intraperitoneally, or mice were left untreated. Forty-two min-
utes later, mice were anesthetized with ketamine (Ve´toquinol AG,
Uznach, Switzerland) and xylazine (Streuli AG, Uznach, Switzerland;
intraperitoneally 100 and 0.5 g/g, respectively). They were then per-
fused through the left ventricle with Ringer solution that contained
collagenase and protease (5 and 1 mg in 15 ml, respectively; Sigma)
while the lower vena cava was opened. Kidneys were removed and cut
transversally in 2-mm slices that were incubated for 10 min at 38°C in
a collagenase solution (1 mg/ml Ringer solution). These tubule prep-
arations were then transferred to ice-cold Ringer (1 h after aldosterone
injection), washed, and resuspended three times. Segments (75 to 85) of
cortical collecting duct/connecting tubule (CCD/CNT; approximately
1.1 mm of total length) were identified under a binocular microscope
(SMZ1000; Nikon AG, Egg, Switzerland) at 4°C and transferred directly
into RLT lysis buffer of the Qiagen RNeasy Micro Kit (Qiagen AG,
Hombrechtikon, Switzerland) that contained 1% -mercaptoethanol
(Sigma-Aldrich, Buchs, Switzerland) using a pair of sharp forceps
(F.S.T. GmbH, Heidelberg, Germany). For plasma aldosterone and
corticosterone measurements, mice were anesthetized as described, and
blood was collected by puncture of the vena cava. Plasma aldosterone
and corticosterone levels were measured using an ELISA and a 125I-RIA
kit from Immuno-Biologic Laboratories (Hamburg, Germany), respec-
tively.
RNA Purification and Quality Control, Microarray Target
cRNA Preparation, Target cRNA Hybridization and
GeneChip Scanning, Real-Time Reverse Transcriptase–PCR,
Quality Control of Microarrays, and Statistical Analyses
Please refer to online supplementary materials for detailed methods.
Prediction of Mineralocorticoid Hormone Response Elements
in the Promoter Region of the Mouse Usp2-45 Gene and
Western Blotting of Usp2-45 in Microcollected Mouse
Kidney CNT and CCD
Please refer to online supplementary materials for detailed methods.
Cloning of Mouse Usp2-45, Usp2-69, and Usp15; Site-
Directed Mutagenesis and cRNA Preparation; and
Coexpression of mUsp2-45, Usp2-69, mUsp15, XENaC,
and XSgk in Xenopus laevis Oocytes
Please refer to online supplementary materials for detailed methods.
Two-Electrode Voltage Clamp on Xenopus Oocytes,
Ubiquitylation of ENaC in Hek293 Cells, and Culture and
Retroviral Transduction of mpkCCD Cells
Please refer to online supplementary materials for detailed methods.
Western Blotting and Real-Time PCR of Usp2-45 in
mpkCCDc14 Cells and Transepithelial Electrophysiologic
Measurements
Please refer to online supplementary materials for detailed methods.
Results
Microarray to Identify Early Aldosterone-Regulated mRNA
in Mouse ASDN
To identify other early aldosterone-regulated gene products
in kidney target cells in vivo, we first established a short-term
aldosterone treatment scheme in mice. Female C57BL/6J mice
that received 0.3% NaCl in their water to repress partially their
endogenous aldosterone production were administered an in-
jection at 10:00 a.m. (4 h after beginning of daytime) with
aldosterone (10 g/kg body wt; Figure 1, A and B) or were left
untreated. The aldosterone injection led to a transient increase
in plasma aldosterone that 15 min after injection was at a level
of approximately 10 nM, a value within the range expected for
mice on a low-salt diet (27). The plasma aldosterone concentra-
tion was nearly back to the initial value of approximately 0.5
nM after 60 min.
To obtain kidney aldosterone-target tissue RNA 1 h after
hormone injection, mice were anesthetized 42 min after aldo-
sterone injection and rapidly perfused with collagenase solu-
tion. Kidneys were removed, sliced, and further digested in
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collagenase solution at 38°C for the rest of the hour (in the
absence of aldosterone). The tubule preparation was then trans-
ferred to 4°C, and segments of CNT/CCD were microselected.
The RNA samples that were prepared from single mice were
tested in terms of quantity, integrity, enrichment, contamina-
tion, and response to aldosterone (Figure 1, C and D). These
measurements revealed that in microisolated CNT/CCD seg-
ments, ENaC mRNA was enriched 15- to 40-fold over total
kidney, whereas thick ascending limb–specific triple co-trans-
porter Na,K,Cl co-transporter 2 (NKCC2) mRNA was not
increased. Sgk1 mRNA was enriched three- to four-fold over
the total kidney preparation and specifically further increased
five- to six-fold by aldosterone. It is interesting that the mere
manipulation of the mice increased plasma corticosterone
slightly (Figure 1, A and B) but did not have an impact on Sgk1
expression (Figure 1, C and D). More than two thirds of the
prepared RNA samples fulfilled the selection criteria of quan-
tity, integrity, enrichment, lack of contamination, and Sgk1
induction and could be used as template for cDNA amplifica-
tion and labeled target RNA synthesis. Target cRNA made
from six control and from six aldosterone-injected mice were
separately hybridized to mouse full genome GeneChip mi-
croarrays (MOE 430 v2; Affymetrix, Santa Clara, CA). Raw
array data were processed using the GCRMA and the MAS5
algorithms (Microarray data are available at Array Express
with the accession number E-TABM-229.) The data were fil-
tered using a t test with a cutoff P  0.05 and using a fold-
change limit of 2.0. The cumulative list of genes that fulfilled
these criteria after processing with one of the algorithms com-
prised 90 genes (73 genes with GCRMA and 39 with MAS5). As
detailed in Table 1, 22 genes fulfilled these criteria with both
algorithms, nine that are upregulated and 13 that are down-
regulated. A scatter plot and the hierarchical clustering of the
results that were calculated by the GCRMA method are shown
in Supplementary Figure 1B. We retested the differential ex-
pression level of eight mRNA that were identified in the mi-
croarray screen by real-time RT-PCR (see primers and probes
sequences in the online supplementary material) on RNA from
three other mice per condition. As shown in Table 1, the regu-
lation was verified in six cases.
Aldosterone-Induced Usp2-45 Deubiquitylates ENaC
Ubiquitylation of ENaC had previously been shown to play
an important role in the control of Na reabsorption (12) and
our screening had confirmed that Sgk1, a kinase that is known
to inhibit the action of the ubiquitin-protein ligase Nedd4-2 on
ENaC, was rapidly induced by aldosterone. We focused now
on Usp2, a ubiquitin-specific protease that was also induced
and belongs to a large protein family that is involved in revers-
ing the ubiquitylation of target proteins (28–30). We specifically
investigated the potential role of the isoform Usp2-45 that we
detected in kidney by reverse transcriptase–PCR (RT-PCR),
unlike the other isoform Usp2-69 that is expressed only at low
levels in the kidney (31) (P.F. and F.V., unpublished observa-
tion) and in mpkCCDc14 cell (10-fold difference; discussed fur-
ther). The analysis of the promoter region around the TATA
box of the Usp2-45 isoform identified at least four potential
hormone response elements that support the possibility of a
direct regulation by aldosterone (see Supplementary Figure 2).
An induction by aldosterone of the shorter Usp2-45 isoform but
not of the Usp2-69 isoform was also detected in mpkCCD cells
(discussed further).
To test whether the aldosterone-induced Usp2-45 mRNA
induction translates in vivo into an increase in Usp2-45 protein,
we performed Western blotting of proteins that were prepared
from microselected segments of CNT/CCD that were obtained
from mice that were subjected to the same hormone treatment
as previously performed for the mRNA studies. As shown in
Figure 2, the polyclonal rabbit anti-mouse Usp2-45 antibody
recognized a 45-kD band that was blocked by competing im-
munizing peptide. This band was selectively increased 1 h after
an aldosterone injection by a factor of approximately 2, as
Figure 1. Conditions of short-term aldosterone stimulation. (A)
Time course of plasma aldosterone and corticosterone levels
after intraperitoneal aldosterone injection (10 g/ kg body wt)
at 10 a.m. (means  SEM, n  3 mice per time point). (B)
Comparison of plasma aldosterone (aldo) and corticosterone
(cort) at 10 a.m. and at 10:30 a.m. with or without injection of
vehicle at 10 a.m. (means  SEM, n  3 to 6 mice per point). (C
and D) Test for enrichment and aldosterone stimulation of
RNA prepared from microselected connecting tubule/cortical
collecting duct (CNT/CCD). Mice were administered an injec-
tion of aldosterone as in A or canrenoate or were left untreated,
and RNA was prepared from tubules that were obtained after
1 h. The abundance of  and  epithelial sodium channel
(ENaC), Sgk1 and Na,K,Cl co-transporter 2 (NKCC2)
mRNA was measured by real-time reverse transcriptase–PCR
(RT-PCR) in RNA that was prepared from total kidney (C) and
from microselected tubule segments (D). Given are means rel-
ative to -actin  SEM; n  6 mice. ***P  0.0001 by one-way
ANOVA.
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previously shown for the mRNA. That the Usp2-45 mRNA
indeed encodes an active ubiquitin-specific protease was con-
firmed by the fact that its core domain that is produced in
Escherichia coli very efficiently cleaves ubiquitin off from a test
substrate in vitro (B. Oberfeld et al., unpublished observations)
(32).
To test the possible impact of Usp2-45 on ENaC function, we
coexpressed it with ENaC in Xenopus laevis oocytes and com-
pared the effect of Usp2-45 with that of Sgk1, the kinase that
inhibits endogenous Nedd4-2. Coexpression of Usp2-45 with
ENaC increased the level of amiloride-sensitive Na current
nearly four-fold, an effect similar to that of Sgk1 (Figure 3A and
Supplementary Figure 3, A and B). It is interesting that coex-
pression of Sgk1 with Usp2-45 did not further increase ENaC
function, suggesting that these two enzymes have an impact on
the same regulatory mechanism (Figure 3A and Supplementary
Figure 3B).
To test whether the effect of Usp2-45 was mediated by its
protease activity, we mutated its cysteine 67 that corresponds to
one of the catalytically active amino acids of its cysteine pro-
tease motif (31,33). Consistent with a requirement for an enzy-
matically active Usp2-45, this mutant did not affect ENaC ac-
tivity at the membrane (Figure 3B and Supplementary Figure
3C). To control whether this effect of Usp2-45 was specific for
this ubiquitin-specific protease, we carried out the same exper-
iment with another randomly chosen ubiquitin-specific pro-
tease, Usp15. The results indicated that the effect of Usp2-45 is
specific, because coexpression of Usp15 in contrast rather de-
creased ENaC function (Figure 3C and Supplementary Figure
3D). It is probable that this latter effect is due to the deubiqui-
tylation of other proteins that interfere with the expression of
ENaC. In addition, we coexpressed the longer Usp2-69 isoform
that turned out not to have an impact on ENaC function (Figure
Table 1. Kidney CNT/CCD RNA that changed two-fold or more by 1 h of aldosteronea
RNAb
Affymetrix GeneChip Real-Time RT-PCR
Genebank
Accession
No.
Fold
Changec Range P
Fold
Changed P
Upregulated genes
protein related to DAN and cerberus NM_011825 7.2 2.1 to 17.7 0.045 5.6 0.029
serum/glucocorticoid regulated kinase NM_011361 4.0 3.0 to 5.1 0.0001 8.1 0.001
activating transcription factor 3 BC019946 3.5 2.5 to 4.9 0.001 8.6 0.018
cAMP responsive element modulator NM_013498 3.0 1.3 to 4.5 0.004 1.1 0.651
mus musculus transcribed sequences AI098139 2.9 1.7 to 3.6 0.001
RIKEN cDNA clone 6430570G24 BG069663 2.8 1.7 to 4.4 0.004
ubiquitin specific protease 2 AI553394 2.2 1.2 to 3.8 0.019 1.6 0.001
growth arrest and DNA-damage-inducible 45 gamma AK007410 2.2 1.5 to 3.2 0.001
RIKEN cDNA clone 6430570G24 BG069663 2.2 1.5 to 2.9 0.0001
Downregulated genes
RIKEN cDNA 4833417L20 gene AK017914 0.5 0.3 to 0.9 0.014
imilarity to pir:A45973 (H.sapiens) AI597080 0.5 0.3 to 0.6 0.009
argininosuccinate synthetase 1 BM213298 0.4 0.3 to 0.5 0.007
RIKEN cDNA clone:D630044A17 BB498095 0.4 0.2 to 0.6 0.006
partial mRNA for hypothetical prot. BG817292 0.4 0.3 to 0.6 0.006
fatty acid binding protein 1, liver NM_017399 0.4 0.2 to 0.8 0.006
transcribed sequences BE991175 0.4 0.2 to 0.6 0.006
RIKEN cDNA clone:C230084M03 BM123508 0.4 0.2 to 0.8 0.005
RIKEN cDNA 4833417L20 gene BM217861 0.4 0.3 to 0.4 0.004
H/K-ATPase alpha, nongastric NM_138652 0.4 0.1 to 0.8 0.004 1.0 0.946
Slc22a8 (Oat3) AV330315 0.3 0.1 to 0.6 0.004 0.1 0.024
G0/G1 switch gene 2 NM_008059 0.3 0.2 to 0.6 0.003 0.2 0.015
RIKEN cDNA clone E030031K24 BB533736 0.3 0.2 to 0.5 0.003
aRNA in italics were also tested by real-time reverse transcriptase–PCR.
bRNA with fold-change 2 and t test P  0.05 using GCRMA and MAS5 algorithms.
cValues were obtained using GCRMA.
dReal-time PCR data were obtained with specific intron spanning primer/probe sets, n  3 mice.
Figure 2. Usp2-45 detected by Western blot in CNT/CCD. Al-
dosterone treatment and tubule microselection were as de-
scribed for mRNA preparations. (A) Western blot with rabbit
anti-mouse Usp2-45 antibody with or without immunizing
peptide identifies a 45-kD band that is competed by immuniz-
ing peptide. (B) Representative pair of Western blots from a
control and an aldosterone-treated mouse. The top panels show
the actin band, and the bottom panels show the Usp2-45 band
visualized on the same blots. (C) The Usp2-45 signals were
normalized to the actin signal of the same mouse (n 3 for each
condition), and the means are shown. **P  0.01.
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3D). In this case, we also verified by Western blotting that this
ubiquitin-specific protease isoform was indeed expressed as
expected (Figure 3E).
We then asked whether Usp2-45 interferes with Nedd4-2–
dependent regulation of ENaC, a mechanism that involves the
interaction of Nedd4-2 with PY motifs that are present on the
C-termini of the ENaC subunits and is defective in Liddle
syndrome (14). ENaC that was devoid of PY motifs ( Y673A,
 Y618H,  Y628A) is resistant to Nedd4-2 and thus displayed
a higher level of amiloride-sensitive Na current than did
wild-type ENaC. This current was indeed resistant to the stim-
ulatory action of Usp2-45 (Figure 3F). This observation sup-
ports the hypothesis that Usp2-45 cleaves off ubiquitin moieties
that Nedd4-2 ligates onto ENaC. The involvement of direct
ENaC ubiquitylation was then verified by coexpressing
Usp2-45 with ENaC that was devoid of potential ubiquitylation
sites (lysine residues of the intracellular NH2-terminal domains
of all three subunits mutated to arginine) in Xenopus oocytes.
As expected for the case that Usp2-45 deubiquitylates ENaC
directly, this mutant channel was not activated in the presence
of Usp2-45 (Figure 3G).
To verify that the effect of Usp2-45 on ENaC function was not
an artifact that was due to the coexpression of two proteins in
Xenopus oocytes but also takes place with endogenous ENaC in
CCD cells, we addressed this question using the mouse CCD
cell line mpkCCDc14 (34). We actually first verified whether
Usp2-45 is expressed and regulated by aldosterone in these
cells. The relative expression of the two isoforms in mpkCCDc14
cells was similar to the observation made in microdissected
CNT/CCD with a 10-fold higher expression of the Usp2-45
Figure 4. Expression of endogenous and exogenous Usp2-45 in
mpkCCDcl4 cells. (A) Regulation of endogenous Usp2-45, Usp2-
69, and Sgk1 mRNA by aldosterone (106 M; see Materials and
Methods in online supplementary material and reference [35])
in mpkCCDc14 cells. Usp2-45 upregulation is slightly more
delayed than that of Sgk1. Unlike its isoform Usp2-45, Usp2-69
is not induced by aldosterone. Baseline mRNA abundance of
Usp2-45 was 10-fold higher than that of Usp2-69. Fold changes
of normalized means relative to -actin  SEM are given (n 
3). The isoform-specific real-time RT-PCR primers and probes
are shown in online supplementary material. (B) Baseline trans-
epithelial Iamil across mpkCCDcl4 cell monolayers that were
cultured on permeable supports is significantly increased in
cells that overexpressed Usp2-45 compared with vector-trans-
duced negative control cells (NC) and cells that were trans-
duced with protease-dead Usp2-45mut (). *P  0.05; n  9 to
12. Aldosterone (300 nM) given for 3 h increased Iamil similarly
in the monolayers that were made of the different mpkCCDcl4
cell populations ( ).
Figure 3. Usp2-45 increases amiloride-sensitive Na current (Iamil)
carried by coexpressed -ENaC. Original tracings are shown in
Supplementary Figure 3. (A) Summary of amiloride-sensitive
whole-cell currents at a holding potential of 100 mV. Coexpres-
sion of Usp2-45 or of XSgk1 increased the ENaC-mediated amilo-
ride-sensitive Iamil to a similar extent. These effects were not
additive. Data are means  SEM; n  23 to 27. **P  0.01; ***P 
0.001. (B through D) Characterization of Usp2-45 stimulatory ef-
fect on Iamil in Xenopus oocytes. (B) Cys67Ala protease-dead
Usp2-45 mutant (Usp2-45mut) does not stimulate XENaC current
Iamil at100 mV. Data are means SEM; n 12 to 15. **P 0.01.
(C) Another Usp (Usp15) does not stimulate XENaC-mediated
Iamil at100 mV. Data are means SEM; n 20 to 24. *P 0.05;
***P 0.001. (D) The Usp2-45 isoform does not stimulate XENaC-
mediated Iamil at 100 mV. Data are means  SEM; n  20 to 22.
***P  0.001. (E) Western blot made with lysate of control and
Usp2-45– and Usp2-69–expressing Xenopus oocytes and incu-
bated with a pan-Usp2 antibody shows specific bands that corre-
spond to each isoform, confirming that both were similarly ex-
pressed and that the lack of ENaC stimulation by Usp2-69 was not
due to a lack of expression of this isoform. (F) Effect of Usp2-45 on
ENaC-mediated Iamil is prevented bymutation of rENaC PYmotif
(rENaC-PYm). Iamil at100 mV is shown. Data are means SEM;
n  4 independent experiments with a total of 20 oocytes. *P 
0.05 using paired t test. (G) Effect of Usp2-45 on ENaC-mediated
Iamil is prevented by mutation of rENaC ubiquitylation site (ly-
sine-mutant rENaC-Km). Iamil at 100 mV is shown. Data are
means SEM; n 4 to 5 independent experiments with a total of
20 and 25 oocytes, respectively. *P 0.05; **P 0.01; ***P 0.001.
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mRNA. The time course of the regulation by aldosterone re-
vealed that only the Usp2-45 isoform was regulated (Figure
4A). To investigate the effect of Usp2-45 on the transepithelial
Na transport function, we expressed exogenous Usp2-45 as
well as mutant protease-dead Usp2-45 in mpkCCD cells by
retroviral transduction and verified by Western blot that the
expression levels were equal (Supplementary Figure 4). As
expected, when ENaC expression and activity were limited by
its ubiquitylation, expression of functional Usp2-45 increased
the baseline transepithelial amiloride-sensitive Na transport
(Figure 4B). In contrast, the expression of the protease-dead
mutant had no effect. The increase in Na transport that was
induced by aldosterone (300 M; see Materials and Methods in
the online supplementary material and reference [35]) that was
given for 3 h was not modified significantly by the expression
of wild-type and mutant Usp2-45, as expected considering that
short-term aldosterone prevents the Nedd4-2–mediated ubiq-
uitylation of ENaC by inducing Sgk1. These results that were
obtained in CCD cells confirm that Usp2-45, a ubiquitin-specific
protease that was identified because of its in vivo regulation by
aldosterone, also acts on endogenous ENaC in kidney tubule
cells.
To test directly the hypothesis that Usp2-45 counteracts the
effect of Nedd4-2 by deubiquitylating ENaC, we used Hek293
cells as an expression system. Coexpression of Nedd4-2 with
ENaC in Hek293 cells massively increased the ubiquitylated
form of the channel that was visualized with anti-ubiquitin
antibody on immunoprecipitates of - and -ENaC, thereby
confirming that ENaC was itself ubiquitylated (Figure 5A). The
impact of ubiquitylation on the total amount of ENaC was
demonstrated by the decreased amount of ENaC that was
visualized in the same samples with anti-ENaC antibody. Im-
portantly, Usp2-45 coexpression decreased the amount of ubiq-
uitylated ENaC and increased total ENaC, demonstrating that
Usp2-45 antagonizes the effect of Nedd4-2 by directly deubiq-
uitylating ENaC. The low level of ubiquitylated ENaC and the
substantial level of total ENaC that was observed with Usp2-45
coexpression were similar to those that were observed with
Nedd4-2cs, a catalytically inactive Nedd4-2 (Figure 5A).
Discussion
Early Aldosterone-Regulated Gene Products
The number of mRNA the level of which was changed two-
fold or more in mouse ASDN within 1 h after an aldosterone
injection is relatively low (22 mRNA). It is noteworthy that the
signal intensity of these regulated mRNA on control mice ar-
rays differs by more than two orders of magnitude, indicating
large differences in their absolute baseline expression levels
(see Supplementary Figure 1A). Not unexpected, the gene
product with the highest absolute expression level and the
second highest relative level of induction is Sgk1, the only early
aldosterone-regulated gene product of mammalian kidney that
has been identified earlier and shown to activate ENaC.
The gene product with the highest fractional increase (7.2-
fold in Affymetrix screen, 5.6-fold by real-time RT-PCR) is
Grem2 (protein related to DAN and cerebrus [PRDC]), an an-
tagonist of bone morphogenic proteins 2, 4, 6, and 7 (36). The
second upregulated gene product on the list is the already
mentioned Sgk1 that is followed by two members of the cAMP
response element binding (CREB) family of transcription fac-
tors, activating transcription factor 3 and cAMP responsive
element modulator.
Our list of early aldosterone-regulated mRNA also included
13 mRNA that are downregulated (Table 1). The known mRNA
with the highest fractional decrease (0.3-fold in Affymetrix
screen, 0.2-fold by real-time RT-PCR) encodes G0s2, a putative
G0/G1 switch gene the downregulation of which might pre-
vent proliferation and thus favor differentiation. It is interesting
Figure 5. Inverse regulation of ENaC ubiquitylation and ENaC
amount. (A) The ubiquitylated and the total amount of ENaC
expressed in Hek293 cells are visualized by Western blotting
(IB) of immunoprecipitated (IP) HA- and Flag-tagged - and
-rENaC subunits, respectively. The molecular weight of
marker proteins is indicated in kD. Coexpression of Nedd4-2
and not of ligase-inactive Nedd4-2 (Nedd4-2cs) increases the
ubiquitylation of both tested ENaC subunits, whereas it de-
creases their total amount. In the presence of Usp2-45, ENaC
ubiquitylation is decreased and the total subunit amount is
increased. (B) Schematic representation of the convergent effect
of Sgk1 and Usp2-45 that both decrease the amount of ubiqui-
tylated ENaC and thus increase the amount of intact channel.
The subcellular localization of these ubiquitylation/deubiqui-
tylation reactions has not yet been identified.
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that there are also two transport proteins among the downregu-
lated gene products, namely the polyspecific organic anion
transporter 3 (Slc22a8) and the colonic H,K-ATPase.
Role of Deubiquitylation in Aldosterone Action
The regulation of the gene products discussed in the previous
section seems to favor a decrease in proliferation of aldosterone
target cells and to foster their differentiation. In addition, our
screen identified with Sgk1 and Usp2-45 two aldosterone-in-
duced gene products that interfere with protein ubiquitylation.
As mentioned at the beginning of this article, Sgk1 was identi-
fied earlier as aldosterone-induced mRNA and protein, and its
effect on ENaC function has been shown to be mediated to a
large extent by its inhibitory action on the ubiquitylating en-
zyme Nedd4-2.
We have now indeed shown that the newly identified aldo-
sterone-induced Usp2-45 directly deubiquitylates ENaC in the
Hek273 cell expression system (Figure 5A). As expected, if the
ubiquitylation of ENaC would lead to ENaC degradation, then
the presence of Usp2-45 not only decreases the amount of
ubiquitylated ENaC but also increases the total amount of
ENaC. This biochemical evidence of ENaC deubiquitylation by
Usp2-45 is supported by functional experiments made in Xeno-
pus oocytes that show an increase in ENaC function that spe-
cifically is mediated by Usp2-45 and that depends on the in-
tegrity of its protease motif. Furthermore, we show both that
the disruption of ENaC PY motifs and the disruption of ENaC
lysine residues that potentially are targeted by Usp2-45 prevent
the action of Usp2-45 on ENaC function. These results also
strongly support the hypothesis that Usp2-45 acts on ubiquitin
moieties that are ligated onto ENaC by the ubiquitin ligase
Nedd4-2 (Figure 5B).
That a deubiquitylating enzyme that acts on ENaC is induced
by aldosterone strengthens the notion that ubiquitylation plays
a central role in the short-term regulation of ENaC. Although
deubiquitylation of target proteins has been described since the
early days of the ubiquitin system discovery (37), it has only
recently gained considerable interest as a regulatory mecha-
nism (for a review on deubiquitylation, see reference [29]). The
mouse as the human genome encodes approximately 100 pu-
tative deubiquitylating enzymes, the function of most of which
is not known. The Affymetrix screen that was presented in this
article revealed that approximately 26 of these Usp are ex-
pressed in the aldosterone target cells of the mouse kidney
tubule (present calls), but only Usp2-45 appeared in the list of
regulated RNA (Table 1). On the basis of our results, the deu-
biquitylation of ENaC by Usp2-45 seems to be specific for
Usp2-45, because none of the four other Usp that we tested in
expression systems activated and/or deubiquitylated this chan-
nel (Figure 3, C and D; unpublished results). As yet, actually
only a few examples of plasma membrane protein deubiquity-
lation have been published. One such example is the deubiq-
uitylation of yeast membrane permeases that leads to their
targeting to the vacuole (equivalent to the mammalian lyso-
some) by the ubiquitin-specific protease Doa4 (38). Another is
the deubiquitylation and stabilization of the EGF receptor by
the endosomal ubiquitin isopeptidases AMSH (associated mol-
ecule with the SHB domain of STAM) and UBPY (ubiquitin-
specific protease Y) (39,40).
The identification of ENaC as a target of Usp2-45 represents
the first report of a hormonally controlled channel-deubiquity-
lating mechanism. It is noteworthy to mention that this effect is
not selective for kidney tubule, because Usp2-45 is also ex-
pressed and regulated in distal colon, yet another target epi-
thelium of aldosterone (P.F. and F.V., unpublished observa-
tions). Previously published data on Usp2 suggest that its
isoform Usp2-69 is regulated by androgens in liver and pros-
tate, where it deubiquitylates and stabilizes fatty acid synthase
(33). Furthermore, Usp2 was shown to be regulated in bone by
parathyroid hormone (41), indicating that the Usp2 gene prod-
ucts mediate various important hormonally regulated func-
tions.
That the stimulatory action of Usp2-45 on ENaC depends on
previous ENaC ubiquitylation indicates, however, that Usp2-45
induction cannot explain the effect of aldosterone on Liddle-
type mutant ENaC (see the beginning of this article) (23,24).
Therefore, it is expected that still other aldosterone-induced
gene products, possibly also identified in our screen, act via
different pathways on ENaC expression and function.
Conclusion
Our list of early aldosterone-regulated gene products con-
tains two induced elements that interfere with the ubiquityla-
tion of ENaC. Besides Sgk1, we identified Usp2-45 that we
show to deubiquitylate ENaC in expression systems and thus
represents a first example of a deubiquitylating enzyme acting
on a channel.
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5.2 Usp2 
The results concerning Usp2 shown in this section were part of a research article 
published in January 2007 in JASN.  
The ubiquitylation of ENaC had previously been shown to play an important role for the 
regulation of transepithelial Na+ transport (Rotin, Staub et al. 2000; Debonneville, Flores 
et al. 2001). Our screening identified in addition to Sgk1 (a 4-fold upregulated kinase 
known to decrease ENaC ubiquitylation) Usp2, a deubiquitylating enzyme that was 
significantly up-regulated 2.2 fold. Usp2 belongs to a large protein family involved in 
reversing the ubiquitylation of target proteins (Loffing, Loffing-Cueni et al. 2000; 
Wilkinson 2000; Amerik and Hochstrasser 2004). Since Nedd4-2, an ubiquitin ligase, 
suppresses ENaC activity at the plasma membrane by ubiquitylation, we asked whether 
Usp2 counteracts the Nedd4-2 effect by deubiquitylating ENaC. 
 
5.2.1 Usp2-45 but not Usp2-69 affects ENaC function in X. laevis oocytes 
To investigate the function of Usp2 I initially co-expressed the two known isoforms of 
Usp2 (Usp2-45, Usp2-69) (Gousseva and Baker 2003) with αβγXENaC in X. laevis 
oocytes and recorded the amiloride sensitive Na+ currents (Iamil) by two electrode voltage 
clamp (TEVC) electrophysiology. cRNA injected X. laevis oocytes were incubated for 
two days in a low Na+ solution (ND10) before testing. Inward Na+ currents can be 
observed when clamped oocytes are switched from a low to a high Na+ solution (ND96) 
(Figure 12 A). ENaC mediated currents are specifically blocked by amiloride (10 µM). 
The Iamil represents ENaC activity on the cell surface (Figure 12 A). The TEVC recording 
showed that co-expression of Usp2-45 increases Iamil significantly, while Usp2-69 does 
not affect the Iamil (Figure 12 A, B, C). The current voltage (I-V) plot in figure 10 B shows 
that this is true over a range of given voltages (-140 to 20 mV). To exclude that the 
stimulation of ENaC by Usp2-45 was due to a difference in Usp2 protein expression in 
the oocytes, Western blots were performed using oocyte lysates. The specific bands of 
Usp2-45 and Usp2-69 that were detected by a pan-Usp2 antibody show that similar levels 
of Usp2-45 and Usp2-69 protein are expressed (Figure 12 D).  
Figure 12 
 
Figure 12: Usp2-45 but not Usp2-69 increases Iamil. (A) Typical recordings of TEVC measurements done in 
X. laevis oocytes. Bath Na+ concentrations and the presence of 10 µM amiloride are indicated. The 
measurements were done at a stable membrane potential of -50 mV. Switching from 10 to 96 mM Na+ 
increased the positive inward current that was blocked with 10 µM amiloride.  Iamil is increased by co-
expression of Usp2-45 but not of Usp2-69. (B) Current-voltage (I-V) relations of Iamil; Data are means ± 
SEM, n = 20-22.  Iamil is shown for a range of given voltages (-140 mV- 20 mV). (C) Means ± SEM of the 
Iamil at -100 mV; n = 20 to 22. ***P <0.001. (D) Western blot performed with lysates of control, Usp2-45- 
or Usp2-69- expressing X. laevis oocytes. Specific bands, detected with a pan-Usp2 antibody appear at ~45 
kDa (Usp2-45) and at ~69 kDa (Usp2-69) indicated by arrows on the right.  
 
To control whether the effect of Usp2-45 on ENaC function is specific, further 
experiments were performed with another arbitrarily chosen ubiquitin-protease, Usp15 
that is ubiquitously expressed (Angelats, Wang et al. 2003). Usp15 co-expression 
decreases ENaC mediated Iamil while Usp2-45 increases it (Figure 13 A). The I-V plot 
shown in figure 13 B indicates that these effects are consistent over a wide range of 
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membrane voltages.  These results point out that the effect is Usp2-45 specific, since co-
expression of Usp15 does not increase ENaC function (Figure 13). The fact that co-
expression of Usp15 decreases Iamil may be due to the deubiquitylation of other proteins 
that interfere with the expression of ENaC in X. laevis oocytes.  
 
Figure 13 
 
 
 
 
 
 
 
 
 
 
Figure 13: Usp15 does not increase Iamil in X. laevis oocytes. (A) Summary of Iamil means ± SEM at -100 
mV holding potential; n = 20 - 24. *P < 0.05; ***P < 0.001. (B) Current-voltage relationship of Iamil 
measured at a range of given voltages (-140 to 20 mV). Data are means ± SEM, n = 20-24 
 
 
5.2.2 Co-expression of Usp2-45 with Sgk1 does not further increase Iamil
Sgk1 increases ENaC currents by inhibiting its ubiquitylation via phosphorylation of 
Nedd4-2. Since both Sgk1 and Usp2-45 act on the ubiquitylation / deubiquitylation of 
ENaC, Usp2-45 was co-expressed with Sgk1 to test whether the effects of Usp2-45 and 
Sgk1 on Iamil influence each other. Control experiments showed that Sgk1 increases Iamil 
in X. laevis oocytes co-expressed with ENaC as expected (Chen, Bhargava et al. 1999) 
(Figure 14). The stimulation of Iamil by Sgk1 was not enhanced by Usp2-45 and vice versa 
(Figure 14). These results demonstrate that effects of Sgk1 and Usp2-45 are not additive 
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and are consistent with the hypothesis that Sgk1 and Usp2-45 act on the same regulatory 
pathway, namely the ubiquitylation of ENaC.  
 
Figure 14 
 
Figure 14: Usp2-45 increases Iamil of co-expressed ENaC. (A) Summary of Iamil at a holding potential of -
100 mV. Co-expression of Usp2-45 or Sgk1 increased the ENaC-mediated Iamil to a similar extent. Data are 
means ± SEM; n = 23 to 27. **<P 0.01; ***P < 0.001. (B) Current-voltage (I-V) relationships of the Iamil; 
Data are means ± SEM, n = 23 - 27. 
 
5.2.3 The protease dead Usp2-45 mutant does not increase Iamil in 
          X. laevis oocytes 
Since protein ubiquitylation and deubiquitylation regulate many cellular functions we 
asked whether the effect of Usp2-45 on ENaC was specific to its protease activity. The 
protease dead Usp2-45 mutant was constructed by substitution of cysteine 67, which 
corresponds to one of the catalytically active amino acids of its cysteine protease motif, 
with alanine (Gousseva and Baker 2003). Iamil measured by TEVC in X. laevis oocytes co-
expressing the protease dead Usp2-45 mutant (Usp2-45mut) with ENaC was similar to 
that in oocytes expressing ENaC alone. The control experiment with wild type Usp2-45 
showed an increase in ENaC mediated Iamil (Figure 15 A). The I-V curves demonstrate 
that these effects are consistent over a broad range of membrane potentials (Figure 15 B). 
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Further it was shown -by Benjamin Oberfeld- that the core domain of Usp2-45 produced 
in E. coli very efficiently cleaves ubiquitin off from a test substrate in vitro (Oberfeld, 
Verrey and Pos, unpublished results). Taken together, these results confirm that Usp2-45 
is an active ubiquitin protease acting on ENaC.  
 
Figure 15 
 
Figure 15: Cys67Ala protease-dead Usp2-45 mutant (Usp2-45mut) does not stimulate ENaC current. (A) 
Summary of Iamil at -100 mV, data are means ± SEM; n =12 -15. **P < 0.01. (B) Corresponding current-
voltage (I-V) relationship over a range of given voltages from -140 to +20 mV; Data are means ± SEM, n = 
12-15. 
 
5.2.4 Usp2-45 increases transepithelial Iamil in mouse CCD cells 
To test whether Usp2-45 effects on ENaC function also occur with endogenous ENaC in 
CCD cells, I performed measurements of the transepithelial Iamil in mpkCCDc14 cells 
(Bens, Vallet et al. 1999; Summa, Mordasini et al. 2001). Usp2-45, as well as Usp2-
45mut was expressed in mpkCCDc14 cells using retroviral transduction. Western blot 
analysis confirmed that Usp2-45 and Usp2-45mut proteins are expressed at similar levels 
(Figure 16). Transepithelial Iamil was measured in mpkCCDc14 monolayers that were 
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cultured on permeable supports using an Ussing chamber setup (Materials and Methods, 
(Ussing and Zerahn 1951)). The expression of functional Usp2-45 increased the baseline 
transepithelial Iamil (Figure 16).  Expression of the protease-dead mutant Usp2-45mut had 
no effect, consistent with the hypothesis that the activity of endogenous ENaC was 
limited by its ubiquitylation in polarized mouse collecting duct cells.  The increase in Na+ 
transport induced by aldosterone within 2.5 hours is not affected by the over-expression 
of wild type and mutant Usp2-45. This result was expected considering that the induction 
of endogenous Sgk1 by aldosterone prevents the Nedd4-2-mediated ubiquitylation of 
ENaC in CCD cells.  
 
Figure 16 
 
 
 
Figure 16: Usp2-45 increases transepithelial Na+ current. (A) Transepithelial Iamil across mpkCCDcl4 cell 
monolayers. The baseline Iamil is depicted by light grey bars and the aldosterone induced Iamil by dark grey 
bars.  Baseline Iamil is significantly increased in cells over-expressing Usp2-45 compared with vector-
transduced negative control cells (NC) and cells that were transduced with Usp2-45mut. Iamil increased 2.5 h 
after application of 300nM aldosterone to the same level in all three tested mpkCCDcl4 cell populations *P ≤ 
0.05; n = 9 - 12. (B) Western blotting of Usp2-45 in mpkCCDc14 cells. In transduced mpkCCDc14 cells, 
Usp2-45 wild type (lane 2) and protease dead mutant (lane 3) appear as ~41 kDa bands (arrow head) of 
similar intensity. Endogenous Usp2-45 is not clearly visible in wild type and vector-transduced mpkCCDcl4 
cells (lane 4). Lane 1 shows Usp2-45 expressed in X. laevis oocytes. The band at ~36 kDa in lane 2 - 4 
(mpkCCDc14 lysate) is unspecific. 
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5.2.5 Summary concerning Usp2 regulation 
 
It could indeed be shown that the newly identified aldosterone-induced Usp2-45 activates 
ENaC in the X. laevis oocyte and mpkCCDc14 cell expression systems. The biochemical 
evidence of ENaC deubiquitylation by Usp2-45 done in Hek 273 cells was published 
together with the latter section of my thesis in the Journal of the American Society of 
Nephrology in january 2007 and supports the functional experiments made in X. laevis 
oocytes. Additional tests done in Prof. Olivier Staubs laboratory showed that the 
disruption of ENaC PY motifs and the disruption of ENaC lysine residues that potentially 
are targeted by Usp2-45 prevent the action of Usp2-45 on ENaC function. Taken together, 
these results strongly support the hypothesis that Usp2-45 removes ubiquitin molecules 
that are ligated onto ENaC by the ubiquitin ligase Nedd4-2 (Adam, Fakitsas et al. 2007).  
5.3 Usp53 
Usp53 is a member of a large protein family involved in reversing the ubiquitylation of 
target proteins (Loffing, Loffing-Cueni et al. 2000; Wilkinson 2000; Amerik and 
Hochstrasser 2004). Little is known about the function of Usp53. Since it lacks a highly 
conserved residue near the Usp protease catalytic site (Hu, Li et al. 2002), Usp53 is 
considered a non-protease homologue of the Usp family (Quesada, Diaz-Perales et al. 
2004). Nevertheless, we found Usp53 mRNA significantly upregulated by aldosterone in 
microselected CNT/CCD tubules in the gene chip analysis performed in our laboratory. 
 
5.3.1 Usp53 exists in two different isoforms 
Two splice variants of Usp53 exist: the full-length (Usp53fl) and the truncated isoform 
(Usp53t).  Usp53t lacks the entire N-terminal domain comprising the complete catalytic 
site (Figure 17 A). cRNA from both Usp53 isoforms was injected in X. laevis oocytes. 
Using our pan mouse Usp53 antibody, the expression of both Usp53 isoforms in X. laevis 
oocytes was shown by Western blot 3 days after cRNA injection (Figure 17 B). The 
specific bands are visible at ~120 kDa (Usp53fl) and ~80 kDa (Usp53t) (Figure 17 B). 
 
Figure 17 
  
 
 
 
 
 
 
Figure 17: Two different isoforms of Usp53 are expressed in X. laevis oocytes. (A) Simplified sketch 
showing the truncated (Usp53t) and the full length form of Usp53 (Usp53fl). Usp53t is lacking the catalytic 
site which comprises a cystein (Cys) and a histidin-asparagine (His-Asp) box. (B) Western blot analysis 
showing the expression of both Usp53t and Usp53fl detected in lysates of injected X. laevis oocytes.  
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5.3.2 Usp53 does not modulated ENaC mediated Iamil in X. laevis oocytes 
To see whether Usp53 has an impact on the function of individual members (i.e. ENaC, 
Na+-K+-ATPase, K+-channels) of the Na+ transport machinery of the ASDN, I carried out 
TEVC measurements of Iamil on X. laevis oocytes expressing Usp53. Oocytes injected 
with Usp53t and Usp53fl respectively and ENaC cRNA were incubated for 2 days. Iamil 
recordings revealed that Usp53t, as well as Usp53fl do not impact on the ENaC mediated 
Iamil (Figure 18).  
 
Figure 18 
 
 
 
 
 
 
 
 
Figure 18: Usp53 does not affect ENaC mediated currents in oocytes. Iamil was measured at a holding 
potential of  -50 mV. The left panel compares Iamil in oocytes expressing ENaC or ENaC and Usp53t ; data 
are means ± SEM; n = 15. The right panel shows the Iamil of oocytes coexpressing Usp53fl with ENaC or 
expressing ENaC alone. Data are means ± SEM; n = 12 - 15.  
 
 
 
5.3.3 In X. laevis oocytes Usp53t increases exogenously expressed  
         Na+-K+-ATPase function  
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The Na+-K+-ATPase, a member of the Na+ transport machinery of the ASDN, is a 
possible target for the deubiquitylating enzyme Usp53 as it had been shown to be 
ubiquitylated (Dada, Welch et al. 2007). To test this hypothesis the Na+-K+-ATPase was 
co-expressed in X. laevis oocytes with the different Usp53 isoforms and TEVC recordings 
were performed. Since oocytes express endogenous Na+-K+-ATPase a special protocol 
was used to distinguish between endogenous and exogenous pump currents (see materials 
and methods) (Jaisser, Horisberger et al. 1992). Three days after cRNA injection whole 
cell currents were recorded. The coexpression of Usp53fl does not influence currents 
carried by the endogenous or exogenous Na+-K+-ATPase (Figure 19 A). Interestingly 
coexpression of Usp53t tends to increase the function of the exogenous Na+-K+-ATPase, 
but does not affect the endogenous one (Figure 19 B). However, co-expression of Usp2-
45 did not affect endogenous or exogenous Na+-pump currents (Figure 19 C). 
 
Figure 19 
 
 
 
Figure 19: Endogenous pump currents were not affected by Usp53t or Usp53fl. Exogenous pump currents: 
light gray bars; endogenous pump currents: dark gray bars. The middle panel shows that Usp53t has the 
tendency to increase currents of the exogenously expressed Na+-K+-ATPase but has no effect on the 
endogenous one (means ± SEM; n = 16 - 21; P = 0.062).  Usp2-45 as well as Usp53fl exhibit no significant 
effect on either of the pump currents measured ( means ± SEM, n = 5-9). 
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5.3.4 Usp53 expression in mpkCCDc14 cells 
The endogenous mRNA expression of Usp53 in wild type mpkCCDc14 cells (derived from 
principal cells of the collecting duct) was determined by quantitative RT real-time PCR. 
The primers used for RT-real-time PCR detect the two isoforms of Usp53, since they 
recognize a common region in the C-terminal part of both (Figure 17). The bargraph in 
figure 18 shows that the Usp53 mRNA level did not change significantly after aldosterone 
treatment relative to the level of non treated cells (Figure 20).  
 
Figure 20 
 
 
 
 
 
 
 
 
 
Figure 20: Usp53 mRNA abundance in mpkCCDc14 cells. Quantitative RT real-time PCR was performed on 
total RNA extracted from cultured and aldosterone treated mpkCCDc14 cells. CT values are relative to the 
housekeeping gene HPRT and normalized to the value at time point zero (n = 4). 
 
 
76 
 
 77 
 
5.4 The voltage gated proton channel Hv1/mVSOP 
 
It was shown by electrophysiology that almost every cell type, from cultured cancer cells 
to native tissue, expresses voltage gated proton channels (DeCoursey and Cherny 1998; 
Decoursey 2003; Okamura 2007). However, until 2006 they were not identified at a 
molecular level and not much is known about their role in the regulation of cellular 
functions. A putative voltage gated proton channel was recently identified by two groups 
in parallel. Sasaki and colleges and Ramsey and co-workers investigated the function of 
two orthologs (mouse: mVSOP (Sasaki, Takagi et al. 2006), human: Hv1(Ramsey, Moran 
et al. 2006)) of a voltage sensor domain protein. Both described that it functions as a 
voltage gated proton channel. We observed in the gene screen performed in our lab that 
this voltage gated proton channel is significantly upregulated by aldosterone in 
microselected CNT/CCD of mouse kidney. I started to investigate the possible action of 
the mouse ortholog of this channel, Hv1 (or mVSOP) in the context of aldosterone 
regulated Na+ transport.   
 
 
5.4.1  Hv1 is suggested to localize at the apical side of principle cells in      
the ASDN 
 
Using an affinity purified rabbit antibody raised against the Hv1 peptide 
CSEKEQEIERLNKL according to Ramsey, Moran et al 2006, the localization of the Hv1 
protein was examined in mouse kidney by immunofluorescence. Double stainings were 
performed using a commercially available aquaporin 2 (AQP2) antibody that is a marker 
for principal cells in the distal nephron (Loffing, Loffing-Cueni et al. 2000). Several 
experiments showed labeling suggesting that the channel is mainly localized in the apical 
side of principal cells in the collecting duct, since AQP2 staining  could by observed in 
the same cells (Figure 21 A, B). In some cases AQP2 positive cells were not labeled by 
the Hv1 antibody, but instead staining of intercalated cells (AQP2-negative) could be 
detected. Since pendrin is a marker for β-intercalated cells co-staining with a polyclonal 
pendrin antibody (Schulz, Dave et al. 2007) revealed that Hv1 antibody labeled the apical 
pole of β-intercalated cells (Figure 21 B, C). No Hv1 labelling could be detected in α-
intercallated cells (data not shown). Based on the practical experience of Prof. J. Loffing 
this staining was however rejected as probably artifactual. Taken together, these results 
suggest that Hv1 is localized on the apical pole of principle cells in the collecting duct.  
 
Figure 21 
 
 
 
 
 
 
 
 
  
Figure 21: Expression of Hv1 in the mouse kidney. Staining of mouse kidney cryosection with Hv1 antibody 
showed a localization of Hv1 in the collecting duct. (A) A labeling of the apical pole of principal cells using 
the Hv1 antibody is visualized in red. (B) AQP2 antibody stains principal cells (green). (C) Labeling of the 
apical pole of an intercalated cell in the CD with the Hv1antibody. (D) Staining with AQP2 antibody shows 
labeling of principal cells in the same tubule. (E, F) Hv1 was detected in the same cell (red fluorescence, E) 
like Pendrin, a specific marker for β-intercalated cells (green labeling, F).  
 
 
5.4.2 Hv1 is endogenously expressed in the mpkCCDc14 cell line 
The endogenous expression of Hv1 was tested in cultured mpkCCDc14 cells (Bens, Vallet 
et al. 1999) using real-time RT PCR performing four independent experiments. After 
aldosterone application at a pharmacological level that stimulates also the glucocorticoid 
receptor (1 µM) cell populations grown on plastic dishes were harvested and total mRNA 
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was extracted every hour. This experiment was repeated four times. A comparison of non-
treated and aldosterone treated cell populations shows that Hv1 mRNA level was 
apparently increased ~2 fold after aldosterone treatment but without reaching a level of 
significance. It could further be observed that the variation between the tested cell 
populations is very high (Figure 22). The reason for the differences between the single 
experiments could be the fact that the cells were probably in different stages of 
differentiation which affects the mRNA expression pattern.  
 
Figure 22 
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Figure 22: Hv1 mRNA abundance in mpkCCDc14 cells. Quantitative RT real-time PCR was performed on 
total RNA extracted from cultured aldosterone treated mpkCCDc14 cell populations. CT values were 
normalized to the housekeeping gene HPRT. The graph shows Hv1 mRNA levels after aldosterone 
application (1µM) relative to the level of nontreated cells (n = 4). 
 
 
5.4.3 Functional expression of Hv1 in X. laevis oocytes 
Since Hv1 is upregulated by aldosterone in the ASDN and is probably localized in the 
apical pole of principal cells in the collecting duct we planned to investigate its potential 
functional role in the modulation of salt reabsorption in the kidney. A common and well 
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established tool to explore the function of ion channels is the X. laevis oocyte expression 
system. The action of Hv1 was initially tested in X. laevis oocytes heterologously 
expressing Hv1. The cRNA of Hv1 was injected into X. laevis oocytes 2-3 days before 
functional tests were performed. The expression of myc-tagged Hv1 could be detected in 
lysed oocytes by Western blot using a commercial anti-myc antibody (Figure 23 A).  A 
specific band for Hv1 appears at the apparent molecular weight of 35 kDa as it was 
reported before (Ramsey, Moran et al. 2006). As a negative control non-injected (NI) or 
ENaC injected (ENaC) oocytes were used.  
Since this first series of experiments suggested that exogenous Hv1 is functionally 
expressed at the surface membrane of oocytes, further experiments to characterize its 
function were undertaken. The following describes results that could however not confirm 
the functional surface expression of Hv1.  
The possible activity of exogenous Hv1 in the plasma membrane of oocytes was examined 
by eletrophysiology. The analysis of pre-steady-state currents evoked by voltage steps 
uncovered in some experiments, but not in all a distinct behavior of Hv1 expressing 
oocytes compared to non-injected ones. During repolarisation slow inward tail currents 
are observed in Hv1 expressing cells which are not seen in non-injected ones (Figure 23 
A). Tail currents are thought to result from charge movements over the membrane 
mediated by Hv1 molecules. A characteristic feature of voltage gated proton channels is 
their unique pH dependence of gating, in which the voltage activation relationship 
depends strongly on both  the intracellular (pHi) and extracellular pH (pHo) (Sasaki, 
Takagi et al. 2006). To examine whether Hv1 exhibits this feature in X. laevis oocytes, we 
applied bath solutions with different pHs and tested the function of Hv1 by TEVC. I-V 
relations were measured from the same cell at 2 different extracellular pHs (pH 6, pH 8). 
Considering that pHi is ~ 7.3-7.5 (Broer 2003) the ratio pHo/pHi is < 1 applying pH 6 in 
the extracellular solution and pHo/pHi is > 1 when pHo = 8. I-V relations measured in 
noninjected oocytes did not change in conditions with different pH ratios. Oocytes 
expressing Hv1 showed a decrease in outward currents at depolarizing voltages when 
pHo/pHi is > 1 (pHo = 8) but not when pHo/pHi < 1 (pHo = 6) (Figure 23 C). Sasaki and 
coworkers showed that the I-V curve in Hv1 expressing Hek293 cells shifted about 50 mV 
in the positive direction at pHo/pHi is < 1 and to the same extend towards the negative 
direction at pHo/pHi is > 1. This observation could not be confirmed in the oocyte system 
since no shift of the I-V curves (or Erev) could be observed (Figure 23 C). Under 
conditions with pHo/pHi is > 1 we did not see any differences in the I-V relation 
compared to the control group (Figure 23 C). The reason for these discrepancies could be 
endogenous oocyte specific ion conductances that are switched on at strong membrane 
depolarization and that could cover the effects mediated by Hv1. 
 
Figure 23  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Hv1 was functionally expressed in X. laevis oocytes. (A) Expression of myc-tagged Hv1 in X. 
laevis oocytes is shown by Western blot using lysates from oocytes co-/expressing Hv1 with and without 
co-expression of ENaC (Hv1, Hv1 ENaC). (B) Single TEVC recordings showing slow inward tail currents 
(arrow) in Hv1 (Hv1) expressing oocytes in comparison to noninjected (NI) oocytes. (C) I-V relations 
evoked by a series of voltage steps in 20 mV increments (-100 to 180 mV) under pHo = 8 (cycles) or 6 
(squares). NI = Non-injected oocytes, Hv1 = Hv1-injected oocytes.  
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As described earlier, zinc a specific blocker for proton channels, blocks proton currents 
mediated by Hv1(Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006). Tail currents 
during repolarisation to various potentials were elicited after depolarizing prepulses to 
observe the effect of zinc on Hv1 expressing and control oocytes. Oocytes were clamped 
at -50 mV before +100 mV was applied to depolarize the cell. The following voltage 
steps reach from -100 mV to +20 mV before the oocyte is clamped again at -50 mV 
(Figure 22 A). The reversal potential (Erev, intersection of the I-V curve with the x-axis) 
shifted strongly towards the negative direction in Hv1 expressing oocytes as 1 µM ZnCl2 
was added to the bath solution (Figure 25 B). Furthermore a flattening of the I-V curve 
could be observed after ZnCl2 treatment in oocytes expressing Hv1. I-V relations of the 
noninjected oocytes tested did not change after ZnCl2 application. So far, these results are 
compatible with the possibility that Hv1 is functionally expressed on the surface of X. 
laevis oocytes and is affected by zinc. Indeed, that the I-V relation flattens after the 
addition of ZnCl2 is in line with the results obtained in the Hek cell expression system by 
Sasaki and coworkers. Application of extracellular zinc in a µM range could be shown to 
inhibit proton channels (Byerly and Suen 1989; Cherny and DeCoursey 1999; Ramsey, 
Moran et al. 2006; Sasaki, Takagi et al. 2006). In contrast, the shift in Erev in the oocytes 
was unexpected and can not be explained by the inhibition of a proton conductance. We 
therefore have to consider the possibility that the expression of Hv1 in X. laevis oocytes 
does not itself lead to the zinc-inhibitable conductance but that it influences endogenous 
ion conductance that could be affected by the addition of zinc.  
 
 
 
 
 
 
 
Figure 24 
 
Figure 24: Plots of tail current amplitude against membrane potential under conditions with and without 
1µM ZnCl2 (A) Simplified scheme of the applied voltage step protocol. (B) Plots of tail current amplitude 
against membrane potential.  Hv1 expressing oocytes (Hv1) and noninjected oocytes (NI) were perfused 
with ND96 solution with (closed squares) or without (open squares) 1 µM ZnCl2. 
 
 
5.4.4 Co-expression of Hv1 decreases ENaC mediated Iamil in X. 
laevis oocytes 
To address the question whether there is a relationship of Hv1 and aldosterone regulated 
salt reabsorption, ENaC was co-expressed with Hv1 in X. laevis oocytes. TEVC 
measurements demonstrated that Hv1 has an inhibitory effect on ENaC function over the 
entire range of tested voltages (Figure 25 A). In an initial experiment 20 ng Hv1 cRNA 
were injected into each oocyte to test its effect on Iamil (Figure 25 A). Afterwards the 
amount of injected Hv1 cRNA per oocyte was titrated down to 5ng per oocyte. The I-V 
curve for Iamil shows that the expression of Hv1 using 20 ng Hv1 cRNA for injection leads 
to a major inhibition of Iamil, whereas the expression after injection of 10 ng and 5ng Hv1 
cRNA respectively showed a moderate effect on Iamil (Figure 25 B). We conclude from 
these results that the amount of Hv1 cRNA is crucial for the amplitude of the decrease of 
Iamil. Since it is known that zinc blocks the proton conductance of Hv1(Ramsey, Moran et 
al. 2006; Sasaki, Takagi et al. 2006), I tested whether the application of ZnCl2 would 
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reestablish ENaC mediated Iamil which was previously inhibited by Hv1. Treatment of co-
expressing X. laevis oocytes with ZnCl2 in a range from 0.05- 100 µM does not abolish 
the effect of Hv1 on ENaC currents (Figure 25 C). Even the incubation of oocytes in a 
zinc-containing bath solution over night showed similar results (Data not shown). 
Furthermore, the I-V relations shown in figure 25 C reveal that addition of ZnCl2 to the 
bath solution increases Iamil in oocytes that express ENaC alone. This data is consistent 
with the observation of other investigators that showed that Iamil can be induced by the 
addition of extracellular zinc (Sheng, Perry et al. 2004) (Figure 25 C). The fact that the 
inhibitory effect of Hv1 on ENaC is not reversed by addition of extracellular zinc leads to 
the assumption that inhibition of ENaC by Hv1 is independent of its proton conductance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 
 
 
 
 
Figure 25: Co-expression of ENaC with Hv1. Current-voltage relationships of Iamil measured by TEVC.  
(A) Co-expression of Hv1 (20 ng Hv1 cRNA / oocyte) with ENaC (0.05 ng / SU / oocyte) showed a 
remarkable decrease in Iamil at the range of voltages applied: -100 mV to 100 mV. Data are means ± SEM; n 
= 17. (B) 20 ng and 10 ng Hv1 cRNA were co-injected with ENaC respectively. Data are means ± SEM, n = 
4. (C) Oocytes were incubated +/- 1 µM ZnCl2.  
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5.4.5 Hv1 decreases ROMK2 activity in X. laevis  oocytes 
 
To address the question whether the effect of Hv1 on ENaC is specific Hv1 was co-
expressed with the potassium channel ROMK2 in X. laevis oocytes. The expression of 
ROMK2 in X. laevis oocytes is well established and ROMK2 mediated K+ currents can be 
determined using a simple protocol. Whole cell potassium currents (IK) were measured at 
a clamped membrane potential of – 50 mV and blocked by the substitution of MgCl2 with 
BaCl2 in the bath solution (ND96). Currents recorded while perfusing with the control 
solution were subtracted from those obtained after switching to the substituted solution. 
Subsequently the results were normalized to those obtained from noninjected control 
oocytes. Initially ROMK2 was chosen to serve as a negative control and it was expected 
that Hv1 would probably not affect its function. Nevertheless, the results of the TEVC 
measurements showed that Hv1 decreases ROMK2 mediated IK significantly in three 
independent experiments (Figure 26 A). These results could lead to the interpretation that 
the inhibitory effect of Hv1 co-expression is a X. laevis oocyte artifact. Nevertheless, 
ROMK2 is also one of the key players in the aldosterone regulated salt reabsorption in the 
ASDN which could be regulated by Hv1 similar to ENaC. To further test whether the 
effects of Hv1 on ROMK2 and ENaC are due to artifacts of the X. laevis oocyte 
expression system another transport protein, the type IIb Na+/Pi cotransporter (NaPi-IIb) 
(Forster, Wagner et al. 1997) was co-expressed with Hv1. NaPi-IIb was cloned from 
flounder because of its 5- to 10-fold higher expression in X. laevis  oocytes (Forster, 
Wagner et al. 1997) compared with its mammalian cousins (Bacconi, Ravera et al. 2007). 
Function of NaPi-IIb can be tested by using TEVC recordings at a clamped membrane 
potential of -50 mV.  Since it is well established that extracellular Pi induces inward 
currents in the presence of extracellular Na+, TEVC recordings of Napi-IIb mediated 
currents were obtained by using ND96 solution supplemented with phosphate (Pi). At a 
stable membrane potential of -60 mV co-expression of Hv1 does not affect the Pi current 
in oocytes expressing NaPi-IIb (Figure 26 B). The fact that Hv1 did not influence the 
function of NaPi-IIb in X. laevis oocytes is compatible with the assumption that the effect 
of Hv1 on ENaC and ROMK2 is not an artifact occurring in the used expression system, 
but is rather a specific effect targeting to the modulation of the activity of ion channels 
that are involved in the Na+ reabsorption in aldosterone target cells.   
 
Figure 26 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Effect of Hv1 coexpression on ROMK2 and NaPi-IIb. (A) Coexpression of Hv1 in X. laevis 
oocytes with the potassium channel ROMK2 reduced ROMK2 mediated potassium currents at -60 mV 
significantly. Data are means ± SEM; n = 14-16; *P < 0.001. IK obtained from noninjected control oocytes 
were subtracted. (B) Coexpression of Hv1 with the Na+ dependent Pi cotransporter NaPi-IIb did not affect 
phosphate currents at -60 mV membrane potential (n = 10-11; P ≥ 0.05).  
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6 Discussion 
 
6.1 Usp2-45 increases ENaC activity by deubiquitylation 
 
As rate-limiting luminal Na+ influx pathway of aldosterone target epithelia, ENaC plays a 
central role for the regulation of Na+ absorption. It belongs to the ENaC/DEG gene 
family, the members of which show a high degree in functional heterogeneity and a wide 
tissue distribution (Kellenberger and Schild 2002). ENaC is expressed in a variety of 
osmoregulatory tissues in vertebrates, like the frog skin, urinary bladder, lungs, sweat 
glands and kidney (Garty and Palmer 1997; Kellenberger and Schild 2002; Snyder 2002) 
where it is crucial for the regulation of water and ion homeostasis of the body (Uchiyama 
and Konno 2006). The fact that Na+ reabsorption is such an important task is in line with 
the observation that ENaC is regulated by a complex network of pathways which is 
modulated by many diverse contributions. More and more mechanisms and regulatory 
cross-talks that impact on ENaC function have been discovered in the last few years 
(Rotin, Staub et al. 2000; Kamynina, Debonneville et al. 2001). The mineralocorticoid 
hormone aldosterone is modulating the transcription of genes that are involved in the 
regulation of transepithelial Na+ transport (Wald, Goldstein et al. 1996; Naray-Fejes-Toth 
and Fejes-Toth 2000; Staruschenko, Nichols et al. 2004; Staruschenko, Patel et al. 2004; 
Soundararajan, Zhang et al. 2005) and is a major regulator of ENaC activity and 
trafficking (Verrey 1998; Booth, Johnson et al. 2002; Connell and Davies 2005; Fuller 
and Young 2005; Rozansky 2006). The inputs that impact on transepithelial Na+ transport 
in the short term (up to 3 h) appear to converge onto a dominating repressor system that 
involves ENaC ubiquitylation and deubiquitylation. Deubiquitylation of target proteins 
has lately gained great importance as a regulatory mechanism although it has already been 
described at the time of the ubiquitin system discovery (Hershko, Ciechanover et al. 1980; 
Amerik and Hochstrasser 2004). A number of studies using overexpression systems and 
cells that express ENaC endogenously showed that ENaC is ubiquitylated through the E3 
ligase Nedd4-2 (Staub, Gautschi et al. 1997; Staub, Abriel et al. 2000; Debonneville and 
Staub 2004; Wang, Traub et al. 2006). ENaC ubiquitylation was found to take place in the 
apical membrane (Wiemuth, Ke et al. 2007; Zhou, Patel et al. 2007) of epithelial cells but 
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it remains uncertain whether mono-, poly- or multiubiquitylation of ENaC induces its 
internalization (Butterworth, Edinger et al. 2007; Zhou, Patel et al. 2007). Our list of early 
aldosterone-regulated mRNAs of mouse connecting and collecting tubules revealed that 
indeed two of the most prominent upregulated genes encode proteins that appear to be 
directly involved in the ubiquitylation and deubiquitylation of proteins, namely Sgk1 and 
Usp2. Sgk1, already known as an early aldosterone-regulated gene product that regulates 
ENaC (Snyder, Cheng et al. 1998; Chen, Bhargava et al. 1999; Naray-Fejes-Toth, 
Canessa et al. 1999; Naray-Fejes-Toth and Fejes-Toth 2000; Verrey, Pearce et al. 2000), 
was 4-fold up-regulated in our screen. The serine/threonine protein kinase Sgk1 inhibits 
the function of Nedd4-2 by phosphorylation which leads to the decrease of ENaC 
ubiquitylation and trafficking (Snyder 2002; Pearce 2003). Nevertheless, a 
deubiquitylating step avoiding trafficking of ubiquitylated ENaC towards degradation is 
also required (Hurley, Lee et al. 2006; Butterworth, Edinger et al. 2007; Lu, Pribanic et al. 
2007). Usp2, which was 2.2 fold upregulated in our gene screen, is a member of the 
ubiquitin specific protease family and possibly able to facilitate the deubiquitylation of 
ENaC. To test this hypothesis, I investigated the potential role of Usp2 on ENaC. An 
induction of ENaC mediated currents by the short Usp2 isoform (Usp2-45) but not by the 
long one (Usp2-69) was detected using TEVC recordings of Iamil in ENaC expressing X. 
laevis oocytes (Figure 12). That only Usp2-45 influences ENaC activity goes in line with 
the fact that Usp2-69 is expressed just at low levels in the kidney (unpublished 
observation PF, VF) (Gousseva and Baker 2003). The human homologue of Usp2-69, 
Usp2a, was found to deubiquitylate antiapoptotic proteins in prostate cancer cells and 
represents a therapeutic target in prostate cancer (Priolo, Tang et al. 2006). In contrast the 
short isoform Usp2-45 was not yet investigated in terms of its physiological function. 
Around 100 different Usps are found in mammalians (Hemelaar, Galardy et al. 2004; 
Nijman, Luna-Vargas et al. 2005), so that an increase in ENaC mediated currents could be 
also mediated by any other ubiquitin protease, that is expressed in the kidney. We 
randomly selected Usp15, a widely expressed ubiquitin specific protease that is also 
present in the mouse kidney (Angelats, Wang et al. 2003) to test its function on ENaC in 
X. laevis oocytes. Its co-expression with ENaC did not increase but rather decrease Iamil 
which indicates that the effect of Usp2-45 is specific (Figure 13). The decrease in Iamil 
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mediated by Usp15 is probably the result of the deubiquitylation of other proteins which 
are involved in ENaC mRNA or protein stability, transcription, translation or trafficking.  
As expected we observed that the stimulation of ENaC by Sgk1 was not further increased 
by co-expression of Usp2-45 (Figure 14) taking into account that the action of Sgk1 
decreases the amount of ubiquitylated ENaC. Thus, assuming that Sgk1 prevents that 
ENaC is ubiquitylated and therefore increases its amount at the cell membrane, Usp2-45 
is then not able to additionally increase its surface expression by deubiquitylation. These 
results strongly support the hypothesis that Usp2-45 cuts off ubiquitin moieties that have 
been ligated onto ENaC by the ubiquitin ligase Nedd4-2.  
Since it was not clarified at that point whether Usp2-45 actually increases ENaC function 
by its protease activity we tested the action of a protease dead mutant on ENaC. The 
substitution of one crucial amino acid in the catalytic core entirely abolished the action of 
Usp2-45 on ENaC (Figure 15). These results support the hypothesis that ENaC is 
deubiquitylated by Usp2-45 dependent on the integrity of its protease motif.   
To examine whether the stimulatory effect of Usp2-45 on ENaC function is not an 
artefact only occurring in the X. laevis oocyte expression system, we tested its function on 
endogenous ENaC in cultured mpkCCDc14 cells. The over-expression of Usp2-45 
increased the basal (no aldosterone) transepithelial Iamil in mpkCCDc14 cells significantly 
compared to the control and to cells transfected with the protease dead mutant (Figure 
16). The fact that transepithelial Iamil are similar in Usp2-45 and mock-transfected cells 
after aldosterone stimulation is not surprising, since it is expected that ENaC is mostly 
deubiquitylated due to the action of Sgk1 that was shown to be rapidly induced in 
mpkCCDc14 cells by aldosterone (data not shown). Taken together these results strongly 
suggest that Usp2-45, a gene product that is rapidly induced by aldosterone in vivo, 
deubiquitylates ENaC, the main player of transepithelial Na+ transport. Further 
biochemical and functional experiments done on X. laevis oocytes and the Hek273 cell 
expression systems were carried out by Dorothée Daidiée and Dr. Miguel Van Bemmelen 
in the laboratory of Prof. Olivier Staub. Their results reinforce the conclusion that ENaC 
is deubiquitylated by Usp2-45 and therefore prevented from endocytosis and degradation 
(see Adam, Fakitsas et al. 2007). Considering that Sgk1 indirectly regulates ENaC 
ubiquitylation via phosphorylation of Nedd4-2, Usp2 is apparently the first gene product 
identified that is induced by aldosterone and directly acts on ENaC. However, it is 
expected that still other aldosterone induced gene-products, possibly also identified in our 
screen, act via different pathways on ENaC expression and function. The question 
whether the deubiquitylation event takes place in the plasma membrane or in transport 
vesicles inside the cells could not be answered yet. Nevertheless it became clear that 
Usp2-45 increases ENaC function dramatically by deubiquitylation in overexpression 
systems. Recently Butterworth et al uncovered that also UCH-L3, another 
deubiquitylating enzyme regulates the apical membrane recycling of ENaC (Butterworth, 
Edinger et al. 2007). It can be assumed that several deubiquitylating enzymes are 
involved in ENaC deubiquitylation at the various points of the recycling pathway from 
endosomal vesicles back towards the apical membrane (Butterworth, Edinger et al. 2007). 
However, transcription of Usp2 was not only found to be regulated by aldosterone but 
also by other hormones like androgens and parathyroid hormone, indicating that the Usp2 
gene products are involved in the mediation of diverse essential hormonally regulated 
functions (Miles, Sluka et al. 2002; Graner, Tang et al. 2004). 
 
 
Figure 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Graphic illustration of the convergent effect of Sgk1 and Usp2-45. Both enzymes decrease the 
amount of ubiquitylated ENaC and hence increase the amount of active channel proteins in the membrane. 
This figure was adopted from Adam, Fakitsas et al. 2007. 
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6.2 Does Usp53 act on Na+ transport? 
 
Considering, that ENaC and other channels and transporters involved in aldosterone 
regulated Na+ absorption in the ASDN are ubiquitylated (Coppi and Guidotti 1997; Staub, 
Gautschi et al. 1997), a second deubiquitylating enzyme, Usp53 that is significantly 
upregulated in the gene screen obtained immediately our attention. Usp53 is also a 
member of the family of deubiquitylating enzymes but lacks an essential histidine residue 
located nine amino acids N-terminal of the histidine at the catalytic site (Hu, Li et al. 
2002; Quesada, Diaz-Perales et al. 2004). Hence, Usp53 was classified as a non-protease 
homologue according to the MEROPS data base nomenclature (Quesada, Diaz-Perales et 
al. 2004; http://merops.sanger.ac.uk/). A protease activity assay done by Quesada et al 
revealed that Usp53 has indeed no proteolytic function on the tested substrate. After 
checking the NCBI database (http://www.ncbi.nlm.nih.gov/Database/) we found that 
Usp53 protein exists in two different isoforms, that we named Usp53fl for Usp53 full 
length and Usp53t for the truncated form. Usp53t annotated in the database with the 
accession number AAH22221 lacks the first 392 amino acids at the N-terminus which 
includes the complete catalytic site (Figure 17 A). Therefore it was not surprising that this 
truncated form of Usp53 does not affect ENaC mediated Na+ currents in co-expressing X. 
laevis oocytes. However, the co-expression of Usp53fl with ENaC does not change Iamil 
either (Figure 18). Neither Usp53fl nor Usp53t influence ENaC function; although both 
forms could be expressed at a reasonable protein level in oocytes which was tested by 
Western blot using an antibody against Usp53 (Figure 17 B). Subsequently I tested 
whether Usp53 has an impact on the Na+-K+-ATPase which is known to be involved in 
the transepithelial Na+ transport by pumping Na+ out of the cell at the basolateral side and 
thereby establishing the driving force for Na+ reabsorption in the kidney (Greger 2000). 
The outcome of the experiment performed was quite unexpected since Usp53t, despite 
lacking its whole protease domain increased the exogenous Na+-K+-pump current in a 
number of batches of X. laevis oocytes significantly. However repeating this experiment 
could not confirm the first observations but there is still a tendency that Usp53t increases 
Na+-K+-ATPase currents (Figure 19 B). Usp53fl in contrast does not influence the pump 
current at all (Figure 19 A) which implies that the regulation is not based on a 
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deubiquitylation event. The fact that also Usp2-45 does not impact on the Na+-K+-ATPase 
(Figure 19 C) suggests the hypothesis, that the effect of Usp2-45 on ENaC is rather 
specific. Since Usp53t has no ubiquitin specific protease function the mechanism by 
which it activates Na+ pump function remains entirely unknown. The observation that 
Usp53 is endogenously expressed in mpkCCDc14 cells on mRNA level supports the idea 
that this Usp has important tasks in the control of Na+ absorption or differentiation. One 
hour after aldosterone treatment the mRNA abundance of Usp53 increased ~0.5 fold 
(Figure 20). The fact that aldosterone-induced Usps stimulate the function of ENaC and 
of the Na+-K+-ATPase supports the hypothesis, that ubiquitylation and deubiquitylation 
plays a central role in transepithelial Na+ transport regulation.  
The characterization of Usp53 generates in the moment more questions than answers. The 
results of TEVC recordings are unclear. Even though our Usp53 antibody detects Usp53 
protein in Western blot it was not possible to perform localization studies using 
immunofluorescence on kidney sections with this antibody. These technical limitations 
and other factors made me stopping the investigation of Usp53 function. Nevertheless I 
continued my work on the characterization of another early aldosterone regulated gene 
product: Hv1, a voltage gated proton channel.  
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6.3 Hv1 influences important players of the Na+ reabsorption in 
the ASDN 
 
The analysis of the lists of early aldosterone induced mRNAs showed that one of these 
encodes a protein comprising an ion channel domain structure. Interestingly this protein 
turned out to be a member of the VSPs and was characterized recently in the HEK cell 
expression system as a voltage gated proton channel (Ramsey, Moran et al. 2006; Sasaki, 
Takagi et al. 2006).  
 
 
Hv1 is expressed in aldosterone target cells 
Since it was rather surprising to find a voltage gated proton channel within aldosterone 
regulated gene products we were curious to investigate its function in the context of 
aldosterone regulated salt reabsorption in the kidney. The lack of an Hv1 antibody, giving 
a specific signal in Western blot prevented the testing of the impact of short term 
aldosterone treatment on the protein expression level of Hv1 in the ASDN. Nevertheless 
the up-regulation of mRNA levels in CNT/CCDs could be verified by quantitative real-
time RT PCR (P.F. data not shown). Interestingly Hv1 was found to be predominantly 
expressed in immune tissues and just to a very small extent in the kidney (Ramsey, Moran 
et al. 2006; Sasaki, Takagi et al. 2006). Nonetheless the accomplishment of 
immunofluorescence studies on mouse kidney sections suggested that Hv1 protein is 
expressed in aldosterone target cells in the kidney of non-treated mice. The localization 
was detected by an anti-Hv1 antibody. Viewing of the images and discussion with Prof. 
Jan Loffing supported the suggestion that the staining at the apical pole of principal cells 
in the CD (Figure 21 A, B) is most likely specific and that the rather sporadic staining of 
β intercalated cells is possibly unspecific (Figure 21 C, D, E, F). Treatment of mice with 
aldosterone 1h before tissue fixation did lead to a visible enhancement or redistribution of 
Hv1 signal in the kidney (data not shown). The fact that Hv1 is also endogenously 
expressed in mpkCCDc14 cells on mRNA level (Figure 22) strengthens our supposition 
that Hv1 plays a role in the aldosterone regulated salt reabsorption across principal cells. 
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That aldosterone treatment increases Hv1 mRNA expression in these cells confirmes the 
results obtained with the beforehand performed gene screen. The big inter-experimental 
variations, that lead to rather large error bars (Figure 22) are probably due to the variable 
differentiation status of the mpkCCDc14 cells. Experiments to investigate the subcellular 
localization of Hv1 in CCD cells need still to be done. Nevertheless these results give 
evidence that the voltage gated proton channel Hv1 is rapidly up-regulated by aldosterone 
which leads to the assumption that it could play an important role in the regulation of 
transepithelial Na+ transport in the ASDN. 
 
 
Characterization of Hv1 in Xenopus laevis oocytes 
First, several experiments using Hv1 expressing X. laevis oocytes were performed to test 
whether the channel is functionally active in this particular system.  After the expression 
of Hv1 protein in X. laevis oocytes was verified by Western blot (Figure 23 A) functional 
experiments were performed using electrophysiology. Consistent with observations of 
Ramsey and colleges and Sasaki et al in the HEK cell expression system, Hv1 expressing 
oocytes exhibit inward tail currents during repolarisation (Figure 23 B). Sasaki et al and 
Ramsey et al observed that Erev shifts ~50 mV per pH unit difference between pHi and 
pHo indicating that Hv1 is acting as a proton channel considering the Nernst potential for 
protons (Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006). We did not observe 
consistent pH dependence in X. laevis oocytes expressing Hv1 (Figure 23 C), suggesting 
that Hv1 is not expressed at the surface membrane in X. laevis oocytes. Zinc, a common 
blocker for proton channels caused a flattening of the I-V curve and a shift of Erev towards 
more negative potentials. These results are not in line with observations done in HEK 
cells (Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006) and are rather induced by 
endogenous X. laevis oocyte procedures. Taken together these results suggest that Hv1 is 
not functional at the surface membrane of X. laevis oocytes and could be expressed in 
intracellular compartments. 
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Hv1 affects ENaC and ROMK currents 
Until recently the molecular identity of voltage gated proton channels was still unknown 
or rather speculative. Hv1 is the first voltage gated proton channel that was molecularly 
identified (Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006; Okamura 2007). Ten 
years ago Gekle and co-workers performed studies on Madin-Darby canine kidney 
(MDCK) cells showing that aldosterone induces a Zn2+ sensitive proton conductance, 
which is dependent on the membrane potential (Gekle, Silbernagl et al. 1997). This goes 
in line with the identification of Hv1 as an aldosterone induced gene product in our screen 
that is considered to mediate Zn2+-sensitive proton currents (Ramsey, Moran et al. 2006; 
Sasaki, Takagi et al. 2006). A large variety of cells have been reported to express voltage 
gated H+ channels including different types of mammalian epithelia (Decoursey 2003) as 
well as cultured cells like HEK-cells and MDCK cells. By performance of real-time RT 
PCR we found Hv1 endogenously expressed on the mRNA level in mpkCCDc14 cells, too 
(Figure 22). 
It has been shown that intracellular acidification reduces ENaC activity in X. laevis 
oocytes (Chalfant, Denton et al. 1999). Since ENaC currents are directly modified by 
changes of pHi but not of pHo it had been suggested that amino acids at the intracellular 
N- and C-termini of the ENaC subunits are involved in that regulation (Chalfant, Denton 
et al. 1999). Chuard and colleagues studied the reciprocal relationship between pHi and 
transepithelial Na+ transport in A6 cells and suggested that pHi mediates the dialogue 
between the apical and basolateral side of polarized epithelial cells (Chuard and Durand 
1992). The action of pHi as a regulator of Na+ transport had been reviewed by L.G. 
Palmer in 2001 (Palmer 2001). He suggested that pHi could serve as a second messenger 
for rapid effects of aldosterone (Palmer 2001). It has been proposed that aldosterone 
increases pHi via a nongenomic effect that affects the activity of the Na+/H+ exchanger 
(Oberleithner, Weigt et al. 1987; Cooper and Hunter 1996). One hypothesis is that 
aldosterone itself is regulating epithelial transport through modulation of pHi (Palmer 
2001), since alkalinisation of the intracellular compartment is supporting the Na+ and K+ 
transport (Palmer 2001). One suggested situation, in which such a regulation may make 
sense, is the occurance of metabolic stress. The excessive usage of ATP for instance by 
the Na+-K+-ATPase to support high Na+ transport can cause intracellular acidosis (Frindt, 
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Silver et al. 1995). Under these circumstances Na+ and K+ transport would be down-
regulated and therefore the cell is saved from excessive usage of metabolic resources 
(Palmer 2001).  
We investigated the function of the new identified aldosterone regulated gene product 
Hv1 on Na+ transport by coexpression of ENaC in X. laevis oocytes. Since Hv1 is an early 
aldosterone regulated gene product our expectation was that Hv1 would rather have an 
activating effect on Iamil considering that aldosterone increases the Na+ reabsorption in the 
ASDN. We hypothesised, that the local depolarisation of the apical membrane mediated 
by the Na+ transport of ENaC would favour the efflux of protons through Hv1 into the 
tubular lumen, which is in line with the observation that aldosterone increases the 
acidification of the tubular fluid in the collecting ducts (Koeppen and Helman 1982). The 
resulting local alkalinisation of the cytosol would have a stimulatory effect on ENaC 
function (Palmer 2001). This situation could be amplified by the transcriptional activation 
of Hv1 by aldosterone. An increased Hv1 abundance on the apical membrane could then 
activate ENaC function via two additive mechanisms. (1) Removing protons from the 
local environment of ENaC would be activated by the local alkalinisation (Figure 28). (2) 
The efflux of protons would counteract the depolarisation of the membrane and so favour 
the influx of positively charged Na+ ions via ENaC. This situation would basically be 
more weightily when pHo/pHi > 1 (Figure 28). 
 
Figure 28 
 
 
 
 
 
 
 
 
 
 
Figure 28: Graphic illustration of a possible mechanism by which Hv1 could increase ENaC function in the 
apical membrane of an epithelial cell. Hv1 localised close to ENaC on the apical membrane of aldosterone 
target cells could influence ENaC mediated Na+ transport. Local depolarisation of the apical membrane 
through Na+ influx mediated by ENaC causes the activation of Hv1 which mediates the efflux of protons. 
This induces local alkalinisation of the cytosol and stimulates ENaC, subsequently leading to an enhanced 
Na+ reabsorption in the ASDN. 
 
 
However, in our experiments we observed that Hv1 co-expression inhibits ENaC function 
in the oocyte expression system (Figure 25, 29). ENaC mediated currents were 
substantially decreased by Hv1 co-expression over the entire range of tested membrane 
voltages (Figure 25). Nevertheless, considering that Hv1 would mediate a proton inward 
current in the oocytes these results would be consistent with the observations that low pHi 
decreases ENaC function (Chuard and Durand 1992; Chalfant, Denton et al. 1999; 
Ramsey, Moran et al. 2006; Sasaki, Takagi et al. 2006). Since it is known that aldosterone 
action is acidifying the tubular fluid in the collecting duct it is expected that the ratio 
pHo/pHi is < 1 in the ASDN after aldosterone action. The proton gradient in this situation 
would support the influx of protons through Hv1 but the depolarized membrane potential 
would rather oppose it (Figure 29). However, a proton influx could mediate ENaC 
inhibition and therefore protect the cell from excessive Na+ uptake. However, our 
observation that ZnCl2 did not affect the inhibition of ENaC by Hv1 in X. laevis oocytes 
was then rather unexpected, since it means that Hv1 mediated inhibition of ENaC function 
is not dependent on its proton conductance (Figure 25 C). The reason for the failure to 
block Hv1 mediated ENaC inhibition by ZnCl2 application suggested that the inhibiting 
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action of Hv1 is not at the surface membrane. This latter hypothesis is coherent with the 
fact that we could not show in our experiments on X. laevis oocytes that Hv1 is indeed 
conducting protons through the plasma membrane.  
 
 
Figure 29 
 
 
 
 
Figure 29: Graphical scheme of a possible mechanism by which Hv1 would decrease ENaC function in the 
apical membrane of an epithelial cell.  ENaC action locally depolarises the membrane, Hv1 is activated and 
mediates a proton influx. This influx is permitted by the acidic pH in the extracellular fluid. ENaC function 
is shut down by the acidification of the microenvironment. 
 
 
Considering the possibilities mentioned above that imply that Hv1 would be expressed at 
the apical surface does not lead to a clarifying hypothesis as regards its potential role. 
There are pros and cons for the two possible functional mechanisms. On the one hand,  
the fact, that intracellular acidification is inhibiting ENaC function supports the results 
obtained in oocytes co-expressing ENaC if considering Hv1 mediates a proton influx and 
therefore increases at least local intracellular acidification. On the other hand, it is 
questionable why an aldosterone induced gene product could have an inhibitory effect on 
ENaC and ROMK2 decreasing the transepithelial Na+ transport in aldosterone target 
tissues. We could speculate that this mechanism is a negative regulatory feedback system 
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to protect the cell from excessive Na+ intake when the apical membrane depolarizes to a 
certain extend that is triggered by too much Na+ influx.  
Several groups reported that a decrease in pHi  also negatively affects apical and 
basolateral K+ channels that are responsible for K+ recycling in aldosterone target cells 
and therefore also are crucial players in transepithelial Na+ transport (Fakler, Schultz et al. 
1996; Urbach, Van Kerkhove et al. 1996; Choe, Zhou et al. 1997). Considering that Hv1 
is acidifying the microenvironment inside the oocyte by conducting protons, our 
observation that Hv1 co-expression decreases ROMK2 mediated K+ currents is consistent 
with these studies. Considering that several researchers already proposed that intracellular 
pH acts as a second messenger system (Gekle, Silbernagl et al. 1997; Palmer 2001), Hv1 
could mediate the translation of changes in membrane potentials into intracellular signals 
(in this case pH) that are able to regulate specific target proteins. 
A third possible mechanism of action for the regulation of ENaC or ROMK2 by Hv1 
could be a direct interaction between the two molecules. Changes in transmembrane 
voltages could induce intra-molecular movements within Hv1. These movements could 
directly impact on the modulation of ENaC function based on the model of voltage gated 
K+ channel regulation (Jiang, Ruta et al. 2003).  The fact that Hv1 was shown to be 
expressed at the apical pole of principal cells is a first sign that ENaC and Hv1 could be 
expressed in close proximity in vivo. Whether ENaC directly interacts with Hv1 has to be 
investigated by co-immunoprecipitation.  
Nevertheless, the decrease of ENaC and ROMK2 function by Hv1 co-expression can also 
be due to artefacts that occur in the X. laevis oocyte expression system.  
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7 Future perspectives 
Usp2-45 
Usp2-45 is a new aldosterone regulated gene product that we have shown to 
deubiquitylate ENaC. Its action on the regulation of Na+ conductance was documented in 
over-expression systems such as X. laevis oocytes and mammalian cell lines. The next 
logical question is therefore whether ENaC is an Usp2-45 in vivo target as well. To 
address this question it is important to examine the localization of Usp2-45 in vivo. Our 
hypothesis and expectation would be that Usp2-45 co-localizes with ENaC in aldosterone 
target cells in the mouse kidney. ENaC is not only present at the plasma membrane but 
also located in intracellular compartments. Aldosterone induces ENaC translocation from 
the intracellular compartment towards the plasma membrane (Loffing, Zecevic et al. 
2001). One important question is at which point of trafficking Usp2-45 co-localizes with 
ENaC. Knowledge on this particular point would suggest at what level deubiquitylation 
takes place. It appears possible that Usp2-45 deubiquitylates ENaC directly at the plasma 
membrane. It is also possible that deubiquitylation takes place at the level of intracellular 
transport vesicles, for instance in early endosomes.  
The exact molecular mechanism of the deubiquitylation of ENaC is not yet fully clarified. 
One suggestion is that Usp2-45 acts as a single protein on ENaC but it is also imaginable 
that Usp2-45 interacts with Nedd4-2 (the ubiquitin specific ligase acting on ENaC) or 
other proteins to deubiquitylate ENaC. An elegant way to show an interaction between 
Usp2-45 and possible partners would be a co-crystallization. Current investigations aim 
towards the structural clarification of Usp2-45 with and without possible interacting 
partners. The result could give more information about a specific site of interaction on 
Usp2-45 which might be crucial for its substrate specificity. A very important aspect is 
whether Usp2-45 has a physiologically relevant effect on aldosterone regulated Na+ 
reabsorption, a question that could be tested on an Usp2-45 knock out mouse model.  
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Usp53 
Transcription of Usp53 was found to be significantly up-regulated by aldosterone. 
However, functional investigations did not show a significant impact of its expression on 
Na+ transport molecules in X. laevis oocytes. A possibly useful other approach would be 
to do further tests on differentiated distal nephron cell cultures, for instance cultured 
mpkCCDc14 cells, that over-express Usp53. It would be of particular interest to detect its 
subcellular localization in a cell line as well as in vivo. Functional studies with 
mammalian cell lines, including Usp53 knockdowns, would give more information on the 
functional role of Usp53 in the regulation of transepithelial Na+ transport.  
 
Hv1 
The most exciting finding concerning Hv1 was certainly that this voltage gated proton 
channel inhibits ENaC function in X. laevis oocytes despite the fact that it was found to be 
induced by aldosterone. Until now it could not be clarified whether Hv1 reduces ENaC 
function by influencing its surface expression or its open probability at the plasma 
membrane. Therefore future experiments could aim to visualize possible changes in 
ENaC surface expression in oocytes co-expressing Hv1. So far it is still unknown which 
mechanism could underlie the inhibitory action of Hv1 on ENaC and ROMK2. In this 
respect it would be crucial to investigate a possible interaction between Hv1and ENaC or 
ROMK2. The hypothesis that Hv1 could inhibit ENaC function by modulation of the 
intracellular proton concentration has not been tested yet, since it is not possible to control 
the intracellular pH within the oocytes. In this respect a cut open oocyte system would be 
a useful tool for having access to the cytosolic side of the oocyte and to apply defined 
conditions to it. By mutating specific amino acid residues within the Hv1 protein the 
mechanism of ENaC regulation could be uncovered in an elegant way.  
 
Hv1 expression was detected in the ASDN by real-time RT PCR and our 
immunofluorescence data suggest that Hv1 protein is expressed in the apical pole of 
principal cells in the CD. Nevertheless, these results did not give clear enough 
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information on the exact subcellular localization. Investigations aiming to identify the 
subcellular protein localization in cultured kidney cells would be necessary to show 
whether and where the proton channel co-localizes with ENaC or ROMK2. Knowing the 
precise localization also could give additional information about the mechanism of ENaC 
and ROMK2 modulation. Co-localization of ENaC and Hv1 in intracellular vesicles for 
instance would confute the regulation of ENaC open probability by Hv1.  
Since the experiments I have performed in X. laevis oocyte expression system were 
essentially of electrophysiological nature, alternative mechanisms leading to ENaC and 
ROMK2 inhibition involving rather intracellular effects possibly also independent of a 
proton conductance are not excluded. To address this question, cell biological 
experiments, in particular of subcellular localization should be performed. Possibly 
however the X. laevis oocytes over-expression system is not an optimal system to 
reconstitute the role of a proton conductance in the aldosterone-regulated Na+ 
reabsorption and K+ secrection. Alternative in vitro systems are for instance HEK cells in 
which exogenous surface-expression of Hv1 was successful (Ramsey, Moran et al. 2006; 
Sasaki, Takagi et al. 2006) or a cell line such as mpkCCDc14 cells that express a polarized 
CCD principal cell type Na+ transport. 
Finally, an Hv1 knockout mouse model would be crucial to obtain information about the 
physiological role of Hv1 in the context of aldosterone regulated salt reabsorption in the 
kidney and therefore blood pressure maintenance.  
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